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Lay Summary of Thesis 
 
Respiratory viruses are a leading cause of chest infections (pneumonia and bronchiolitis) in young 
children. The global burden of disease due to chest infections related to seasonal influenza virus 
(influenza) in children is unknown. This thesis aims to estimate the hospital admissions and deaths 
due to influenza related chest infections worldwide in children younger than five years. This thesis 
also aims to provide tools for estimating influenza disease burden using data from sentinel 
surveillance for hospital admissions for chest infections in developing country settings. 
The thesis has used data from systematic review of studies published between January 1995 and 
December 2011 supplemented by unpublished data from two research consortia of 15 and 24 sites 
based primarily in developing countries to estimate the disease burden due to influenza related chest 
infections in children younger than 5 years.  
The thesis estimates that approximately 1 million children younger than 5 years were hospitalised 
worldwide in 2008 for influenza related chest infections. The rate of infection was highest in children 
younger than 6 months. Furthermore, influenza related chest infections resulted in about 21,500 
(based on 20 studies) to 115,000 deaths (based on only 1 study) in under-five children that year. The 
hospitalizations and deaths varied substantially from year to year in any one setting. The disease 
burden was disproportionately higher in children residing in developing countries (where 90 percent 
of global under-five population reside) which accounted for 93 percent of all hospitalizations and 99 
percent of all influenza related deaths. There are significant gaps in data (particularly mortality 
related data) from developing countries (especially in the Middle East and Africa).  
Influenza related chest infections are common in young children and result in a substantial burden on 
hospital inpatient services worldwide. Influenza contributes to about 8 percent of all hospitalisations 
and about 7 percent of all deaths due to chest infections in children younger than 5 years. Sufficient 
data to precisely estimate the role of influenza in childhood mortality from ALRI are not presently 
available. Effective use of sentinel surveillance data for disease burden estimation would greatly 
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Abstract 
Background 
Respiratory viruses are a leading cause of acute lower respiratory infections (ALRI) 
in young children. The role of seasonal influenza virus in childhood ALRI is 
generally underappreciated. This is because the global burden of disease due to ALRI 
attributable to seasonal influenza virus in children is unknown. This thesis aims to 
estimate the global and regional hospital admissions for seasonal influenza-
associated ALRI and the possible boundaries for influenza-associated ALRI 
mortality in children younger than five years. The WHO has developed guidelines 
for influenza surveillance using severe acute respiratory infections (SARI) sentinel 
surveillance network. However, data from sentinel surveillance are not routinely 
used in estimating disease burden in a population. This thesis also aims to provide 
tools for estimating influenza disease burden using data from SARI sentinel 
surveillance in developing country settings. 
Methods 
Incidence data for influenza-associated ALRI (from passive, hospital-based studies) 
were collected using a systematic review of studies published between January 1, 
1995 and October 31, 2010. These data were supplemented by unpublished data from 
15 population-based studies that were obtained by forming a consortium of 
researchers (Influenza Study Group) working in developing countries. The incidence 
meta-estimates were applied to global and regional population estimates for 2008 to 
calculate the estimated number of hospitalised influenza-associated ALRI cases that 
year. The possible bounds for influenza-associated mortality were estimated by 
combining incidence estimates with in-hospital case fatality ratios and identifying 
studies with population-based data for influenza seasonality and monthly ALRI 
mortality.  
The data to estimate the incidence of all-cause hospitalised ALRI were collected 
using a systematic literature review that was supplemented with unpublished data 
from 24 population-based studies that were obtained by collaborating with research 
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sites in developing countries (Severe ALRI Working Group). The hospitalised ALRI 
incidence meta-estimates were applied to global and regional population estimates 
for 2008 to calculate the estimated number of all-cause hospitalised ALRI cases that 
year. Data on the proportion of hospitalised ALRI cases that were positive for 
influenza were collected using a systematic review of the studies published between 
January 1, 1995 and December 31, 2011. The meta-estimates of the proportion of 
hospitalised ALRI cases positive for influenza were applied to the estimated number 
of hospitalised ALRI cases in the year 2008 to estimate the number of hospitalised 
influenza-associated ALRI cases globally and for the six WHO regions using this 
alternative method.  
The tools for estimating influenza disease burden using surveillance data were 
developed after a literature review and a survey of 27 end-users (influenza 
epidemiologists) in 24 countries.  
Results 
Thirty nine studies (21 from developing and 18 from industrialised regions) 
satisfying the eligibility criteria, provided data on the incidence of influenza-
associated hospitalised ALRI. The incidence is highest in infants in the first six 
months of life, both in developing as well as industrialised countries. It is estimated 
that the incidence of hospitalised influenza-associated ALRI in children under the 
age of five years was about 1.5 (95% CI 1.0 to 2.3) and 1.2 (95% CI 0.9 to 1.6) per 
1000 children in developing and industrialised countries respectively. This translates 
to about 911,000 (95% CI 617,000 to 1.4 million) hospitalisations worldwide due to 
influenza-associated ALRI in children younger than five years in 2008, 93% of the 
cases occurring in developing countries (where 90% of the global under-5 population 
reside). An estimated 21,500 (based on 20 studies) to 115,000 deaths (based on only 
1 study) in under-five children were attributable to influenza-associated ALRI in 
2008. Incidence and mortality varied substantially from year to year in any one 
setting. 
Eighty five studies (61 from developing and 24 from industrialised) reported 
incidence of hospitalised ALRI in children aged 0 to 4 years. It is estimated that 
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about 11.3 (95% CI 9.5 to 13.5) million episodes of ALRI resulting in hospitalisation 
occurred worldwide in children aged 0 to 4 years in 2008, 92% of these occurring in 
developing countries. Twenty three studies (19 from developing and 4 from 
industrialised) reported data on proportion of hospitalised ALRI cases testing 
positive for influenza using laboratory tests. The estimated proportion of influenza-
positive hospitalised ALRI cases was about 5.0 (95% CI 3.6 to 7) percent and 8.4 
(95% CI 4.2 to 16.7) percent in developing and industrialised countries respectively. 
This translates to about 772,000 (95% CI 343,000 to 1.8 million) cases of influenza-
associated hospitalised ALRI in children younger than five years worldwide in the 
year 2008.  
A manual (targeted at developing countries) describing the methods to estimate the 
disease burden associated with seasonal influenza using the various surveillance data 
was developed after considering the results of the preliminary survey. An electronic 
tool (based on a spread sheet model) to help the end-users (epidemiologists at 
sentinel surveillance sites and Ministries of Health) to estimate the disease burden at 
local and national levels was developed as an adjunct to the manual. The manual 
along with the electronic tool were piloted at three different sites in two developing 
countries (India and Ghana) and feedback from the end-users was obtained to make 
the version more user-friendly. The final draft of the manual along with the tool has 
been submitted to the WHO for final clearance. The member states and the WHO 
Eastern Mediterranean Regional Office decided to adopt the manual and in the first 
instance estimate the influenza disease burden in 8 member states having the 
requisite data for undertaking disease burden estimation. 
Conclusions 
Influenza is a common pathogen identified in children with ALRI and results in a 
substantial burden on hospital inpatient services worldwide. There are significant 
gaps in published data from developing countries (especially the African and Eastern 
Mediterranean regions of the WHO).  Sufficient data to precisely estimate the role of 
influenza in childhood mortality from ALRI are not presently available. Effective use 
of sentinel surveillance data for disease burden estimation would greatly improve the 
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quality and precision of disease burden estimates (especially those resulting in 
hospitalisation). Improved disease burden estimates (particularly at the national 
level) would inform policy makers and national governments in formulating 
immunization policies for vaccinating high-risk groups, and planning annual 
requirements for vaccines and anti-viral drugs against seasonal influenza. 
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Chapter 1. Introduction 
1.1. Acute lower respiratory infections 
Acute lower respiratory infections (ALRI) comprising mostly clinical pneumonia and 
bronchiolitis are the leading cause of morbidity and mortality in young children. 
Rudan and colleagues estimated that globally 156 million new episodes of ALRI 
occurred in the year 2000 of which 151 million (about 97%) were in developing 
countries (Rudan et al., 2008). It is estimated that approximately 1.57 and 1.39 
million children died as a result of ALRI in the year 2008 and 2010 respectively, 99 
per cent of these in developing countries (Liu et al., 2012, Black et al., 2010). ALRI 
disease burden is disproportionately high in developing countries where 90% of the 
global under-five population lives. Presently, there are no systematically established 
global estimates of the incidence of severe ALRI (hospitalised or otherwise) in 
children less than 5 years of age. The best estimates are those by Rudan and 
colleagues (based on six studies) which indicate that 6 to 12% of all ALRI cases may 
progress to severe disease and require hospitalization (Rudan et al., 2004). 
The three major causal agents of ALRI in young children (28 days – 59 months) are 
Steptococcus pneumoniae, Haemophilus influenzae type B (HiB) and Respiratory 
Syncytial Virus (RSV). Viral aetiologies are responsible for the majority of episodes 
of ALRI. Steptococcus pneumoniae and HiB, the leading bacterial causes are 
together estimated to be responsible for 13% and 27% of all ALRI and severe ALRI 
episodes respectively; and 50% of ALRI associated mortality in children below the 
age of 5 years (O'Brien et al., 2009, Watt et al., 2009). Published studies have shown 
that RSV is the most important viral pathogen isolated in ALRI cases worldwide 
(Weber et al., 1998, Simoes, 1999) although there were no precise RSV-associated 
ALRI global burden estimates prior to the start of this doctoral thesis. In order to 
pilot the methods for data collection and analysis used for this thesis, an RSV Study 
Group (comprising investigators from developing countries) was established. A 
systematic review of published literature along with unpublished data from the RSV 
Study Group indicate that about 22% and 30% of all ALRI and severe ALRI 
episodes respectively; and 3 to 9% of all ALRI deaths in children aged below five 
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years are attributable to RSV (Nair et al., 2010). Thus, RSV is the single largest 
cause of ALRI in young children.  
Among viral aetiologies, apart from RSV, seasonal influenza viruses (type A and B), 
human metapneumovirus (hMPV), parainfluenza viruses (type 1, 2 and 3), and 
adenovirus have been found to be other important causes of childhood ALRI 
(Straliotto et al., 2002, Karaivanova, 1995, Kusel et al., 2006, Graham, 1990). It is 
now generally believed that a substantial proportion of ALRI in children are mixed 
infections (a combination of viral or mixed viral-bacterial infections). This evidence 
of mixed viral-bacterial infection has been recorded in up to 45% of cases of 
community-acquired pneumonia in children (Lahti et al., 2009, Juven et al., 2000, 
Tsolia et al., 2004, Cilla et al., 2008, Hamano-Hasegawa et al., 2008, Nascimento-
Carvalho et al., 2008, Samransamruajkit et al., 2008, Cevey-Macherel et al., 2009, 
Wolf et al., 2010). Not surprisingly, the most common combination in mixed viral 
bacterial infections is that of Streptococcus pneumoniae with various respiratory 
viruses. In a study from the Gambia, 33% of children with pneumococcal pneumonia 
also had evidence of a respiratory virus infection diagnosed using viral culture or 
serologic tests (Forgie et al., 1991). Johnson and colleagues demonstrated in a study 
from Nigeria that about 16% of all community-acquired pneumonia cases were 
mixed viral bacterial in origin. (Johnson et al., 2008).  
Over the past decade, Haemophilus influenzae type B (HiB) and pneumococcal 
conjugate vaccines (PCV) have been introduced into immunisation programmes in 
developing countries. It is generally believed that as the coverage of these vaccines 
increases, the relative proportion of respiratory viruses as causes of childhood ALRI 
will increase. Additionally, it is very likely that the landscape of bacterial pathogens 
will change due to replacement by non-vaccine serotypes in PCV vaccinated 
population. The emergence of severe acute respiratory syndrome (SARS), avian 
influenza A (H5N1), and influenza A (H1N1)pdm09 has re-emphasised the 
important role of respiratory viruses as contributors to severe ALRI. New respiratory 
viruses such as human metapneumovirus, corona viruses NL 63 and HKU1, and 
human boca virus have been discovered during the past decade. In the next few 
years, the focus of international scientific community, agencies like the Bill and 
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Melinda Gates Foundation and the World Health Organization is increasingly likely 
to be on viral bacterial interactions and the synergistic effect introduction of a 
vaccine against viral pathogens (e.g. influenza vaccine) would have on pneumonia 
disease burden reduction in the presence of a sustained high coverage for 
Haemophilus influenzae type B and pneumococcal conjugate vaccines in developing 
countries. 
Influenza has long been considered as a disease of the elderly because of the high 
incidence, hospitalisation and mortality rates in those over 60 years of age (Iskander 
et al., 2007). It was considered to be serious only in those children with underlying 
chronic medical conditions who were at a higher risk of developing complications. 
However, studies over the past decade have shown that the burden of disease due to 
influenza in healthy young children is as much as in the elderly if not more 
(Thompson et al., 2004, Brotherton et al., 2004, Neuzil et al., 2002, Poehling et al., 
2006). Moreover, the incidence rates for influenza in childhood are inversely related 
to the age of the child, the rate being highest in infants in the first year of life 
(Poehling et al., 2006, Moore et al., 2006). Brotherton and colleagues estimated that 
in Australia influenza-associated mortality rate in children is only one-tenth of those 
aged over 60 years (0.1 compared with 1.1 per 100000) (Brotherton et al., 2004). 
Presently, there are no estimates of the global incidence and mortality due to 
seasonal influenza-associated ALRI in young children. 
1.2. Influenza virus 
Influenza viruses belong to the family orthomyxoviridae and are classified as A, B or 
C. They are negative sense single stranded RNA viruses that contain 8 separate gene 
segments of RNA. The segmented nature of the genome is important because it 
allows genetic re-assortment, a process by which different influenza viruses co-
infecting the same host cell can exchange genes, resulting in progeny viruses 
containing genes from both parent viruses. Influenza A and B viruses are responsible 
for seasonal epidemics of what we generally think of as influenza illness, while 
influenza C viruses cause sporadic cases of mild common cold-like illness. Influenza 
A viruses are further categorized into subtypes (e.g. H1N1 or H3N2) on the basis of 
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surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA) (Figure 1). 
While antigenically distinct B strains are currently circulating globally, these are not 
different enough from each other genetically to be called subtypes.  Influenza B 
viruses are rather currently grouped into two lineages (Victoria and Yamagata) but 
not sub-typed. Influenza A viruses circulate among a diverse range of host species, 
including birds, swine, horses and humans but B viruses only infect humans. The 
large pool of genetically distinct influenza A viruses circulating among animal 
species serves as a source of “novel” viruses to which humans have little or no 
immunity. The introduction of these viruses into human populations is responsible 
for periodic worldwide influenza pandemics. At the level of individual patients both 




Figure 1: Diagrammatic representation of the human influenza virus 
Pandemic influenza refers to a global epidemic of influenza that occurs when an 
influenza A virus bearing novel HA or HA/NA combination emerges and spreads. 
Four influenza pandemics have occurred in the past century, the most recent being in 
2009-10 (Figure 2). The first pandemic of the twentieth century occurred in 1918-19, 
with the emergence and spread of influenza A(H1N1), or “Spanish flu” which 
resulted in more than 20 million deaths worldwide , more than the total casualties of 
World War I. In 1957-58, the emergence of influenza A (H2N2) led to a pandemic of 
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“Asian flu”. The third pandemic occurred in 1968-69 in association with the 
emergence of influenza A (H3N2), or “Hong Kong flu”. The fourth and most recent 
pandemic occurred with the emergence of influenza A(H1N1)pdm09 or “swine flu” .  
   
 
 
Figure 2: Influenza pandemics since 1900 
 
Antigenic change is one of the hallmarks of influenza viruses and occurs through one 
of two distinct mechanisms:  antigenic drift and antigenic shift. Antigenic drift refers 
to a process by which point mutations in the RNA genome of influenza virus result in 
antigenic variants. When these changes result in a survival advantage for the virus, 
the new antigenic variant can become the predominant circulating strain. As an 
increasing number of individuals within the population develop antibody against the 
new circulating strain, selective pressure favours the emergence of one of the variant 
strains, which then becomes the next predominant strain in an on-going global 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
Introduction  6 
process. Each new antigenic strain typically predominates in circulation for a few 
years before it is displaced by the next emerging strain.  
Antigenic shift resulting in a global pandemic occurs by one of the two mechanisms:  
genetic re-assortment between animal and human influenza viruses; or a direct jump 
from animal species to humans of a virus that has acquired the ability to easily spread 
from human-to-human. In the former, genetic re-assortment can occur if a suitable 
host such as swine is co-infected by both human and non-human (animal) influenza 
viruses allowing the two viruses to intermingle their genetic material. This 
mechanism appears to have resulted in the 1957 influenza A(H2N2), 1968 influenza 
A(H3N2),  and influenza A(H1N1)pdm09 pandemic viruses. The second mechanism 
is less well understood but likely occurs when animal influenza viruses that generally 
do not infect humans develop mutations that allow them to more easily infect 
humans. Antigenic shift occurs relatively infrequently. It is as yet not very clear if 
the 1918 influenza A (H1N1) pandemic virus was a genetic re-assortment or an 
adaptive mutation of hitherto avian influenza virus (Gibbs and Gibbs, 2006, 
Taubenberger et al., 2005).   
1.1.1. 2009 Influenza pandemic 
The first pandemic of this century occurred with the emergence of influenza 
A(H1N1)pdm09 or “swine flu” with the US Centers for Disease Control and 
Prevention (CDC) reporting the detection of two cases in children in Southern 
California, USA on April 21, 2009. The pandemic may have begun sometime earlier 
in March when health authorities in Mexico started detecting a surge in influenza like 
illness (ILI) in the country, later confirmed to be caused by the same virus detected 
by the CDC. Over the next couple of weeks, the pandemic which started in North 
America spread rapidly across the world. Two hundred and fourteen countries from 
all over the world reported laboratory confirmed cases of influenza A(H1N1)pdm09 
to WHO (WHO, 2010). During the pandemic period (21 April 2009-10 August 
2010), around 18500 deaths were reported to have been caused by this disease. This 
is likely to be a gross underestimation as diagnostic specimens are not always 
collected from fatal cases and viruses might no longer be detectable by the time of 
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hospital admission/death in some people. Dawood and colleagues estimate that 
globally there were over 200,000 respiratory deaths (range 106,000 to 396,000) and 
an additional 83,000 cardiovascular deaths (range 46,000 to 180,000) associated with 
influenza A(H1N1)pdm09 (Dawood et al., 2012). Presently, there are no reliable 
estimates of the global incidence of influenza A(H1N1)pdm09 associated respiratory 
infections in children or of the excess burden of disease due to the pandemic virus 
over the seasonal influenza virus during this period. 
 
1.2. Laboratory diagnosis of influenza 
A presumptive diagnosis of influenza can be confirmed by one of the four 
approaches: virus isolation, detection of viral proteins, detection of viral RNA, or 
serological diagnosis. In children (and in adults), influenza virus is isolated most 
often from respiratory secretions that are obtained by nasal swab, throat swab, or 
nasal aspirate within the first few days of illness. In young children, viral titres are 
higher and viral shedding may continue for several more days than in adults. Viral 
culture is considered to be the “gold standard” because it has high specificity and 
high sensitivity, although the sensitivity is lower than with Polymerase Chain 
Reaction (PCR) assay. Specimens should be transported to the laboratory using a 
transport media and on wet ice and inoculated into eggs or tissue culture (including 
Madin-Darby Canine Kidney (MDCK) Cells and primary Rhesus monkey kidney 
(RMK) cells). Virus can be detected from cell culture from about two thirds of 
infected patients within three days (of inoculation) and almost all with positive 
specimens in fewer than seven days. The technique is time consuming, expensive 
and requires special handling all of which limit its use in routine clinical settings. 
One of the important advances in influenza diagnosis is the introduction of rapid 
diagnostic assays (Cox and Subbarao, 1999). The expression of viral antigens can be 
detected by immunofluorescence within 24 to 48 hours after infection (Espy et al., 
1986). Tests for influenza antigens on exfoliated nasopharyngeal cells using direct or 
indirect immunofluorescence have shown variable sensitivity (40-100%) and 
specificity (86-99%) (Rawlinson et al., 2004) (Table 1) . Several rapid diagnostic kits 
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that rely on immunoassay or detection of viral nucleic acid using PCR assay are 
commercially available (Table 1). These rapid diagnostic kits can be used for point-
of-care testing and can provide a result within 30 minutes. PCR based assays offer 
high sensitivity and specificity, although contamination of specimens is a concern 
(Stockton et al., 1998) (Table 1). The optimal use of rapid diagnostic assays in the 
clinical setting is a point of concern mainly because it is still not practical to test all 
patients and that too within the first 48 hours of onset of illness mainly because of 
cost involved and poor access to care especially in developing countries.  
Table 1: Comparison of the sensitivity and specificity of various diagnostic assays 
against viral culture (gold standard) 
Diagnostic Assay Sensitivity (%) Specificity (%) 
Reverse Transcriptase Polymerase Chain 
Reaction (RT-PCR) (Templeton et al., 
2004)  
100-110 * 93 
Direct immunofluorescence (DFA) (Mahony, 
2008) 
70-100 80-100 
Indirect immunofluorescence (IFA) 
(Rawlinson et al., 2004) 
90-100 100 
Enzyme-linked Immunoassay (EIA) 
(Mahony, 2008)  
70-75 90-95 
Rapid Point of Care (POC) Tests  
Quickvue / Directigen (Grijalva et al., 2007a, 





                                                 
* Sensitivity has been computed using viral culture as gold standard. If more samples test positive for 
seasonal influenza using RT-PCR compared to when simultaneously tested using viral culture, the 
sensitivity for RT-PCR based test will exceed 100% 
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Diagnostic Assay Sensitivity (%) Specificity (%) 
Z-stat Flu (Rawlinson et al., 2004) 65-77 77-97 
  
The US CDC has introduced the Taqman Array Card (TAC) across its field sites 
globally after the 2009 influenza pandemic (Fields, personal communication). The 
premise of TAC is to be able to test for multiple pathogens from a single specimen; 
at this point only respiratory specimens have been used. This offers a significant 
advantage when specimen volumes are minimal; and also decreases the costs and 
turnaround time for results. Currently, the utility of TAC is being assessed at 
International Emerging Infections Program (IEIP) field sites along with National 
Influenza Centres (NIC) in developing countries. TAC has high sensitivity and 
specificity in general though this varies with pathogen (Table 2). The widespread use 
of TAC can help understand the aetiology of acute lower respiratory infections 
especially those that are viral in origin and also estimate the burden of co-infections. 
  
Table 2: Sensitivity and specificity of Taqman Array Cards (TAC) specific pathogen 
assays compared to individual qPCR assays using a Ct † cut-off value of 43 in 
nasopharyngeal / oropharyngeal swabs 
Target Sensitivity (95% CI) Specificity (95% CI) 
Influenza A 92 (80 to 100)% 99 (96 to 100)% 
Influenza A – H1 100 (100 to 100)% 100 (100 to 100)% 
Influenza A – H3 83 (65 to 100)% 99 (96 to 100) % 
Influenza B 100 (76 to 100)% 100 (100 to 100)% 
                                                 
† A cycle threshold (Ct) (the PCR cycle where the fluorescent signal exceeds that of the threshold 
value) <43 was scored as a positive result 
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Target Sensitivity (95% CI) Specificity (95% CI) 
Respiratory syncytial virus 100 (100 to 100)% 97 (94 to 100)% 
Human parainfluenza virus 
(Type1) 
100 (100 to 100)% 100 (100 to 100)% 
Human parainfluenza virus 
(type 2) 
79 (55 to 100)% 96 (92 to 100)% 
Human parainfluenza virus 
(type 3) 
95 (86 to 100)% 100 (100 to 100)% 
Human metapneumovirus 95 (85 to 100)% 99 (96 to 100)% 
Rhinovirus 98 (93 to 100)% 91 (84 to 97)% 
Enterovirus 100 (100 to 100)% 92 (86 to 98)% 
Human paraechovirus 100 (100 to 100)% 100 (100 to 100)% 
Adenovirus 97 (90 to 100)% 100 (100 to 100)% 
 
In spite of the emerging popularity of rapid diagnostic tests, viral culture remains 
important because the characterization of viral isolates yields more genetic data than 
any other technique, and the information provided is critical for annually updating 
the influenza vaccine and for identifying the potential pandemic viruses. Another 
technique, which was popular until the early 1990s is serologic diagnosis of 
influenza which requires demonstration of a four-fold or greater increase in antibody 
titre between paired acute and convalescent sera obtained at least 2 weeks apart. 
Measurement of antibody titre in a single sample is of limited value except in cases 
where infection with a novel influenza virus is in question (Rennels et al., 2002). 
Measurements of haemagglutination inhibition (HAI) antibodies are used most 
commonly for serology, although complement fixation testing is also used. Presently, 
serologic diagnoses are only used in epidemiologic studies.  
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1.3. Natural history of disease 
Influenza infection in children can manifest itself in varied presentations (Figure 3). 
It commonly presents as a mild “influenza like illness” in which case patients may 
complain only of fever, myalgia, malaise, headache and sometimes vomiting and 
diarrhoea. In children, it could also present or progress to an upper respiratory 
infection (URI) presenting with non-productive cough, rhinitis and sore throat. In 
infants, rhinitis may be the only respiratory manifestation of the disease. One of the 
important complications of influenza-associated URI is acute otitis media (AOM) 
(Heikkinen et al., 1999, Chonmaitree et al., 2008). It is estimated that 3 to 5 per cent 
of children experience influenza-associated AOM annually (Neuzil et al., 2002, 
Ruuskanen et al., 1989). In some cases it can also result in acute 
laryngotracheobronchitis (Croup) (Principi et al., 2004). Influenza infection can also 
lead to viral pneumonia and less commonly bronchiolitis (both of which constitute 
ALRI). Typically the course of influenza-associated ALRI progresses over a few 
days with worsening of the symptoms. Influenza-associated ALRI can be 
complicated by secondary bacterial pneumonia, usually attributable to Streptococcus 
pneumoniae and occasionally caused by Staphylococcus aureus or Streptococcus 
pyogenes (Klugman et al., 2009, O'Brien et al., 2000, Reed et al., 2009, van der 
Sluijs et al., 2010), although in children S pneumoniae is by far the commonest 
cause.  Secondary bacterial pneumonia has been responsible for majority of deaths in 
all age groups during the 1918 and 1957 influenza pandemics. This secondary 
bacterial pneumonia generally occurs after a period of improvement of the primary 
illness with recrudescence of fever associated with symptoms of pneumonia. Thus, a 
10 to 30 per cent increase in the number of antimicrobial courses prescribed to 
children in a defined study population in the US has been recorded during the 
influenza season (Neuzil et al., 2000). Influenza-associated illness may be 
complicated infrequently by cardiopulmonary complications like myocarditis (Coffin 
et al., 2007), and exacerbation of asthma. (Miller et al., 2008); neurological 
complications like Guillain-Barre Syndrome (Tam et al., 2006, Sivadon-Tardy et al., 
2009, Sivadon-Tardy et al., 2006), febrile seizures (Chiu et al., 2001, Lester-Smith et 
al., 2009), transverse myelitis,  postinfectious encephalitis and encephalopathy 
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including Reye’s Syndrome (Togashi et al., 2004, Kasai et al., 2000, Morishima et 
al., 2002, Okabe et al., 2000).  It has also been rarely associated with myoglobinuria 
accompanying myositis rarely progressing on to renal failure (Lester-Smith et al., 
2009, Buss et al., 2009)- more commonly seen after an infection of influenza B 
rather than influenza A.  
 
Figure 3:  Natural history of disease due to influenza virus infection in children 
Viral pneumonia (particularly those associated with a secondary bacterial 
pneumonia) have a high mortality rate (Rennels et al., 2002). However, available 
literature from industrialised countries seems to suggest that the case fatality ratio 
(CFR) and the absolute number of deaths attributable to influenza is higher in elderly 
population (aged above 65 years) than in young children. The CFR in US  children 
has been estimated to be about 3.8 per 100,000 cases (Glezen, 1996). However, this 
is likely to be much higher in developing countries where access to and quality of 
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hospital care is generally limited and variable.  Post influenza encephalitis or 
encephalopathy has a high CFR and survivors are often severely neurologically 
damaged. Since 1994, more than 200 cases of severe, acute necrotizing 
encephalopathy associated with influenza infection have been reported in young 
Japanese children (Kasai et al., 2000, Morishima et al., 2002, Togashi et al., 2004). 
However, a causal relationship has not yet been established.  
1.4. Current influenza disease burden estimates 
(modelling approaches) 
 Estimating the burden of influenza on hospitalizations and deaths is very 
challenging.  Severe clinical outcomes are often caused by secondary bacterial 
infections or exacerbation of underlying chronic conditions and the primary infection 
may be unrecognised. Additionally laboratory confirmation of influenza infection is 
rarely conducted (Viboud et al., 2006). As a result, most influenza related 
hospitalizations and deaths are not attributed to influenza on discharge forms and 
deaths, thus necessitating the use of statistical models to assess the true burden of 
influenza on health. Traditionally, for temperate countries, estimates of the impact of 
a particular influenza epidemic relied on two approaches- either the comparative 
method or the Serfling method. The former is based on identifying periods without 
influenza activity to generate a model of expected winter baseline deaths (or cases) 
which then is used to estimate the excess deaths or excess cases by either subtracting 
this baseline from the observed number of deaths or hospitalisations during influenza 
epidemics (Collins et al., 1930, Simonsen et al., 1998). The latter on the other hand, 
is based on setting a baseline for excess number of events by fitting a linear 
regression function to the data of the period assumed to have low virus circulation 
(Serfling, 1963, Simonsen et al., 2005). One major limitation of both these methods 
is that a number of respiratory viruses like RSV and hMPV co-circulate during the 
influenza season and a large proportion of ILIs may in fact be caused by these 
viruses. Extremes of temperature, especially cold spells, that are likely to cause 
substantial mortality, is an important confounder in these syndromic surveillance 
models (Donaldson and Keatinge, 2002). The US CDC developed a Poisson 
regression model to simultaneously estimate both age-specific influenza subtype-
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specific mortality as well as RSV-associated mortality (Thompson et al., 2003) in the 
United States. Instead of using the observed numbers of deaths and excess deaths to 
define influenza epidemics, data from virological surveillance were used and excess 
mortality was calculated as the difference between the expected values when the 
observed proportion of virus isolations is fitted and the values when no virus 
circulation is assumed. In this approach the errors introduced by subjectively 
defining periods of high and low influenza virus activity can be minimized. A 
modification of the model was developed to provide estimates of influenza-
associated hospitalizations in the United States (Thompson et al., 2004). The key 
assumptions, strengths and limitations of these approaches are outlined in Table 3.
 
Table 3: Key features of the common statistical modelling approaches to estimate influenza disease burden  
Modelling 
approach 
Data used Assumptions Strengths Limitations 
     
Comparative  Weekly, monthly or 
annual time-series 
of mortality 
 Months or years without 
influenza activity are 
considered baseline (e.g. peri-
influenza period, right before 
influenza activity starts, can 
be used as baseline) 
 Influenza attributable deaths= 
deaths during the epidemic 
period minus deaths during 
baseline periods  
Extremely simple  Need to identify baseline period prior to 
modelling 
 Imprecise, especially if annual data are 
used and has a tendency to 
underestimate influenza burden 
     
Serfling Monthly or weekly 
time-series of 
mortality 
 Periods without influenza 
activity are used to generate a 
model baseline of expected 
winter deaths 
 Fits a seasonal regression to 
deaths in non-influenza 
periods 
 Impact of a particular 
influenza epidemic is 
estimated as the number of 
excess deaths above a seasonal 
baseline 
 Assumes that the seasonal 
baseline accounts for the 
 Does not require virological 
data where seasonality of 
influenza virus has been 
previously documented 
 Adjusts for the impact of 
non-influenza respiratory 
viruses through seasonal 
baseline 
 Need to identify baseline period prior to 
modelling 
 Not suited to studying disease burden of 
seasonal influenza in tropics where there 
is no well demarcated influenza season 
 RSV activity is known to vary annually 
and is not suited to estimate influenza 
morbidity and mortality in young 
children (<5 years) where the burden of 
RSV is highest (and therefore the 
estimates are likely to be confounded) 
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Modelling 
approach 
Data used Assumptions Strengths Limitations 
burden of non-influenza, 
respiratory pathogens 
including, RSV, and has no 
annual variation 
     




series of viral 
activity 
 Virological surveillance data 
are used to guide disease 
burden models  
 Assumes a proportional 
relation between virus activity 
and the number of 
hospitalisations or deaths 
attributable to influenza 
 
 Can be used to 
simultaneously study the 
burden of different influenza 
subtypes (if such data from 
virological surveillance are 
available), and RSV 
 Can be used to estimate 
influenza disease burden in 
tropical and subtropical 
regions 
 Requires excellent virological 
surveillance data since weekly/monthly 
increases in viral activity are linked to 
weekly/monthly increase in influenza-
associated deaths 
 Does not allow for variations in the 
severity of influenza A strains between 
years; better suited to estimate an 
average burden across many years rather 
than the burden in an individual year 
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The above methods are however not valid in the tropics where influenza viruses 
circulate throughout the year without a clearly demarcated and predictable epidemic 
peak or periods of viral activity. Assessments based solely on peak epidemic periods 
will underestimate the burden of influenza (Simonsen, 1999). Wong and colleagues 
used a modification of the Serfling-Poisson model proposed by Thompson 
(Thompson et al., 2004) to estimate influenza-associated hospitalisations and 
mortality in Hong Kong by defining periods of influenza predominance and baseline 
periods using data from virological surveillance (Wong et al., 2004, Wong et al., 
2006).  
Other approaches to estimate the morbidity and mortality due to influenza which are 
seldom used include: 
i.Peri-seasonal and summer seasonal rate-difference models which are based 
on the comparative method (Izurieta et al., 2000, Barker and Mullooly, 1980, 
O'Brien et al., 2004, Mullooly et al., 2007)  
ii.Cyclical regression model which has the Serfling method as its underlying 
basis (Simonsen et al., 1997) 
iii.Autoregressive integrated moving average (ARIMA) model which uses a 
comparison of the ratio of  pneumonia and influenza deaths to all-cause 
mortality during the epidemic and non-epidemic periods (Choi and Thacker, 
1981) 
Because the models based on the comparative method are simple and require fewer 
assumptions, they have been used in a wide-range of situations. For example, these 
models have been used to make estimates of influenza-associated mortality by 5-year 
age intervals (Thompson et al., 2006). In the case of tropical and sub-tropical 
countries which lack definitive seasonality with regard to influenza virus activity, 
any predictive model based on Serfling or Poisson regression to estimate influenza-
associated mortality in young children would require at the least viral isolation data 
(to define periods of influenza activity), denominator based data on all-cause or 
ALRI mortality in young children by month, as well as weekly data on temperature 
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and humidity. Good quality all-cause / ALRI mortality data from vital registration 
systems may not be available in most developing countries (Rudan et al., 2005) and 
are unlikely to be available by week / month. 
Like the morbidity and mortality burden, the socio-economic burden of influenza is 
dependent on disease severity (which varies from year to year), but in general, 
influenza is associated with substantial socioeconomic consequences on families, 
healthcare services and society (Principi et al., 2003, Neuzil et al., 2002). 
Socioeconomic impact can be estimated by estimating the direct and indirect cost of 
influenza illness in a child. The direct costs include those related to physician visits, 
medications and hospitalisation. Keren and colleagues demonstrated that the mean 
total cost of hospitalisation (direct cost) for an episode of influenza in Philadelphia, 
US was $13159 ‡ (interquartile range $3896 to $10882) with a small number of high 
cost hospitalizations raising the mean cost above 75th percentile (Keren et al., 2006). 
Almost half of the children hospitalised for influenza had one or more chronic 
medical conditions (asthma, chronic lung diseases, cardiac disease, 
immunosuppression, haemoglobinopathies, chronic renal disease etc.) recognised by 
the Advisory Committee on Immunization Practices in the US as risk factors for 
severe influenza. However, the mean total cost of hospitalisation for a patient 
admitted to ICU was $39972 – more than 5 times the mean total cost ($7030) for 
patients cared for exclusively on the wards. The high direct cost of influenza also 
extends to children managed in the community. A population-based prospective 
study in 234 Australian children aged under 5 years showed that outpatient 
laboratory confirmed influenza incurred almost 3 times the cost (AU$904) compared 
to laboratory confirmed RSV (AU$304) (Lambert et al., 2008a). It must however be 
noted, that cost data are country-specific and not directly comparable. In general, 
cost of ALRI hospitalisation (per episode) in industrialised countries is several 
magnitudes higher than those in developing countries (unpublished data).  
                                                 
‡ The mean is higher than the 75th percentile, as some of the cost data are highly skewed towards the 
extreme (higher end).  
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The indirect economic burden, including absence from school, secondary infection of 
household contacts of sick children leading to parental illness, missed work days and 
transmission of influenza to the work place, overshadows the direct costs of 
paediatric influenza and has not been adequately assessed in the past. In a study 
published a few years ago, Tsolia and colleagues found that for each child with 
influenza, a mean of 1.34 work days were lost by the parents to care for the sick child 
and a further 0.36 days for their own illness (Tsolia et al., 2006). The secondary 
bacterial infection rate for influenza, however, was significantly higher than for other 
respiratory viruses (17 compared with 11%; p<0.0001), suggesting a higher rate of 
interfamilial spread compared to other infections. The indirect burden was further 
illustrated in a study by Esposito and colleagues that compared influenza with RSV 
infection in children aged less than 15 years presenting to the emergency department 
for acute conditions (Esposito et al., 2005). The study demonstrated that previously 
healthy children with influenza missed more school days than RSV-positive children 
(12 compared with 5 days, p=0.003). Household contacts of influenza-positive 
children had significantly higher incidence of influenza like illness, and absence 
from work or school compared to those of RSV-positive children.  
1.5. Severe Acute Respiratory Infection 
Surveillance 
The Global Influenza Surveillance Network (GISN) – now rechristened, Global 
Influenza Surveillance and Response System (GISRS) – has been performing 
virological surveillance for influenza since 1952. The GISRS consists of 130 
National Influenza Centres (NICs) around the world that collect and test clinical 
specimens for influenza virus. In the recent years (more particularly following the 
2009 pandemic), the WHO and the global community recognised the need to expand 
influenza surveillance and include epidemiological information to complement the 
virological data collected by GISRS. The lack of any established surveillance for 
severe influenza related disease in most countries and the resulting absence of 
historical data and limited the ability to evaluate the severity of the pandemic in the 
context of previous seasons. The lack of a pre-existing international mechanism for 
sharing epidemiological data presented challenges to understanding global patterns 
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of influenza disease transmission. And, finally, the non-standardised approach to data 
collection and outbreak investigation restricted to such eventualities resulted in data 
that were often incomplete and that could not be clearly interpreted outside the local 
context. The WHO, therefore, has now established guidelines for influenza 
surveillance with a primary focus on the identification of episodes of severe acute 
respiratory infections (SARI) (WHO Global Influenza Programme, 2012). SARI 
surveillance aims to: 
i. collect data on morbidity and mortality related to influenza-associated severe 
disease (resulting in hospital admissions) 
ii. identify and understand the risk factors for severe disease 
iii. provide a platform for undertaking disease burden estimation locally and 
assist in interpreting the results in a global context 
Sentinel surveillance is a mechanism for systematically collecting data on a routine 
basis from a limited number of surveillance sites that are representative of the 
population under surveillance. Sentinel surveillance is a cost-effective and efficient 
way to collect high-quality epidemiological data in a timely manner. Influenza 
surveillance focuses on the two extreme presentations of the disease – ILI sentinel 
surveillance that monitors persons with milder forms of the disease seeking 
ambulatory care; and SARI sentinel surveillance that is aimed to identify persons 
with severe disease who have been admitted to hospital for treatment. When 
combined with laboratory confirmation for influenza, surveillance for both mild and 
severe disease contributes to understanding the complete spectrum of influenza 
illness including differences in the epidemiology of various types and subtypes of the 
influenza virus, risk factors for severe disease, and impact on healthcare delivery 
systems. The underlying population at risk (catchment population) can be estimated 
in the majority of the SARI sentinel sites. Thus, SARI sentinel surveillance is 
extremely useful for calculating incidence rates related to severe disease. 
The WHO have established surveillance case definitions for ILI and SARI (Panel 1) 
(WHO Global Influenza Programme, 2012). The ILI case definition is generally 
intended for use in outpatient clinics while the SARI case definition is aimed at 
inpatient hospital settings. The SARI case definition aims to capture both influenza 
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related ALRI as well as influenza related exacerbations of chronic illnesses such as 
asthma or heart disease (the latter being more common in the elderly population than 
in children). Both case definitions require laboratory confirmation of the influenza 
virus in at least a proportion of the eligible cases (i.e. those satisfying the case 
definition). Since laboratory confirmation can only be conducted in a small 
proportion of ILI cases and catchment population cannot be estimated for most ILI 
sentinel sites, the WHO do not recommend  using ILI sentinel surveillance for 
disease burden estimation. The sensitivity and specificity of the SARI case definition 
varies from 4.2 to 67% (median 55%) and 32 to 95% (median 65%) depending on 
the geographical location of the studies site (Mounts, personal communication). 
However, data from a proportion of studies that have stratified the sensitivity by age 
reveal that while the case definition is highly sensitive (range 70 to 96%) in children 
aged below five years, the sensitivity is lower in older children and adults (range 13 
to 33%).  On the other hand, the specificity of the case definition is poor in young 
children (range 4 to 22.5%), compared to older children and adults (range 80 to 
86%). This means that SARI cases do not accurately reflect the true severe influenza 
disease burden in young children- the majority of the SARI cases are associated with 
other aetiologies. 
However, when used in combination with a specific diagnostic assay like PCR, this 
case definition should capture the majority of the hospitalizations due to influenza-







ILI- acute respiratory infection with: 
• measured fever of ≥ 38°C 
• and cough 
• with onset within the last seven days 
SARI– acute respiratory infection with: 
• history of fever or measured fever of ≥ 38°C 
• and cough 
• with onset within the last seven days 
• and requiring hospitalisation 
Panel 1: Current WHO case definitions for influenza surveillance 
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While the revised WHO surveillance guidelines provide guidance to member 
countries on setting up SARI sentinel surveillance, with an aim to estimate disease 
burden associated with severe influenza, they do not provide methods for this 
purpose (WHO Global Influenza Programme, 2012). Methods / tools for estimating 
disease burden associated with severe influenza have been developed for the WHO 
as part of this doctoral thesis.  
1.6. Evolution of this thesis 
The body of work undertaken during the period of doctoral thesis needs to be viewed 
in three phases: 
Preparatory work: The author led a study to estimate the disease burden due to 
RSV associated ALRI in young children (0-59 months) at global and regional level 
(blue boxes in Figure 4). Data from systematic review of published literature were 
supplemented with unpublished data collected through a consortium of researchers 
on childhood pneumonia and RSV; and primarily based in developing countries 
(RSV Study Group). The data were analysed, and summary estimates generated 
using meta-analysis. The methods for data collection and data analysis used in this 
thesis were thus piloted during this study.  
Ph.D. thesis: The author primarily aimed to estimate the hospitalisations and 
mortality due to influenza associated ALRI in children aged 0-59 months (green 
boxes in Figure 4). In order to estimate hospitalisations indirectly from hospital-
based studies not having a clear denominator population (at risk), the author 
estimated the number of hospital admissions due to severe ALRI in children aged 0-
59 months to which the proportion of hospitalised ALRI cases positive for seasonal 
influenza would be applied (yellow boxes in Figure 4) Additionally, the author aimed 
to develop methods and tools for estimating influenza associated ALRI disease 
burden using SARI surveillance data (yellow boxes in Figure 4). 
Additional outputs: The author estimated the hospital admissions and in-hospital 
deaths due to severe ALRI in children aged 0-59 months; and developed a manual 
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for the WHO to estimate disease burden associated with seasonal influenza (in all 
age groups) using SARI surveillance data (orange boxes in Figure 4). 
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Figure 4: Flow diagram explaining the various components of this doctoral thesis 
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Chapter 2. Aims of the thesis 
Acute lower respiratory infections are a leading cause of morbidity and mortality in 
young children all over the world. Though seasonal influenza is an important cause 
of ALRI, there are no global estimates of the burden of disease due to influenza-
associated ALRI either in the paediatric or the adult age group. At the beginning of 
this thesis, there were only two systematic reviews of published literature on the 
burden of influenza-associated ALRI- one included 28 studies in children aged 0-19 
years from all over the world (Bueving et al., 2005); and the other was based on 35 
articles focussing only on 18 countries in East and South-East Asia and included all 
age groups (Simmerman and Uyeki, 2008). Both studies were unable to provide 
summary incidence rates either globally or for the region under study as data on 
incidence of influenza-associated ALRI were scarce. The 2009-10 influenza 
A(H1N1)pdm09  pandemic highlighted the need for baseline incidence and mortality 
data from seasonal influenza especially in the most vulnerable groups like young 
children. This thesis primarily aims to estimate the burden of disease due to 
influenza-associated ALRI resulting in hospitalisation in children aged less than 5 
years for the year 2008 both globally and for the six WHO regions (please refer to 
section 1.6 and Figure 4 that illustrate how different components of this thesis are 
integrated as a unified body of work).  
The specific primary objectives of are: 
1. Estimate the hospitalisations due to seasonal influenza-associated ALRI 
in young children, both globally and by WHO regions in the year 2008 
using two different approaches-   
a. an incidence-based approach using data from hospital-based studies 
having a clear denominator population (at risk)  
b. a prevalence-based approach using data from hospital-based studies 
NOT having a clear denominator population (at risk)  
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2. Estimate the possible boundaries of seasonal influenza-associated ALRI 
mortality in young children, both globally and for industrialised and 
developing country regions in the year 2008 using two different 
approaches-  
a. in-hospital case fatality ratio in influenza-associated ALRI to estimate 
deaths occurring in healthcare facilities 
b. identifying cause of death data in children not admitted to hospital 
(assigned by verbal autopsy) and concurrent influenza virus isolation 
in the same population to estimate influenza-associated ALRI deaths 
occurring outside healthcare facilities  
As a secondary aim, this study aims to develop methods and tools for estimating 
disease burden associated with seasonal influenza using severe acute respiratory 
infections (SARI) surveillance in low and middle-income countries. The specific 
secondary objectives are: 
i. Conduct a survey of end-users (primarily in low and middle 
income countries) to identify their needs so as to inform the design 
of the manual 
ii. Develop specific methods and tools for estimating incidence, 
proportion of influenza positive cases and number of episodes of 
influenza-associated severe acute respiratory infections using data 
from SARI surveillance in low and middle income countries 
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Chapter 3. Burden of disease due to seasonal 
influenza-associated ALRI in young children 
The guiding principle for the methodology underlying any disease burden estimation 
at global or national levels is that although perfect data sources will not be available 
for every country in every region, the systematic review process will identify 
available data that satisfy the quality criteria and are useful / valid for the generation 
of the best possible estimates. The study to estimate the burden of disease due to 
RSV-associated ALRI which was undertaken to pilot the methods for data collection 
and analysis used for this thesis (Nair et al., 2010), demonstrated that much of the 
aetiology-specific data on childhood pneumonia especially from the developing 
world remain unpublished (Appendix A8) . Hence, in addition to a systematic 
literature review, identifying and obtaining unpublished data especially from 
developing countries was one of the key activities for estimating the burden of 
disease due to seasonal influenza-associated ALRI using an incidence rate approach. 
Current Global Burden of Disease Estimates do not estimate / report hospitalizations 
associated with a disease (World Health Organization, 2008). Hospitalisations 
associated with a disease reflect the burden on hospital inpatient systems and are 
important while allocating resources and planning for augmenting hospital beds and 
associated facilities especially in resource constrained developing countries. In the 
absence of good quality mortality data (for deaths occurring in the community), in-
hospital mortality indicates the likely lower bound of the overall mortality associated 
with the disease.  
3.1. Hospitalisations due to seasonal influenza-
associated ALRI 
There are two sources of data to estimate hospitalisations due to seasonal influenza-
associated ALRI- data from hospital-based studies having a defined denominator 
population at risk (incidence data); and data from hospital based studies where the 
underlying denominator population cannot be defined (proportion positive data).  
3.1.1. Incidence-based approach 
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3.1.1.1. Methods 
3.1.1.1.1. Literature search 
A systematic literature review was conducted across the following electronic 
databases – Medline (Ovid), Embase, CINAHL, Global Health, Web of Science, 
WHOLIS, LILACS, and IndMed. Additionally, a Chinese language database (The 
China National Knowledge Infrastructure or CNKI (www.global.cnki.net), was 
searched for studies (with a clear denominator of the population at risk) published in 
Chinese language during the same period. A grey literature database (SIGLE) was 
also searched. The detailed search strategy is placed in the appendix (Appendix A3). 
The search was limited to studies published between 1 January, 1995, and 31 
October, 2010 for the following reasons: 
• since the estimates are being generated for the year 2008, data from studies 
published prior to 1995 were considered to be dated.  
• most of the studies published prior to 1995 used serologic diagnosis which 
had poor sensitivity and specificity thus making it difficult to combine their 
results with more advanced techniques used in the past decade. 
In order to conform to the PRISMA guidelines for systematic reviews and meta-
analysis, another researcher (Valerie Evans, MSc) independently performed the 
literature search and data extraction. The literature search and data abstraction for 
Chinese language articles were conducted by another researcher (Jian Shayne F. 
Zhang, MPH) who read Chinese as a first language and had access to these 
databases. All identified studies were assessed using the eligibility criteria detailed in 
Panel 2.  No language or publication restrictions were applied. Data were extracted 
onto a data extraction template designed on Microsoft Excel (Microsoft Office 
2003). Any disagreements were discussed and arbitrated by the supervisor for this 
doctoral thesis (Prof. Harry Campbell).  
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Inclusion criteria 
• Studies with data on children with laboratory confirmed influenza and 
hospitalised for ALRI  
• Studies published between 1 January 1995 and 31 October 2010 
• Studies should have been carried out for a minimum of one year (except in 
temperate regions where influenza seasonality is more clearly defined and for 
studies reporting case fatality ratio). This is important as influenza is a seasonal 
disease 
• Studies in children less than 5 years of age, or should have reported data for this 
age group separately 
• Studies reporting influenza incidence or mortality for a minimum of the first year 
of life 
Exclusion criteria 
• Studies where influenza was studied as a co-infection rather than a primary 
outcome 
• Case definition was not clearly defined and / or not consistently applied 
• Case ascertainment was conducted only during an epidemic period 
• Study data after 21 April, 2009 (onset of influenza A(H1N1)pdm09 pandemic 
• Incidence and mortality were estimated using modelling techniques 
Panel 2: Eligibility criteria for selection of studies reporting incidence of hospitalised 
influenza-associated ALRI in young children 
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3.1.1.1.2. Unpublished data 
Thirteen leading researchers on paediatric influenza and pneumonia were identified 
through their publication track record as well as through extensive consultations with 
subject experts- primarily those involved in the RSV-associated ALRI disease 
burden estimation project. This led to the formation of an international consortium 
(“Influenza Study Group”) that consisted primarily of researchers working in 
developing countries. The author organised and led a two-day meeting of the 
Influenza Study Group in Edinburgh, UK on February 3-4, 2010. This meeting was 
funded by the World Health Organisation’s Global Influenza Programme.  
During the two-day meeting, the Influenza Study Group discussed extensively the 
availability of data (with a clear denominator on the population at risk) on paediatric 
influenza in children aged below five years and finalised common case definitions 
for analysing all available data. The group agreed to either re-analyse their already 
published data or share hitherto unpublished data from on-going studies on a 
common data extraction template designed in Microsoft Excel (Microsoft Office 
2003). The group suggested the inclusion of some other research groups who, to the 
best of their knowledge, had conducted similar studies but were not invited to the 
meeting. These groups were contacted and enlisted into the Influenza Study Group. 
Finally, fifteen research sites from 12 countries contributed unpublished data for 
estimating incidence of hospitalised influenza-associated ALRI in children aged 0-59 
months.  
3.1.1.1.3. Case definitions 
Though influenza causes a wide range of illness including (ranging from mild 
influenza like illness to more severe disease and sequelae) (Figure 3), the Influenza 
Study Group agreed that there was a need to limit this exercise to estimation of 
incidence and case fatality related to influenza-associated ALRI in young children 
(due to paucity of data on mild illness and sequelae and costs associated with 
influenza disease). Since the majority of published and unpublished data were for 
influenza-associated ALRI resulting in hospitalisation, and hospitalised cases are 
reflective of disease severity and the overall burden on the healthcare system, this 
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thesis focuses only on incidence and case fatality related to hospitalised influenza-
associated ALRI.  
Most investigators used modified versions of the case definitions for clinical 
pneumonia, severe pneumonia, and influenza surveillance that were established by 
WHO under the Integrated Management of Childhood Illness (IMCI) programme or 
the US Centres for Disease Control and Prevention (US CDC’s) Influenza 
Surveillance Programme (Department of Child and Adolescent Health, 2005, Ortiz et 
al., 2009). The group agreed to use the term ALRI rather than pneumonia because a 
proportion of children with lower respiratory complications of influenza might not 
only present with pneumonia but also with bronchiolitis. Hospitalised influenza-
associated ALRI is defined as identification of influenza virus (using valid diagnostic 
tests) in a child with either cough or difficulty in breathing and hospitalised for a 
respiratory ailment. 
3.1.1.1.4. Ethical approval 
The author conducted a Self-Audit for Level 1 Ethical Review in relation to this 
project. This was done using a checklist developed by the School of Health in Social 
Science and adopted by the Post Graduate Ethics Committee of the College of 
Medicine and Veterinary Medicine, University of Edinburgh. Since no foreseeable 
ethical risks were identified (as all analysis were on secondary data), a formal ethical 
approval was not required. The individual collaborating sites re-analysing primary 
data sought ethical approvals from their respective Institutional Review Boards. A 
copy of the Self-Audit Checklist for Level 1 is placed in the Appendix A1.  
3.1.1.1.5. Statistical analysis 
3.1.1.1.5.1. Data imputation 
While twenty six and thirty three of the 39 included studies reported incidence 
estimates for infants (aged 0-11 months), and young children (0-59 months) 
respectively, only 24 studies reported incidence rates for both 0-11 months as well as 
0-59 months. For the remaining fifteen studies -10 published (Sutmoller et al., 1995, 
Henrickson et al., 2004, Poehling et al., 2006, Coffin et al., 2007, Grijalva et al., 
2006, Grijalva et al., 2007b, Rojo et al., 2006, Forster et al., 2004, Ajayi-Obe et al., 
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2008, Hasan et al., 2006) and 5 unpublished (Bhat and colleagues, unpublished; 
Gordon and colleagues, unpublished; Lindblade and colleagues, unpublished ; Clara 
and colleagues, unpublished ; Lucero and colleagues, unpublished), data imputation 
was employed using the median incidence rate ratio (IRR) as has been employed 
previously by Rudan and Nair (Rudan et al., 2004, Nair et al., 2010). Using incidence 
rate data from the 24 studies reporting incidence rates for the age groups 0-11 
months and 0-59 months, the median incidence rate ratio (IRR) for children in the 
age group 0-23 months and 0-59 months was calculated. Relative to an incidence rate 
of 1.0 in the age group 0-11 months, the median IRR for the age group 0-23 months 
and 0-59 months was calculated to be 0.96 and 0.53 respectively. This median IRR 
was then applied to the reported incidence rates of hospitalised influenza-associated 
ALRI for 0-11 months, or 0-23 months or 0-59 months to estimate the incidence rate 
for the missing age groups. In order to assess the validity of data after imputation, a 
sensitivity analysis was carried out by including only those studies which had data 
for the full age range (0-59 months) (for results see Table 25).  
3.1.1.1.5.2. Adjustments and assumptions 
The following statistical adjustments/assumptions were made for data synthesis: 
• If the duration of the study was not in exact multiples of one year (e.g. 18 
months, 30 months etc.), the annualised incidence rate was calculated and 
reported by adjusting for the population at risk.  
• If clinical specimens were collected in only a proportion of eligible cases 
(using a systematic method) and data on all eligible cases were available, the 
incidence rate was adjusted by scaling for the proportion sampled.  
3.1.1.1.5.3. Meta-analysis 
A meta-analysis of the data (through  April 15, 2009) from studies reporting 
incidence of hospitalised influenza- associated ALRI was conducted (using Stata 
11.2) and the pooled estimates along with 95% CIs have been reported. The random 
effects model (DerSimonian-Laird method) was used since heterogeneity in the data 
was anticipated (DerSimonian and Laird, 1986). The random effects model accounts 
for both in study and between study heterogeneity (Riley et al., 2011). This decision 
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is statistically valid since in the absence of significant heterogeneity (p<0.05), the 
meta-estimates (and 95% CI) from the random and fixed effects models are identical.  
The incidence rates were estimated globally and by regions- for industrialised and 
developing countries as well as for the six WHO regions.  
3.1.1.1.5.4. Number of hospitalised influenza-associated ALRI 
cases in 2008 
The incidence meta-estimates for hospitalised influenza-associated ALRI were 
applied to the population of children younger than 5 years in 2008 both globally as 
well as in the six WHO regions to estimate the number of new episodes of influenza-
associated hospitalised ALRI in 2008. Countries were designated as industrialised or 
developing on the basis of UNICEF’s classification (United Nations Children's Fund, 
2012). The child population estimates for 2008 are as in the UN Population 
Division’s database, “World Population Prospects: The 2010 revision” 
(http://esa.un.org/unpd/wpp/unpp/panel_population.htm). 
3.1.1.2. Results 
Thirty-nine hospital-based studies (24 published and 15 unpublished) using passive 
case ascertainment (i.e. a child with ALRI being brought to a health facility) and 
satisfying the eligibility criteria were identified (Figure 5). Eight studies were in rural 
populations, 15 in urban and the remainder involved a mixture of rural and urban 
populations (Table 4). Fifteen studies were either cohort studies or were nested in a 
demographic surveillance site and were thus able to report the denominator 
population at risk; four studies were able to identify the catchment population for the 
hospital and adjust for the proportion of total population seeking care at the given 
hospital a using healthcare utilisation survey (Azziz-Baumgartner et al., 2012, Feikin 
et al., 2011, Jordan et al., 2009); and 20 studies reported the catchment population 
based on a census-derived denominator. No additional studies were identified from 
the search in Chinese language databases.  
Twenty one of the 39 included studies were from developing countries.  Sixty two 
percent (13/21) of the studies from developing countries were unpublished (Figure 
6). By contrast, unpublished studies contributed only 11 percent (2/18 studies) of the 
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data from industrialised countries. There were no data from the Eastern 
Mediterranean Region. One study in native American Indian population (Bhat and 
colleagues, unpublished) was included in the meta-estimates for developing countries 
as the socio-economic and demographic risk factors for ALRI in these populations 
are similar to those in the developing countries. The data from both the developing as 
well as industrialised countries were significantly heterogeneous (p<0.0005, I2 >80 
percent).   
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Figure 5: Flow diagram for selection of studies reporting incidence of hospitalised influenza-
associated ALRI in young children 
15 unpublished population-based studies identified 
for supplementary data 
4058 records identified from 
database search  
13 records identified from 
other sources 
1625 records after 
duplicates removed 
1625 records screened 
1505 records excluded as not 
relevant to the topic 
120 full-text articles assessed for 
eligibility 
24 full text articles reported incidence 
data in hospitalised children 
39 studies provided incidence data on 
hospitalised influenza-associated severe 
96 full-text articles excluded: 61 did not 
meet inclusion criteria; 35 related to 
influenza A(H1N1)pdm09 
12 full text articles reported in-hospital 
case fatality ratios 
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Figure 6: Location of the 39 studies reporting incidence of hospitalised influenza-associated ALRI in young children by World Health Organization 
Regions
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Table 4: Incidence estimates of influenza-associated ALRI in hospitalised children younger than 5 years from published and unpublished studies 











Case definition Specimen and Diagnostic test(s) 
Incidence of influenza-
associated hospitalised ALRI 







        
Africa 
Soweto, South Africa; 









Hospitalised ALRI cases with lower 
respiratory tract infection diagnosed by a 
physician 
Nasopharyngeal aspirate. DFA 
2.6 2.1 0.9 
Manhiça district, 
Mozambique; rural 







(n= 3291 cyo) 
Children  admitted to hospital with cough 
and difficulty breathing and chest wall 
indrawing 
Nasopharyngeal aspirate. 
Multiplex RT-PCR  
3.5 3.3 1.6 
Kilifi district, Kenya; 








Children admitted to hospital with history of 
cough or difficulty breathing AND one or 
more of the following: lower chest wall 
indrawing, hypoxia, inability to drink or 
breastfeed, impaired consciousness 
Nasal wash. Multiplex real-
time PCR  
3 2.5 1.1 
Bondo district, Kenya; 







A child hospitalized with cough or difficulty 
breathing, plus at least one of the following 
signs:  
Nasopharyngeal and / or 
oropharyngeal wash. Real-
time RT-PCR  
1.3 1.6 1.0 
                                                 
cyo=child years observed; DFA= Direct immunofluorescence ; RT-PCR=Reverse Transcriptase Polymerase Chain Reaction; PCR=Polymerase Chain Reaction 
* Data in parentheses are computed incidence estimates from data imputation 
† Excluded neonates (0-27 days) 
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Case definition Specimen and Diagnostic test(s) 
Incidence of influenza-
associated hospitalised ALRI 







unpublished)† (n=55117) • lower chest wall indrawing  
• nasal flaring   
The Greater Banjul area 
and Upper River 
Region, The Gambia; 
periurban and rural 








A child hospitalized with cough or difficulty 
breathing AND either inability to drink or 
breastfeed or lethargic or unconscious or 
vomits everything or had history of 
convulsions, or chest wall indrawing or 
stridor in a calm child 
Nasopharyngeal aspirate. Mass 
Tag PCR 
0 0.6 0.4 
Lwak, Kisumu, Kenya; 








A child hospitalized with elevated 
respiratory rate for age using IMCI cut-offs 
(for pneumonia) or maternal report of 
convulsions, inability to drink or breastfeed, 
or vomiting everything, or on examination 
has lethargy, unconsciousness, lower chest 
wall indrawing, stridor, or an oxygen 
saturation < 90% 
Nasopharyngeal and 
oropharyngeal swabs. Real-
time RT-PCR  
1.3 0.6 0.8 
        
Americas 
Nashville (TN), USA; 








Hospitalised ALRI Nasal wash. Viral culture  
3.4 3.5 2.3 
                                                 
IFA= Indirect immunofluorescence  
‡ Included children aged 2-59 months 
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Case definition Specimen and Diagnostic test(s) 
Incidence of influenza-
associated hospitalised ALRI 







Rio de Janeiro, Brazil; 







Hospitalised ALRI: tachypnoea, chest 
retractions, wheezing, rales, stridor or 
cyanosis 
Nasopharyngeal aspirate. IFA, 
viral culture  
(4.8) (4.5) 2.5 
Milwaukee (WI), USA; 
mixed urban-rural 









bronchoalveolar lavage, throat 
swabs, endotracheal aspirates. 
Multiplex PCR, tissue culture, 
EIA 
(2.8) (2.6) 1.5 
Monroe County (NY) 
and Davidson County 
(TN), USA; urban 






Hospitalised ALRI Nasal swab and throat swab. 
Viral culture and RT-PCR 
1.7 1.2 0.6 
Nashville,  Rochester 
(NY) and Cincinnati 
(OH), USA; urban 






Hospitalised ALRI Nasal swab and throat swab. 
Viral culture and RT-PCR 
(1.7) (1.7) 0.9 
Philadelphia (PA), 
USA; urban (Coffin et 







Hospitalised ALRI (Discharge diagnosis 
ICD-9 codes: 487, 487.0, 487.1, 487.8 and / 
or lab reports) 
Nasal aspirate. Solid-phase 
immunoassay, DFA and viral 
culture  
(4.2) 4.2 2.1 











Hospitalised ALRI (Discharge diagnosis 
ICD-9 codes: 487.0, 487.1, 487.8, 487.9, 
488.0, 488.1) 
Nasal wash. Viral culture, 
EIA, RT-PCR  
3.9 3.0 0.8 
                                                 
EIA= Enzyme-linked  immunoassay 
§ Incidence estimated with hospital discharge records and laboratory data 
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Case definition Specimen and Diagnostic test(s) 
Incidence of influenza-
associated hospitalised ALRI 







Salt Lake county (UT), 
USA; mixed urban-








Hospitalised ALRI (Discharge diagnosis 
ICD-9 codes that met consensus for ILI) Nasopharyngeal aspirate. DFA  
1.8 1.9 0.9 
Davidson County (TN), 
USA; mixed urban-









Nasal and throat swabs. Viral 
culture, RT-PCR, rapid tests, 
IFA, serology  
(4.6) 4.5 2.4 
Multistate, USA; mixed 
urban-rural (Schrag et 







Hospitalised ALRI (Discharge diagnosis 
ICD-9 codes: 038.8, 038.9, 345.1, 461.0, 
464.0, 464.1, 464.10, 464.11, 464.2, 464.20, 
464.21, 464.4, 465.0, 466.0, 466.1, 478.9, 
480.0-486.0, 487.0, 493.0, 779.0, 780.3, 
780.6) 
Viral culture, DFA, IFA, rapid 
antigen test, RT-PCR  
2.2 1.6 0.9 
Navajo and WMA 
reservations, USA; 








Physician diagnosed hospitalised ALRI Nasopharyngeal aspirate. Viral culture and serology  
(3.1) (3.0) (1.6) 
Davidson County (TN), 
Monroe County (NY) 
and Hamiltion County 
(OH), USA; mixed 









Nasal and throat swabs. Viral 
culture, RT-PCR, rapid tests, 
IFA, serology 
(3.5) 3.4 1.8 
                                                 
** Detailed age-specific incidence estimates obtained directly from authors 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 











Case definition Specimen and Diagnostic test(s) 
Incidence of influenza-
associated hospitalised ALRI 







Multistate, USA; mixed 








Influenza-associated pneumonia: any 
hospitalized child with laboratory-
confirmed influenza who had evidence of a 
new pneumonia on at least 1 chest 
radiograph obtained during the current 
admission or hospitalization 
Nasopharyngeal and 
oropharyngeal swabs. Viral 
culture, DFA, IFA, rapid 
antigen test, RT-PCR  
0.9 0.6 0.4 
Managua, Nicaragua; 









Hospitalised child with cough and 
indrawing of chest wall 
Nasal and throat swabs. RT-
PCR 
(4.2) (4.1) (3.2) 
Santa Rosa, Guatemala; 
mixed rural and small 








Hospitalized pneumonia  and evidence of 
acute infection [fever >38°C, hypothermia 
(temp <35.5° C), abnormal WBC (count 
<5500 or >15000 per cu. mm. or abnormal 
WBC differential) and at least one 
sign/symptom of respiratory disease 
(tachypnea, cough, sputum production, 
pleuritic chest pain, hemoptysis, difficulty 
breathing, shortness of breath, sore throat; in 
children <2 years old only: not eating, 




time RT-PCR  
(1.2) (1.1) 0.6 
Santa Ana, El Salvador,  
mixed urban-rural 







Hospitalized with cough or difficulty 
breathing and at least one danger sign (i.e. 
chest wall indrawing, stridor while calm, 
convulsions, inability to drink, lethargy, 
Nasal and oropharyngeal 
swabs. Real-time RT-PCR 
(3.2) (3.1) 1.7 
                                                 
†† Included children aged 2 years up to 5 years 
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Case definition Specimen and Diagnostic test(s) 
Incidence of influenza-
associated hospitalised ALRI 







unconsciousness or intractable vomiting) 
        
Europe 
Kiel, Germany; urban 






Hospitalisation for ALRI (Discharge 
diagnosis ICD 9 codes: 460 to 490; and J00 
to J22 in ICD-10 ) 
Nasopharyngeal aspirate. RT-
PCR 
1.5 (1.4) 1.2 
Madrid, Spain; urban 







Hospitalisation for ALRI (presence of 
respiratory symptoms and signs along with 
infiltrates on chest X-ray) 
Nasal or throat aspirate. Viral 
culture and subsequent 
fluorescent staining with 
monoclonal antibodies 
(1.1) (1.0) (0.6) 
Multicentre, Germany; 
mixed rural-urban 






ARI requiring hospitalisation Nasopharyngeal aspirate. PCR 
1.8 1.6 (0.9) 
Leicester, United 
Kingdom; mixed 
urban- rural (Nicholson 




(n=56395) ARI requiring hospitalisation Nasal and throat swabs. PCR 
2.4 2.2 1.6 
Gipuzoka, Spain; 
mixed urban-rural 






ARI requiring hospitalisation Nasopharyngeal aspirate. Viral culture and RT-PCR 
2.5 1.6 0.9 
East London, United 
Kingdom; urban 







ARI requiring hospitalisation Nasopharyngeal aspirate. IFA and PCR 
(2.9) 2.8 1.6 
        
South East Asia 
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Case definition Specimen and Diagnostic test(s) 
Incidence of influenza-
associated hospitalised ALRI 















ALRI requiring hospitalisation: h/o fever, 
cough, difficulty in breathing (respiratory 
rate >50 breaths / min in children aged 0-11 
months and >40 breaths / min in children 
aged 12-59 months), wheezing, chest wall 
indrawing 
Nasopharyngeal aspirate. EIA  
(2.0) 2.0 (1.1) 
Kamalapur, 
Bangladesh; urban 






Hospitalised pneumonia with chest wall 
indrawing 
Nasopharyngeal wash. Viral 
culture  
0.8 1.1 0.6 
Sa Kaeo and Nakhon 
Phanom, Thailand; 









Hospitalisation with evidence of acute 
infection (reported fever or documented 
temperature >38.2º C within 24 hours of 
admission, or reported chills or documented 
temperature of <35.5º C within 24 hours of 
admission, or  abnormal white blood cell 
count (WBC>11,000/mm3 or 
WBC<3,000/mm3) or abnormal differential) 
with signs (abnormal breath sounds or 
tachypnea) or symptoms (cough, sputum 
production, hemoptysis, chest pain, 
dyspnea, or rhinitis) of respiratory tract 
disease 
Nasopharyngeal swabs. RT-
PCR and viral culture 
6.0 7.2 5.3 
Kamalapur, 
Bangladesh; urban 






Hospitalised ALRI with chest wall 
indrawing with or without WHO specified 
danger signs 
Nasopharyngeal wash. RT-
PCR and tissue culture  
1.8 2.1 1.0 
                                                 
‡‡ All eligible subjects were followed up weekly at home by trained Field Research Assistants (FRAs) who referred children with findings suggestive of respiratory disease to the clinic 
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Case definition Specimen and Diagnostic test(s) 
Incidence of influenza-
associated hospitalised ALRI 


















Hospitalised ALRI (Discharge diagnosis 
ICD-10 codes J-10 and J-11) 
Details of specimen not 
available. Viral culture, PCR 
1.5 (1.5) 0.6 
Hong Kong SAR, 









Nasopharyngeal aspirate. IF 
followed by viral culture and 
serology 
4.8 4.6 3.0 
Bohol, Philippines; 
mixed urban-rural 









Hospitalised ALRI (cough, difficulty 
breathing with chest indrawing or WHO 
specified danger signs) 
Nasopharyngeal aspirate. Viral 
culture and PCR 
2.4 2.0 (1.3) 
Soma, Japan; urban 











5.6 6.0 4.8 
Hong Kong SAR, 







Hospitalised ALRI Nasopharyngeal aspirate. DFA and viral culture 
7.4 7.3 7.2 
Nha Trang, Vietnam; 








Hospitalised ALRI Nasopharyngeal aspirate. PCR 
16.9 17.7 8.7 
Suzhou district, China; 








Hospitalised ALRI based on physician 
diagnosis Nasopharyngeal aspirate. DFA  
0.6 0.4 0.3 
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Overall, the incidence rates were highest in infants (aged 0-11 months).  The incidence in 
infants (aged 0-11 months) was about 2.5 to 3 times that in children aged 12-59 months 
(Figure 7).  Thirteen studies (seven in developing and six in industrialised countries) reported 
the detailed incidence in the first year of life. Although in general the incidence was highest 
in the first five months of life, this difference was more marked in the studies from 
industrialised countries (Figure 8, Figure 9).  
There were marked regional variations in the incidence of influenza-associated hospitalised 
ALRI in both infants (0-11 months) as well as young children (0-59 months). Globally in 
both groups, incidence rates were highest in the Western Pacific Region of the WHO. At any 
given site, the incidence of influenza-associated hospitalised ALRI varied widely from year 
to year (sometimes by as much as two magnitudes) - depending on the type and sub-type of 
circulating influenza virus (Table 5). Data on incidence of influenza-associated ALRI by type 
and sub-type were scarce. Such data were available only from three sites (Bondo, Kenya; 
Bohol, Philippines; and Hong Kong). Data from all three sites indicate that influenza A 
conferred 64-100% of the disease burden due to seasonal influenza-associated hospitalised 
ALRI in young children.  
The overall incidence of influenza-associated hospitalised ALRI was 1.5 (95% CI 1.0 to 2.3) 
episodes per 1000 children per year in developing countries compared to 1.2 (95% CI 0.9 to 
1.6) episodes per 1000 children per year in industrialised countries (Figure 10). Thus, it is 
estimated that in the year 2008, about 911,000 (95% CI 617,000 to 1.4 million) new episodes 
of influenza-associated severe disease resulted in hospitalisations worldwide in children 
younger than 5 years (Table 6). The burden was disproportionately higher in infants (0-11 
months) - they contributed to over 40 percent of the overall burden in young children.  As 
expected, only seven percent of the overall cases globally occurred in industrialised countries 
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Figure 7: Forest plot of incidence estimates of influenza-associated hospitalised ALRI in 
children aged 0-11 months  
D+L (overall) indicates meta-estimate by random effects analysis 
I-V (overall) indicates meta-estimate by fixed effects analysis 
 
NOTE: Weights are from random effects analysis
.
.
D+L Overall  (I-squared = 98.3%, p = 0.000)
Philadelphia, USA (Coffin et al., 2007)
Suzhou dist., China (Ji et al., 2010)
Nashville, Tennessee, USA (Neuzil et al., 2002)
Soma, Japan (Sako and colleagues, unpublished)
Managua, Nicaragua (Gordon and colleagues, unpublished)
(Tennessee), USA (Iwane et al., 2004)
Lwak, Kisumu, Kenya (Katz and colleagues, unpublished)
Industrialised
Hong Kong SAR, China  (Nelson et al., 2007)
and colleagues, unpublished)
and colleagues, unpublished )
Bohol, Philippines (Lucero and colleagues, unpublished)
Rio de Janeiro, Brazil (Sutmoller et al., 1995)
Mirzapur, Bangladesh (Hasan et al., 2006)
Multistate, USA (Schrag et al., 2006)
Santa Ana, El Salvador (Clara
Madrid, Spain (Rojo et al.,  2006)
(Simmerman and colleagues, unpublished)
Nha Trang, Vietnam (Yoshida et al., 2009)
East London, United Kingdom (Ajayi-Obe et al.,2008)
Kilifi district, Kenya (Berkley
Colorado, USA (Simoes and colleagues, unpublished)
Milwaukee, Wisconsin, USA (Henrickson et al., 2004)
Davidson County (Tennessee), Monroe County (New York)
Soweto, South Africa (Madhi
and colleagues, unpublished)
Sa Kaeo and Nakhon Phanom, Thailand
Multicentric, Germany (Forster et al., 2004)
Kiel, Germany (Wiegl et al., 2005)
Gipuzoka, Spain (Montes et al; 2005)
Santa Rosa, Guatemala (Lindblade
Salt Lake County, Utah, USA (Ampofo et al., 2006)
Davidson County, USA (Grijalva et al., 2006)
Hong Kong SAR, China (Chiu et al., 2009)
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I-V Subtotal
(Roca and colleagues, unpublished)
Name of study
Bondo district, Kenya (Ope and colleagues, unpublished)
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and colleagues, unpublished)
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Multistate, USA (Dawood et al., 2010)
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I-V Overall
and colleagues, unpublished)
D+L Subtotal  (I-squared = 97.3%, p = 0.000)
and Cincinati (Poehling et al., 2006)
Developing
(Bhat and colleagues, unpublished)
Leicester, United Kingdom (Nicholson et al., 2006)
D+L Subtotal  (I-squared = 96.7%, p = 0.000)
Kamalapur, Bangladesh (Brooks
Kamalapur, Bangladesh (Brooks et al., 2009)
I-V Subtotal
and Hamiltion County (Ohio), USA (Grijalva et al., 2007)
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Figure 8: Forest plot of incidence estimates of influenza-associated hospitalised ALRI in 
children aged 0-5 months 
D+L (overall) indicates meta-estimate by random effects analysis 
I-V (overall) indicates meta-estimate by fixed effects analysis 
 
NOTE: Weights are from random effects analysis
.
.
D+L Overall  (I-squared = 96.1%, p = 0.000)
(Simmerman and colleagues, unpublished)
and colleagues, unpublished)
I-V Overall
East London, United Kingdom (Ajayi-Obe et al.,2008)
Lwak, Kisumu, Kenya (Katz and colleagues, unpublished)
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(Roca and colleagues, unpublished)
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D+L Subtotal  (I-squared = 98.1%, p = 0.000)
I-V Subtotal
and colleagues, unpublished)
Multistate, USA (Dawood et al., 2010)
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Salt Lake County, Utah, USA (Ampofo et al., 2006)
D+L Subtotal  (I-squared = 64.7%, p = 0.009)
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and colleagues, unpublished)
Bohol, Philippines (Lucero and colleagues, unpublished)
Bondo district, Kenya (Ope and colleagues, unpublished)
Sa Kaeo and Nakhon Phanom, Thailand
Davidson County (Tennessee), Monroe County (New York)
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and Hamiltion County (Ohio), USA (Grijalva et al., 2007)
Manhiça district, Mozambique
Colorado, USA; Mixed (Simoes
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Figure 9: Forest plot of incidence estimates of influenza-associated hospitalised ALRI in 
children aged 6-11 months 
D+L (overall) indicates meta-estimate by random effects analysis 
I-V (overall) indicates meta-estimate by fixed effects analysis 
NOTE: Weights are from random effects analysis
.
.
D+L Overall  (I-squared = 99.0%, p = 0.000)
and colleagues, unpublished)
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D+L Subtotal  (I-squared = 97.7%, p = 0.000)
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Figure 10: Forest plot of incidence estimates of influenza-associated hospitalised ALRI in 
children aged 0-59 months 
D+L (overall) indicates meta-estimate by random effects analysis 
I-V (overall) indicates meta-estimate by fixed effects analysis 
NOTE: Weights are from random effects analysis
.
.
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Table 5: Annual variation in the incidence of influenza-associated hospitalised ALRI in children younger than 5 years by type and sub-type of 
circulating virus, by World Health Organization Regions 
Location;  (reference) 
Study 
period 
Incidence of influenza A(H1N1 & H3N2)-
associated hospitalised ALRI (per 1000 
children per year) 
Incidence of influenza B-associated 
hospitalised ALRI (per 1000 children 
per year) 
Incidence of influenza (all types and sub-
types)-associated hospitalised ALRI (per 





















Bondo district, Kenya 




0.8 1.4 1.0 0 0 0 0.8 1.4 1.0 
2008-
2009 
1.6 1.7 1.0 0.2 0.2 0.2 1.8 1.9 1.2 
           
Americas 
Nashville,  Rochester 
(NY) and Cincinnati 




NA NA NA NA NA NA NA NA 0.6 
2001-
2002 
NA NA NA NA NA NA NA NA 0.9 
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Location;  (reference) 
Study 
period 
Incidence of influenza A(H1N1 & H3N2)-
associated hospitalised ALRI (per 1000 
children per year) 
Incidence of influenza B-associated 
hospitalised ALRI (per 1000 children 
per year) 
Incidence of influenza (all types and sub-
types)-associated hospitalised ALRI (per 






















NA NA NA NA NA NA NA NA 0.4 
2003-
2004 
NA NA NA NA NA NA NA NA 1.5 
Colorado (CO), USA 
(Simoes and colleagues, 
unpublished)  
2000 NA NA NA NA NA NA 0.8 0.5 0.1 
2001 NA NA NA NA NA NA 2.2 1.6 0.4 
2002 NA NA NA NA NA NA 2.4 2.2 0.7 
2003 NA NA NA NA NA NA 12.1 10 2.7 
2004 NA NA NA NA NA NA 1.1 0.7 0.2 
2005 NA NA NA NA NA NA 4.1 2.9 0.8 
2006 NA NA NA NA NA NA 4.8 3.6 0.9 
2007 NA NA NA NA NA NA 2.8 2.2 0.6 
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Location;  (reference) 
Study 
period 
Incidence of influenza A(H1N1 & H3N2)-
associated hospitalised ALRI (per 1000 
children per year) 
Incidence of influenza B-associated 
hospitalised ALRI (per 1000 children 
per year) 
Incidence of influenza (all types and sub-
types)-associated hospitalised ALRI (per 




















2008 NA NA NA NA NA NA 4 2.9 0.8 
Multistate, USA 
(Dawood et al., 2010) 
2004-
2005 
NA NA NA NA NA NA 0.9 0.6 0.3 
2005-
2006 
NA NA NA NA NA NA 0.9 0.7 0.4 
2006-
2007 
NA NA NA NA NA NA 0.7 0.5 0.3 
2007-
2008 
NA NA NA NA NA NA 1.1 0.8 0.4 
           
Europe 
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Location;  (reference) 
Study 
period 
Incidence of influenza A(H1N1 & H3N2)-
associated hospitalised ALRI (per 1000 
children per year) 
Incidence of influenza B-associated 
hospitalised ALRI (per 1000 children 
per year) 
Incidence of influenza (all types and sub-
types)-associated hospitalised ALRI (per 




















Gipuzoka, Spain (Montes 
et al., 2005) 
2001-
2002 
NA NA NA NA NA NA NA NA 1.2 *  
2002-
2003 
NA NA NA NA NA NA NA NA 0.1 †  
2003-
2004 
NA NA NA NA NA NA NA NA 1.5* 
South-East Asia 
Sa Kaeo and Nakhon 
Phanom, Thailand 
(Simmerman and 
2005 NA NA NA NA NA NA 9.2 10.0 7.1 
2006 NA NA NA NA NA NA 2.1 3.2 2.5 
                                                 
NA- Data not available 
* Circulating strain A/H3N2 
† Circulating strain A/H1N1 and Influenza B 
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Location;  (reference) 
Study 
period 
Incidence of influenza A(H1N1 & H3N2)-
associated hospitalised ALRI (per 1000 
children per year) 
Incidence of influenza B-associated 
hospitalised ALRI (per 1000 children 
per year) 
Incidence of influenza (all types and sub-
types)-associated hospitalised ALRI (per 




















colleagues, unpublished) 2007 NA NA NA NA NA NA 7.4 7.2 4.5 
2008 NA NA NA NA NA NA 5.2 8.3 7.1 
           
Western Pacific 
Bohol, Philippines 




1.1 1.1 NA 0 0 NA 1.1 1.1 NA 
2001-
2002 
1 0.8 NA 0.7 0.4 NA 1.7 1.1 NA 
2002-
2003 
1.7 1.3 NA 1.4 0.8 NA 3.1 2.1 NA 
2003-
2004 
1.8 2.2 NA 0.9 0.7 NA 2.7 2.9 NA 
Hong Kong SAR, China 2003- 7.8 5.5 7 0 0 0.5 7.8 5.5 7.5 
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Location;  (reference) 
Study 
period 
Incidence of influenza A(H1N1 & H3N2)-
associated hospitalised ALRI (per 1000 
children per year) 
Incidence of influenza B-associated 
hospitalised ALRI (per 1000 children 
per year) 
Incidence of influenza (all types and sub-
types)-associated hospitalised ALRI (per 




















(Chiu et al., 2009) 2004 
2004-
2005 
10.4 7.3 5.4 0 1.3 3.1 10.4 8.7 8.5 
2005-
2006 
3.9 4.7 4.1 0 0 1.6 3.9 4.7 5.7 
Suzhou district, China (Ji 
et al., 2010) 
2007 NA NA NA NA NA NA 0.6 0.3 0.2 
2008 NA NA NA NA NA NA 0.6 0.4 0.3 
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Table 6: Estimates of incidence (per 1000 children) and number of new hospitalised cases of 
influenza-associated ALRI in children younger than 5 years in 2008, by World Health 
Organization Regions 
WHO Region 





ALRI in infants 
aged below 1 




aged below 1 








below 5 years 
(95% CI)*  
Number of new 
episodes in 
children aged 
below 5 years in 
2008 (thousands) 
Africa (6) 2.3 (1.6, 3.4) 64 (44, 92) 1.0 (0.9, 1.2) 134 (113, 159) 
Americas (16) 2.5 (1.8, 3.6) 39 (28, 55) 1.2  (1.0, 1.6) 95 (73, 126) 
Europe (6) 1.9 (1.3, 2.8) 21 (15, 31) 1.1 (0.7, 1.6) 55 (37, 82) 
South East Asia (4) 2.2 (0.7, 6.8) 79 (25, 247) 1.4 (0.4, 5.6) 257 (65, 1020) 
Western Pacific (7) 3.6 (1.7, 7.4) 81 (39, 169) 2.1 (0.9, 5.1) 255 (105, 620) 
Summed regional 
estimate † 
 284 (151, 594)  796 (393, 2006) 
Developing 
countries (21) 
2.8 (2.0, 4.1) 348 (239, 507) 1.4 (0.9,2.3) 844 (566, 1269) 
Industrialised 
countries (18) 
2.4 (1.7, 3.0) 26 (20, 33) 1.2 (0.9, 1.7) 67 (50, 87) 
Global estimate 
(39) ‡ 





                                                 
* Data are incidence meta-estimates from random effects model; incidence estimates are per 1000 children per 
year 
† There is no regional estimate for Eastern Mediterranean region as there are no data from this region. This 
contributes to the difference in summed regional estimates and global estimates.  
‡ Number of new cases globally in the year 2008 is the sum of new cases in children residing in developing and 
industrialised countries in 2008; data in parentheses are 95% CIs 
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3.1.2. Prevalence-based approach 
3.1.2.1. Proportion of hospitalised ALRI cases positive for influenza 
3.1.2.1.1. Methods 
3.1.2.1.1.1. Literature search 
A systematic literature review (using the same search strategy as detailed in Appendix A3) 
was conducted across the following electronic databases – Medline (Ovid), Embase, 
CINAHL, Global Health, Web of Science, WHOLIS, LILACS, IndMed; and a grey literature 
database (SIGLE). The search was limited to studies published between 1 January, 1995, and 
31 December, 2011 for the reasons already detailed in section 3.1.1.1.1. In this instance, 
Chinese language databases were not searched, as the assistance of a Chinese researcher was 
no longer available. In order to conform to the PRISMA guidelines, a parallel literature 
search in English language databases and data extraction was independently performed by 
another researcher (Kathryn Lafond, MPH) based at US CDC. For defining influenza-
associated hospitalised ALRI, a case definition identical to that for incidence based studies 
was utilised –i.e. a child with cough or difficulty breathing hospitalised for respiratory 
ailment and testing positive for influenza virus (using valid diagnostic tests). All identified 
studies were assessed using the eligibility criteria detailed in Panel 3.  No language or 
publication restrictions were applied. Data were extracted onto a data extraction template 
designed on Microsoft Excel (Microsoft office 2003). Any disagreements were discussed and 
arbitrated by a senior researcher at US CDC (Dr. Marc-Alain Widdowson). Since the US 
CDC was leading the efforts to collect unpublished data relating to prevalence-based disease 
burden estimates, and the author was collaborating on this project, it was decided that (for the 
doctoral thesis), the estimates for proportion of hospitalised ALRI positive for seasonal 
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3.1.2.1.1.2. Ethical approval 
The author conducted a Self-Audit for Level 1 Ethical Review in relation to this project. This 
was done using a checklist developed by the School of Health in Social Science and adopted 
by the Post Graduate Ethics Committee of the College of Medicine and Veterinary Medicine, 
University of Edinburgh. Since no foreseeable ethical risks were identified (as all analysis 
were on secondary data), a formal ethical approval was not required. The individual 
collaborating sites re-analysing primary data sought ethical approvals from their respective 
Institutional Review Boards. A copy of the Self-Audit Checklist for Level 1 is placed in the 
Appendix A1.  
3.1.2.1.1.3. Statistical analysis 
A meta-analysis of the data (through  April 15, 2009) from studies reporting proportion of 
hospitalised ALRI cases positive for seasonal influenza  was conducted (using Stata 11.2) and 
Inclusion criteria 
• Studies with data on children aged less than 5 years with laboratory confirmed influenza 
and hospitalised for ALRI  
• Studies published between 1 January 1995 and 31 December 2011 
• Study should have been carried out for a minimum of one year (except in temperate 
regions where influenza seasonality is more clearly defined) 
Exclusion criteria 
• Studies where influenza was studied as a co-infection rather than a primary outcome 
• Studies that reported a denominator population at risk and were thus able to compute 
incidence rates 
• Case definition was not clearly defined and / or not consistently applied 
• Studies reporting data for age groups other than the full 0-59 month age range 
• Study data after 21 April, 2009 (onset of influenza A(H1N1)pdm09 pandemic 
• Case ascertainment was conducted only during an epidemic period 
Panel 3: Eligibility criteria for selection of studies reporting the proportion of hospitalised ALRI 
cases positive for seasonal influenza in young children 
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the pooled estimates along with 95% CIs have been reported. As discussed previously in 
section 3.1.1.1.5.3, the random effects model (DerSimonian-Laird method) was used since 
heterogeneity in the data was anticipated. The proportion of influenza positive hospitalised 
ALRI cases was estimated by regions- both for industrialised and developing countries as 
well as for the six WHO regions. 
3.1.2.1.2. Results 
Twenty three hospital-based published studies using passive case ascertainment (i.e. a child 
with ALRI being brought to a health facility) and satisfying the eligibility criteria were 
identified (Figure 11). All studies were in large tertiary care centres in urban areas (Table 7). 
Nineteen of the 23 included studies were from developing countries (Figure 12).  The data 
from both the developing as well as industrialised countries were significantly heterogeneous 
(p<0.0005, I2 >90 percent). Only 42% of the included studies from developing countries used 
PCR (six studies) or viral culture (two studies) for identification of the influenza virus. Two 
additional studies used viral culture in combination with immunofluorescence to identify 
viral infection. By contrast, 50% (2/4) of the studies from industrialised countries used PCR 
as a diagnostic assay. The two remaining studies used viral culture in combination with 
immunofluorescence to identify viral infection. There was substantial variability in the 
proportion of hospitalised ALRI cases positive for influenza. In general, the proportion of 
influenza positive hospitalised ALRI cases was highest in the Western Pacific region (Table 
8). The proportion of influenza positive hospitalised ALRI cases in young children was about 
5.0 (95% CI 3.6 to 7.0) percent in developing countries and about 8.4 (95% CI 4.2 to 16.7) 
percent in industrialised countries (Figure 13). Eleven studies (8 from developing countries), 
reported on influenza positivity separately for the influenza A virus (Johnson et al., 2008, 
Smuts, 2008, Venter et al., 2011, Carballal et al., 2001, Viegas et al., 2004, Aranda-Romo et 
al., 2010, Bakir et al., 1998, Foulongne et al., 2006, Weigl et al., 2005b, Wolf et al., 2006, 
Samransamruajkit et al., 2008). Data from these studies indicate that influenza A conferred 
70 to 100 percent of the disease burden due to seasonal influenza-associated hospitalised 
ALRI in young children.   
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Figure 11: Flow diagram for selection of studies (in young children) reporting proportion of 




5752 records identified from 
database search  
10 records identified from other 
sources 
4644 records after duplicates 
removed 
4644 records screened 
4385 records excluded as not relevant to 
the topic 
259 full-text articles assessed for eligibility 
23 full text articles reported data on proportion of children (aged 0-
59 months) hospitalised for ALRI and positive for seasonal 
influenza 
236 full-text articles excluded: 186 did not meet 
inclusion criteria; 8 reported denominator 
population; 35 studies did not report data for 0-
59 months age range; 3 studies included 
children with asthma; 2 reported data on 
influenza A(H1N1)pdm09; 2 studies were in 
Chinese language and could not  be translated 
using Google translator 
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Figure 12: Location of the 23 studies (indicated using red diamonds) reporting proportion of influenza positive hospitalised ALRI cases in young 
children by World Health Organization Regions
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Table 7: Proportion of hospitalised ALRI cases in children (aged 0-59 months) positive for 
seasonal influenza 












     
Africa 
Ibadan, Nigeria (Johnson et 
al., 2008) 1992-1995 
Hospitalised ALRI with a 
chest radiograph suggestive 
of pneumonia  
Nasopharyngeal 
aspirate; IFA 15.6 (50/323) 
Soweto, South Africa 
(Madhi et al., 2000) 1997-1998 Hospitalised ALRI 
Nasopharyngeal 
aspirate; DFA, viral 
culture 
8.6 (70/817) 
Cape Town, South Africa 







Pretoria, South Africa 





     
Americas 
Rio de Janerio, Brazil 
(Sutmoller et al., 1995) 1987-1989 Hospitalised ALRI 
Nasopharyngeal 
aspirate; IFA  1.4 (7/501) 
Multicentre, Argentina 
(Carballal et al., 2001) 1993-1994 Hospitalised ALRI 
Nasopharyngeal 
aspirate; IFA  2.4 (29/1234) 
Buenos Aires City and 
Greater Buenos Aires, 
Argentina (Viegas et al., 
2004) 
1998-2002 Hospitalised ALRI Nasopharyngeal aspirate; IFA  2.8 (531/18561) 
San Luis Potosi, Mexico 
(Aranda-Romo et al., 2010) 2002-2009 
Hospitalisation for 
respiratory symptoms Nasal wash; RT-PCR 4.4 (106/2378) 
Sao Paulo, Brazil 





Hospitalised ALRI with 
chest radiograph compatible 
with pneumonia 
Nasopharyngeal 
aspirate; IFA  9.2 (17/184) 
Sao Paulo, Brazil (Pecchini 
et al., 2008) 2005-2006 Hospitalised ALRI 
Nasopharyngeal 
aspirate; IFA  3.3 (15/455) 
     
Eastern Mediterranean 
Riyadh, Saudi Arabia 
(Bakir et al., 1998) 1993-1996 Hospitalised ALRI  
Nasopharyngeal 




(Barakat et al., 2011) 2007-2009 
SARI: Hospitalised for 
cough or difficulty breathing 
with or without wheezing or 
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Europe 
Beer-Sheva, Israel (Wolf et 
al., 2006) 2001-2002 Hospitalised ALRI  
Nasal wash; DFA, 
viral culture 15.1 (78/516) 
Kiel, Germany (Weigl et 
al., 2005a) 2002-2004 
Hospitalised ALRI 
(Discharge diagnosis ICD-9 
code 460 to 490, and ICD-10 






(Foulongne et al., 2006) 2003-2004 Hospitalised ALRI  
Nasopharyngeal 
aspirate; DFA and 
viral culture 
3.1 (18/589) 
Lausanne and Geneva, 
Switzerland (Cevey-
Macherel et al., 2009) 
2003-2005 Hospitalised ALRI  Nasopharyngeal aspirate; RT-PCR 14.1 (14/99) 
     
South East Asia 
New Delhi, India (Kabra et 
al., 2003) 1995-2003 Hospitalised ALRI  
Nasopharyngeal 
aspirate; viral culture 5.3 (5/95) 
Bangkok, Thailand 
(Suntarattiwong et al., 
2007) 
2004-2005 Hospitalised ALRI  Nasopharyngeal swab; viral culture  8.6 (39/456) 
Bangkok, Thailand 
(Samransamruajkit et al., 
2008) 
2006-2007 Hospitalised ALRI  Nasopharyngeal swab; RT-PCR 11.3 (27/239) 
     
Western Pacific 
Lanzhou, Gansu, China 
(Zhang et al., 2011) 2004-2005 
Hospitalised ALRI with 
chest radiograph compatible 
with pneumonia 
Nasopharyngeal 
swab; DFA 8.4 (58/688) 
Ho Chi Minh City, 
Vietnam (Do et al., 2011) 2004-2008 Hospitalised ALRI  






Hong Kong SAR, China 
(Tsung et al., 2010) 2005-2007 Hospitalised ALRI  
Nasopharyngeal 
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Figure 13: Forest plot of estimates of proportion of hospitalised ALRI cases positive for 
seasonal influenza in young children 
D+L (overall) indicates meta-estimate by random effects analysis 
I-V (overall) indicates meta-estimate by fixed effects analysis 
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Table 8: Meta-estimates of the proportion of influenza positive hospitalised ALRI cases in 
young children by World Health Organization Regions 
WHO Region (Number of studies) Proportion (%) of hospitalised ALRI cases 
positive for influenza (95% CI) * 
Africa (4) 5.2 (2.4 to 11.1) 
Americas (7) 3.6 (2.6 to 4.9) 
Eastern Mediterranean (2) 2.1 (0.9 to 5.0) 
Europe (4) 8.4 (4.2 to 16.7) 
South East Asia (3) 9.1 (6.8 to 12.3) 
Western Pacific (3) 11.4 (7.9 to 16.3) 
Developing countries (19) 5.0 (3.6 to 7.0) 
Industrialised countries (4) 8.4 (4.2 to 16.7) 
  
                                                 
* Data are proportion meta-estimates from random effects model 
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3.1.2.2. Number of hospitalised ALRI cases in young children in 
2008 
3.1.2.2.1. Methods  
3.1.2.2.1.1. Literature search 
A systematic literature review was conducted across the following electronic databases – 
Medline (Ovid), Embase, CINAHL, Global Health, Web of Science, WHOLIS, LILACS, and 
IndMed. Additionally, three Chinese language databases (The China National Knowledge 
Infrastructure or CNKI (www.global.cnki.net), Wanfang (http://www.wanfangdata.com.cn), 
and Chongqing VIP (http://www.cqvip.com) were searched for studies (with a clear 
denominator of the population at risk) published in Chinese language during the same period. 
A grey literature database (SIGLE) was also searched. The detailed search strategy is placed 
in the appendix (Appendix A4). The search was limited to studies published between 1 
January, 1990, and 31 March, 2012. Studies published since January 1990 (rather than since 
January 1995 as was in the case of search for influenza-associated hospitalized ALRI) were 
included because identification of hospitalised ALRI cases were not based on diagnostic 
assays. Extending the search period would therefore permit inclusion of some important 
studies that were conducted in the latter part of 1980s and early part of 1990s, thereby 
increasing the final number of studies included in the meta-analysis.   Panel 4 shows the 
eligibility criteria. No language or publication restrictions were applied. Only studies that 
reported a well-defined catchment population or were able to estimate the population at risk 
were included. In addition to the author, the literature search and data extraction from English 
language databases was conducted independently by another researcher (Peter Hanlon, 
MBChB). Any disagreements were resolved after discussion with the supervisor for this 
doctoral thesis (Prof. Harry Campbell). Literature search and data abstraction from Chinese 
language databases were performed by another researcher Jian Shayne F. Zhang, MPH who 
read Chinese as a first language and had access to all three databases. The search strategy and 
data extraction were validated during direct discussions with the author. All data were 
extracted onto data extraction template designed on Microsoft Excel (Microsoft Office 2003). 
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3.1.2.2.1.2. Unpublished data 
Twenty three leading researchers on paediatric pneumonia were identified through their 
publication track record as well as through extensive consultations with subject experts- 
primarily those involved in the RSV and Influenza-associated ALRI disease burden 
estimation projects. This led to the formation of an international consortium (“Severe ALRI 
Working Group” (SAWG)) that consisted primarily of researchers working in developing 
countries. The author organised and led a two-day meeting of SAWG in Edinburgh, UK on 
August 30-31, 2010. This meeting was funded by the World Health Organisation’s Global 
Influenza Programme.  
During the two-day meeting, the SAWG discussed extensively the availability of data on 
hospitalised ALRI (from studies having a clear denominator of the population at risk) in 
Inclusion criteria 
• Studies reporting hospitalisation for ALRI in children younger than five years  
• Studies with at least 12 consecutive months of data collection 
• Studies published between January 1990 and March 2012 
• Studies in children less than 5 years of age, or should have reported data for this age group 
separately 
• Studies reporting hospitalised ALRI incidence / mortality for at least the first year of life 
Exclusion criteria 
• Studies reporting only aetiology-specific incidence or mortality estimates 
• Studies reporting incidence or mortality estimates for ALRI confirmed only by a chest 
radiograph 
• Studies where description of the methods for estimating denominator population was not 
clear 
• Case definition not clearly defined and / or not consistently applied 
• Incidence and mortality estimated using modelling techniques 
Panel 4: Eligibility criteria for selection of studies reporting incidence of hospitalised ALRI in 
young children 
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children aged below five years and finalised common case definitions for analysing all 
available data. The group agreed to either re-analyse their already published data or share 
hitherto unpublished data from on-going studies on a common data extraction template 
designed in Microsoft Excel 2003. The group suggested the inclusion of some other research 
groups who, to the best of their knowledge, had conducted similar studies but were not 
invited for the meeting. These groups were contacted and enlisted into the SAWG. Finally, 
24 research sites from 16 countries contributed unpublished data for estimating the incidence 
of hospitalised (all-cause) ALRI in children aged 0-59 months.  
3.1.2.2.1.3. Case definitions 
Most investigators used modified versions of WHO case definitions for pneumonia (Table 9) 
(World Health Organization, 1991, Department of Child and Adolescent Health, 2005). 
However, for this thesis, the term ALRI rather than pneumonia has been chosen since a large 
proportion of ALRI in young children present as bronchiolitis which may often be clinically 
indistinguishable from pneumonia. It was decided that children with cough or difficulty 
breathing with increased respiratory rate for age with / without lower chest wall indrawing 
that were hospitalised (based on the judgement of the attending physician) should be referred 
to as hospitalised ALRI.  
3.1.2.2.1.4. Ethical approval 
The author conducted a Self-Audit for Level 1 Ethical Review in relation to this project. This 
was done using a checklist developed by the School of Health in Social Science and adopted 
by the Post Graduate Ethics Committee of the College of Medicine and Veterinary Medicine, 
University of Edinburgh. Since no foreseeable ethical risks were identified (as all analysis 
were on secondary data), a formal ethical approval was not required. The individual 
collaborating sites re-analysing primary data sought ethical approvals from their respective 
Institutional Review Boards. A copy of the Self-Audit Checklist for Level 1 is placed in the 
Appendix A1.  
3.1.2.2.1.5. Statistical analysis 
3.1.2.2.1.5.1. Data imputation 
While fifty one of the 85 studies included in this review provided data for infants (0-11 
months) and 66 studies provided data for the young children (0-59 months), only 43 studies 
provided data for both age ranges (0-11 months and 0-59 months). In order to deal with the 
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missing data in the remaining 42 studies, data imputation was performed separately for the 
developing and industrialised regions by calculating the median incidence rate ratio (IRR) as 
was previously done in similar studies by Rudan and Nair (Rudan et al., 2004, Nair et al., 
2010). For imputing missing data, it was assumed that the age structure is similar across all 
studies from a given region (i.e. developed or industrialised countries).  
Using data from 17 published and 18 unpublished studies from developing countries, relative 
to an incidence rate of 1.0 in the age group 0-11 months, the median IRR for the age group 0-
23 months and 0-59 months was calculated to be 0.75 and 0.37. This median IRR was then 
applied to the reported incidence rates of hospitalised ALRI for 0-11 months, 0-23 months or 
0-59 months to estimate the incidence rate for the missing age groups. In the case of 
industrialised countries, data on full age range were available from 7 published studies and 
one unpublished study. Using incidence rate data from these studies, the median incidence 
rate ratio (IRR) was computed for children in the age group 0-23 months and 0-59 months. 
Relative to an incidence of 1.0 in the age group 0-11 months, the median IRR for the age 
group 0-23 months and 0-59 months was calculated to be 0.70 and 0.45. In order to assess the 
validity of data after imputation, a sensitivity analysis was conducted by including only those 
studies which had data for the full age range (0-59 months) (for results see Table 27).  
3.1.2.2.1.5.2. Meta-analysis 
A meta-analysis of the data (through December 31, 2008) from studies reporting incidence of 
hospitalised ALRI was conducted (using Stata 11.2) and the pooled estimates along with 95% 
CIs have been reported. As discussed in section 3.1.1.1.5.3, the random effects model 
(DerSimonian-Laird method) was used since heterogeneity in the data was anticipated 
(DerSimonian and Laird, 1986). The incidence rates were estimated by regions- for 
industrialised and developing countries as well as for the six WHO regions. These incidence 
estimates were then applied to the population of children younger than 5 years in 2008 both 
globally as well as in the six WHO regions to estimate the number of new episodes of 
hospitalised ALRI in 2008. Countries have been designated as industrialised or developing on 
the basis of UNICEF’s classification (United Nations Children's Fund, 2012). The child 
population estimates for 2008 are as in the UN Population Division’s database, “World 
Population Prospects: The 2010 revision” 
(http://esa.un.org/unpd/wpp/unpp/panel_population.htm). 
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3.1.2.2.1.5.3. Adjustments  
One published study (study period 1998-2005) was identified from Soweto, South Africa 
(Madhi et al., 2005).  Since HIV is a major risk factor for hospitalised ALRI, and the 
prevalence of HIV in children aged below 5 years has decreased substantially and access to 
highly active antiretroviral treatment (HAART) has increased dramatically in South Africa 
from 2002 (median year for the included study from Soweto, South Africa), the reported 
incidence rates for this study (Table 9) were adjusted (as described in Appendix A5) taking 
into consideration both paediatric HIV prevalence (in children aged below 5 years) and 
access to HAART using data for Soweto obtained from National Institute of Communicable 
Diseases, South Africa (Madhi, 2011).  The adjusted rates were used while conducting the 
meta-analysis.  
If the duration of any eligible study was not in exact multiples of one year (e.g. 18 months, 30 
months etc.), the annualised incidence rate has been calculated and reported by adjusting for 
the population at risk.  
  
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
Influenza-associated ALRI disease burden estimate  71 
3.1.2.2.2. Results 
Eighty five hospital-based studies with incidence data satisfied the eligibility criteria (Figure 
14). Of these, 61 were published studies (14 of them in Chinese language) and 24 were 
unpublished studies with data collected through 15 April 2009 (Figure 15).  Twenty nine 
studies were in rural populations, sixteen in urban and the remainder were a mixture of rural 
and urban populations. Forty percent (24/61) of studies from developing countries were either 
cohort studies or were nested in a demographic surveillance site; 8% (5/61) had a well-
defined catchment area and the population was estimated using a healthcare utilization survey 
(Azziz-Baumgartner et al., 2012, Jordan et al., 2009, Feikin et al., 2011); and 52% (32/61) of 
the studies were based in hospitals with a well-defined catchment area (Table 9). Only 43 
studies (24 published and 19 unpublished) reported incidence rates by age group for the full 
age range (i.e. 0-59 months) and data were imputed for the remaining 42 studies.  
The majority of the data (25/85 studies) were from the Western Pacific Region of the WHO. 
Only two studies (both from Pakistan) were identified from the Eastern Mediterranean 
Region. There was considerable variation in the incidence rates across the six WHO regions 
(Table 10). While the incidence rates for infants (aged 0-11 months) were highest in Africa 
and South-East Asia regions (about 49 episodes per 1000 children / year), the overall 
incidence for young children was highest in Africa (about 21 episodes per 1000 children / 
year). The data from developing and industrialised countries were significantly 
heterogeneous (p<0.0005, I2>93 percent).  
Sixty-one hospital-based studies from developing countries reported incidence of hospitalised 
severe ALRI in children aged 0-59 months. The incidence of hospitalised severe ALRI in 
young children aged 0-59 months was 18.9 (95% CI 15.9 to 22.4) episodes per 1000 children 
per year in developing countries (Table 10). The incidence rates were highest in infants aged 
0-11 months [48.6 (95% CI 41.0 to 57.6) episodes per 1000 children per year]. Using data 
from 24 hospital-based studies in industrialised countries, the incidence of hospitalised severe 
ALRI in children aged 0-11 months and 0-59 months residing in industrialised countries was 
estimated to be 19.1 (95% CI 15.7 to 23.4) episodes and 9.6 (95% CI 7.1 to 13.0) episodes 
per 1000 children per year. This translates to about 11.3 (95% CI 9.5 to 13.5) million 
episodes of hospitalised ALRI worldwide in children aged less than 5 years in 2008, with 
disease in infants (0-11 months) contributing to about 52% of this overall “burden” (Table 
10).   
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Figure 14: Flow diagram for selection of studies reporting incidence of hospitalised ALRI in 
young children 
24 unpublished population-based studies 
identified for supplementary data 
5955 records identified from 
database search  
7 records identified from 
other sources 
3678 records after duplicates 
removed 
3678 records screened 
3395 records excluded as not 
relevant to the topic 
283 full-text articles assessed for 
eligibility 
61 full text articles reported incidence 
data 
85 studies provided incidence data 
222 full-text articles excluded: 216 did not 
meet inclusion criteria; 3 reported 
incidence of ALRI confirmed by a chest 
radiograph; 3 studies used community –
based active case ascertainment  
10 full text articles reported case fatality 
ratios 
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Figure 15: Location of the 85 studies reporting incidence of hospitalised ALRI by World Health Organization Regions
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Table 9: Incidence estimates of hospitalised ALRI in children younger than 5 years from 








Case definition  
Incidence of 
hospitalised ALRI * 
(per 1000 children 





     
Africa 
Kassena-Nankana 
District, Ghana; rural; 






Physician diagnosed ALRI 56.8 20.9 
Western Region, The 
Gambia; mixed rural-
urban; 1993-1996 
(Mulholland et al., 




Physician diagnosed ALRI (21.6) (8) 
Soweto, South Africa; 
urban;1998-2001 
(Madhi et al., 




Physician diagnosed ALRI (96.5) 35.7 
Manhiça, Mozambique; 
rural; 1999-2000 




Physician diagnosed ALRI 126 68 
Bamako, Mali; urban; 





Physician diagnosed ALRI 10 3.5 
Agincourt, South 
Africa; rural; 2000-





Physician diagnosed ALRI 332 80 
Bondo district, Kenya; 
rural; 2001-2003 




Physician diagnosed ALRI 13.7 7 
Upper River Division 
and Central River 
Division, The Gambia; 
rural; 2002-2004 





Cough or difficulty breathing and 
chest wall indrawing or grunting 27.8 (10.3) 
                                                 
* ALRI= acute lower respiratory infection 
† Data in parentheses are computed incidence estimates from data imputation 
‡ Included children from 2 months of age 
§ Excluded neonates (0-27 days) 
** Incidence rates adjusted for HIV prevalence (0-59 months) and HAART coverage in 2008 included in meta-analysis 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 








Case definition  
Incidence of 
hospitalised ALRI * 
(per 1000 children 





Kilifi District, Kenya; 






Acute cough / difficulty in breathing 
AND chest wall indrawing or 
tachypnea (>60 breaths per minute) in 










Age≥2 months- cough or difficult 
breathing with chest wall indrawing in 
hospitalised children.  
Age<2 months- cough or difficult 
breathing with tachypnea or chest wall 
indrawing 
65.3 (24.2) 
Bondo district, Nyanza 
province, Kenya;  rural; 






Physician diagnosed ALRI 28.6 16.8 
Upper River Region, 







Physician diagnosed ALRI  
OR 
Cough or difficult breathing with chest 
wall indrawing 
86.4 33.2 








Physician diagnosed ALRI  
OR 
Age ≥2 months- Cough or difficult 
breathing with chest wall indrawing; 
Age <2 months- Tachypnea (>60 
breaths/ min) or chest wall indrawing 
72.9 98.9 
     
Americas 
American Indians and 
Alaska Natives, USA; 
rural; 1990-1995 




Hospitalised bronchiolitis (Discharge 
diagnosis- ICD-9-CM code 466.1)   61.4 11.3 
Tennessee (TN), USA; 
mixed rural-urban; 





Hospitalised bronchiolitis (Discharge 









Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 480-487.0) 15 7.4 
USA; mixed rural-
urban; 1996-




Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 480-487.0)  (40.4) 18.2 
USA; mixed rural-
urban; 1997-2000 (Lee 




Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 480-487.0) 11.6 5.2 
                                                 
†† Day 0 excluded 
‡‡ Detailed age specific incidence estimates obtained directly from authors 
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Case definition  
Incidence of 
hospitalised ALRI * 
(per 1000 children 





American Indians and 
Alaska Natives, USA; 
rural; 1999-2001(Peck 




Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 466.1 and / 
or 480 - 486) 
128.7 32.9 
Colorado (CO), USA; 
mixed rural-urban; 






Physician diagnosed ALRI  43.1 16.9 
Monroe County (NY), 
Davidson County (TN) 
and Hamilton County 
(OH), USA; mixed 
rural-urban; 2000-2004 




Physician diagnosed ALRI 43.9 15.2 
USA; mixed rural-
urban; 2001–2007 
(Grijalva et al., 2010) ‡‡ 
Census-derived 
estimate 
Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 480-487.0) 10.2 5.8 
Paysandú and Salto, 
Uruguay; mixed rural-
urban; 2001-2004 





Physician diagnosed ALRI 77.8 34.5 
Yukon Kuskokwim 








Hospitalised ALRI (Discharge 
diagnosis- ICD-9CM code 480-486, 
507.0 and 487.0) 
223.4 (82.6) 
Concordia and Parana, 
Argentina; urban; 2002 






Acute cough / difficulty in breathing 
AND chest indrawing or tachypnea 
(>60 breaths per minute) in infants 
aged <2 months 
30.3 14.2 
San Lorenzo & 
Comitancillo, 
Guatemala; rural; 2002-






Cough or difficult breathing with 
lower chest wall indrawing in children 
>2 months of age OR cough or 
difficult breathing with tachypnea (60 
breaths / min.) in a child <2 months of 
age 
49.8 (18.4) 
United States; 2003 
(Yorita et al., 2008) 
Census-derived 
estimate 
Physician diagnosed ALRI (Discharge 
code ICD-9-CM 022.1, 031.0, 033, 
095.1, 466, 480-487, 510, 511.1, 513, 
517.1, 770.0) 
41.4 18.6 
Pilar, (Buenos Aires 
Province), Argentina; 
mixed rural-urban; 2003 




Physician diagnosed ALRI 35.5 10.5 
                                                 
§§ All eligible subjects were followed up weekly at home by trained field workers who referred children with findings 
suggestive of respiratory disease to the community clinics and 70-80% of these were attended by a physician 
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Case definition  
Incidence of 
hospitalised ALRI * 
(per 1000 children 








urban; 2003-2006 (Lee 
et al., 2010) 
Census-derived 
estimate 
Physician diagnosed ALRI (Discharge 
diagnosis ICD-9 CM code 480-487.0) 9.3 4.8 








Physician diagnosed ALRI 10 (3.7) 
















Hospitalised ALRI (Discharge 
diagnosis- ICD-10CM codes J10, J11, 
J09-J18.9, J20, J21, J22, J80, J96. For 
new-borns also P23-P23.9) 
95.3 28 
Santa Rosa, Guatemala; 
mixed rural-urban; 2007 






Physician diagnosed ALRI  
OR  
age 2-59 months- cough or difficulty 
breathing with chest wall indrawing; 
age < 2months-  RR>60/min or chest 
wall indrawing 
38.6 14.7 








Cough or difficulty breathing plus any 
danger sign (inability to feed or drink, 
vomiting everything, convulsions, 
lethargy or unconsciousness) or chest 









Cough and / or difficult breathing with 
or without tachypnea AND chest wall 
indrawing or stridor or general danger 
signs (inability to breast feed or drink, 
vomits everything, convulsion, 
lethargy, loss of consciousness) 
40 14.7 









Physician diagnosed ALRI (Discharge 
code-ICD-9 CM 480-486.0 and ICD-
10-AM J12-18)  
3.7 2.2 
Kuopio, Finland; mixed 
rural-urban; 1981-1982 




Physician diagnosed ALRI (41.9) 18.9 
Spain; mixed rural-
urban; 1995-1996 





Physician diagnosed ALRI (Discharge 
code- ICD-9 CM 480-486.0) (11) 4.9 
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Case definition  
Incidence of 
hospitalised ALRI * 
(per 1000 children 






urban; 1995-1998 (Gil 




Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 003.22, 
052.1, 055.1, 073.0, 083.0, 480-487.0) 
(9.3) 4.2 
Valencia, Spain; urban; 
1995-2000 (Garces-




Physician diagnosed ALRI (15.6) 7 
Valencia, Spain; mixed 
rural-urban; 1995–2001 





Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 481, 485, 
486) 
(11.5) 5.2 
Gipuzoka, Spain; mixed 
rural-urban;1996-2000 




Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 466.1) (22.5) 10.1 
Kiel, Germany; urban; 













Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 480-486.0) (6.9) 3.1 
Multicentre, Germany; 
mixed rural-urban; 1999 





Physician diagnosed ALRI 51.7 (23.2) 
Liguria, Italy; mixed 
rural-urban; 2000-2004 




Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 480-487.0) (9.2) (4.1) 
Gipuzoka, Spain; mixed 
rural-urban; 2004-2007 












Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM code 480-486.0) (7.6) 3.4 
Limousin, France; 
mixed rural-urban; 





Hospitalised bronchiolitis 17.7 (8) 
     
South East Asia 
Matlab, Bangladesh; 
rural; 1988-1989 




Cough and / or difficult breathing with 





1999-2000 (Brooks et 




Crepitations on inspiration, with 
respiratory rate >50 breaths / min, with 
chest wall indrawing or other danger 
signs (lethargy, cyanosis, inability to 
(109.6) (40.5) 
                                                 
^ Rates do not include cases with wheezing or rhonchi without crepitations (as these were labelled as bronchiolitis) 
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Case definition  
Incidence of 
hospitalised ALRI * 
(per 1000 children 














Cough or difficult breathing with chest 
wall indrawing OR infant aged < 2 
months with increased respiratory rate 
(≥60 / min.) 
83.6 (30.9) 
Matlab, Bangladesh; 
rural; 1999-2001 (Baqui 




Cough and / or difficult breathing with 
or without tachypnea AND chest wall 
indrawing or stridor or general danger 
signs (inability to breast feed or drink, 
vomits everything, convulsion, 




2004-2007 (Chandyo et 




Cough and / or difficult breathing 
combined with lower chest wall 
indrawing and admittance to hospital 
(11.7) (4.3) 
Kathmandu, Nepal; 
urban; 2004-2007 (Shah 




Cough and / or difficult breathing with 
or without tachypnea AND chest 
indrawing 
(16.8) 6.2 
Nakhon Phanom and Sa 
Kaeo provinces, 
Thailand; rural; 2004-






Hospitalised ALRI- children having 
evidence of acute infection (reported 
fever or chills, documented 
temperature  >38.2ºC or <35.5ºC, or 
abnormal WBC count or abnormal 
differential count) and at least one sign 
or symptom of lower respiratory tract 
disease (abnormal breath sounds on 
chest auscultation, tachypnea, cough, 
sputum production, hemoptysis, chest 










Physician diagnosed ALRI - 
Cough or difficult breathing with / 
without chest wall indrawing OR 
infant aged < 2 months with increased 
respiratory rate (≥60 / min.) 
73.9 19 
Patan, Nepal; urban; 
2005-2006 (Williams et 













Cough or difficulty breathing or fast 
breathing or chest retractions or chest 
wall indrawing or nasal flaring or 
grunting or abnormal auscultation 
69.3 (25.6) 
                                                                                                                                                        
*** All eligible subjects were followed up weekly at home by trained Field Research Assistants (FRAs) who referred 
children with findings suggestive of respiratory disease to the clinic 
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Case definition  
Incidence of 
hospitalised ALRI * 
(per 1000 children 





Bangalore, India; urban; 





Physician diagnosed ALRI (17.3) 6.4 
Kamalapur, 
Bangladesh; urban; 






History of cough with or without 
documented fever (axillary 
temperature - ≥ 38°C), WHO specified 
age specific elevated respiratory rate  
(0 - <2 months of age RR = ≥60/min, 2 
- <12 months of age RR ≥ 50/min and 
12 - <60 months of age RR ≥40/min) 
and chest wall indrawing 
71.7 24 
Multicentre, 







Cough or difficult breathing with chest 
wall indrawing or requiring 
hospitalization 
51.3 14 




urban; 1985 -1987 




Cough and / or difficult breathing with 










Physician diagnosed ALRI 32.1 10.2 
Zhejiang, China; mixed 
rural-urban; 1990-1991 




Cough and / or difficult breathing with 
or without tachypnea AND chest wall 
indrawing  
25 8.6 
Zhejiang, China; rural; 





Cough and / or difficult breathing with 









Cough and / or difficult breathing with 










Cough and / or difficult breathing with 




mixed rural-urban;  





Cough and / or difficult breathing with 









Cough and / or difficult breathing with 










Physician diagnosed ALRI (24.2) 10.9 
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Case definition  
Incidence of 
hospitalised ALRI * 
(per 1000 children 





Fujian, China; rural; 





Cough and / or difficult breathing with 
or without tachypnea AND chest wall 
indrawing  
(65.5) 24.2 
Henan, China; rural; 




Cough and / or difficult breathing with 
or without tachypnea AND chest wall 
indrawing  
52.1 23.2 






Cough and / or difficult breathing with 
or without tachypnea AND chest wall 
indrawing  
33.8 9.4 
Henan, China; rural;  




Cough and / or difficult breathing with 
or without tachypnea AND chest wall 
indrawing  
(128.1) 47.4 
Fujian, China; mixed 
rural-urban; 1994-1995 




Cough and / or difficult breathing with 
or without tachypnea AND chest wall 
indrawing  
52.5 24 
Yunnan, China; rural; 





Cough and / or difficult breathing with 










Cough and / or difficult breathing with 




mixed rural-urban; 1995 




Cough and / or difficult breathing with 










Physician diagnosed ALRI (Discharge 
diagnosis- ICD-10 codes J12-J18, B59, 
B05.2, B37.1, B01.2)  
52 20.9 
Taiwan; 1997-2004 
(Wu et al., 2009) ††† 
Census-derived 
estimate 
Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM codes 480-487) 49.8 39.7 
Bohol, Philippines; 
mixed rural-urban; 






Cough or difficulty breathing with 
chest wall indrawing 89.7 (33.2) 
Tongatapu, Tonga; 
mixed rural-urban; 
2000-2004 (Russell et 
al., 2009) §^ 
Census-derived 
estimate Physician diagnosed ALRI (27.2) 10.1 
Hong Kong, urban; 





Physician diagnosed ALRI (Discharge 
diagnosis- ICD-9 CM codes 481 and 
486) 
(19.1) 8.6 
                                                 
††† Excluded pneumonia in children aged 0-3 days 
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Case definition  
Incidence of 
hospitalised ALRI * 
(per 1000 children 





Suva, Fiji; urban; 2001-





Physician diagnosed ALRI (40) 18 
NhaTrang district, 
Vietnam; mixed rural-
urban; 2005-2006 (Anh 




Physician diagnosed ALRI 69.5 22.6 
Tongatapu, Tonga; 
mixed rural-urban; 2006 





Physician diagnosed ALRI (19.5) 7.2 
NhaTrang city, 
Vietnam; urban; 2007–





Physician diagnosed ALRI 65.8 34 
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Table 10: Incidence and number of new episodes of hospitalised ALRI in young children aged 
below 5 years in 2008, by WHO region 
Region 



















Africa 13 (2) 
49.3 (30.4 
to 79.8) 
1343 (829 to 
2174) 13 (3) 
21.1(13.6 
to 32.8) 
2707 (1742 to 
4206) 
Americas 18 (1) 
38.7 (30.0 
to 50.0)         
601 (466 to 
777) 18 (6) 
17.4 (12.0 
to 25.3) 
1361 (95% CI 
939 to 1974) 
Eastern 
Mediterranean 2 (0) 
27.9 (14, 
55.5) 
432 (217 to 
860) 2 (0) 
12.1 (8.6 
to 17.2) 
894 (631 to 
1266) 
Europe 14 (9) 
14.2 (8.1, 
25) 157 (90 to 277) 14 (4) 
7.3 (4.6 to 
11.6) 
383 (240 to 
611) 
South East 
Asia 13 (6) 
49.8 (33.6 
to 73.8)        
1815 (1225 to 
2688) 13 (4) 
18.6 (11.4 
to 30.3) 
3355 (2057 to 
5474) 
Western 
Pacific 25 (15) 
43 (32.3, 
57.3) 
984 (739 to 
1310) 25 (1) 
17.3 (13.4 
to 22.3) 
1973 (1529 to 
2545) 
       
Developing 
countries 61 (22) 
48.6 (41.0 
to 57.6) 
5690 (4797 to 
6750) 61 (12) 
18.9 (15.9 
to 22.4) 
10764 (9063 to 
12792) 
Industrialised 
countries 24 (11) 
19.1 (15.7 
to 23.4) 
221 (181 to 
270) 24 (6) 
9.6 (7.1 to 
13.0) 
543 (402 to 
735) 
       
Global ††††  85 (33) 
 
5911 (4978 to 
7020) 85 (18) 
 
11309 (9465 to 
13527) 
 
                                                 
‡‡‡ Data in parentheses indicate number of studies with imputed data 
§§§ Data are incidence meta-estimates from random effects model; incidence estimates are per 1000 children per 
year 
**** Data in parentheses are 95% CIs 
†††† Number of new cases globally in the year 2008 is the sum of new cases in children residing in developing 
and industrialised countries; data in parentheses are 95% CIs 
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3.1.2.3. Number of hospitalised influenza-associated ALRI cases in 
2008 
3.1.2.3.1. Methods 
The regional meta-estimates of the proportion of hospitalised ALRI cases positive for 
seasonal influenza (section 3.1.2.1.2) were applied to the regional estimates of (all-cause) 
hospitalised ALRI for the year 2008 that was estimated as described in section 3.1.2.2.2. 
3.1.2.3.2. Results 
Using the prevalence based approach, it is estimated that about 772,000 (95% CI 343,000 to 
1.8 million) hospitalisations due to influenza-associated ALRI occurred worldwide in young  
children (0-59 months) in 2008 (Table 8). South-East Asia and Western Pacific region of the 
WHO accounted for 68% of this global “burden”. The global estimates (772 (95% CI 343 to 
1821) thousand) as well as the regional estimates (except for Americas and Europe) are 
consistent with the estimates obtained using the incidence-based approach (911 (95% CI 617 
to 1356) thousand) (Table 12).    
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Table 11: Estimated number of hospitalisations due to influenza-associated ALRI in young 
children (0-59 months) in 2008 using a prevalence-based approach 
Region 
Proportion (%) of 
hospitalised ALRI 
positive for seasonal 
influenza (95% CI)  
Estimated number of 
episodes of 
hospitalised ALRI in 
2008 (thousands) * 
Estimated number of 
seasonal influenza-
associated 
hospitalised ALRI in 
2008 (thousands)* 
Africa 5.2 (2.4 to 11.1) 2707 (1742 to 4206) 141 (42 to 469) 
Americas 3.6 (2.6 to 4.9) 1361 (939 to 1974) 49 (25 to 97) 
Eastern Mediterranean 2.1 (0.9 to 5.0) 894 (631 to 1266) 19 (6 to 64) 
Europe 8.4 (4.2 to 16.7) 383 (240 to 611) 32 (10 to 102) 
South-East Asia 9.1 (6.8 to 12.3) 3355 (2057 to 5474) 306 (139 to 673) 
Western Pacific 11.4 (7.9 to 16.3) 1973 (1529 to 2545) 225 (122 to 416) 
Global †   772 (343 to 1821) 
 
 
                                                 
* Data in parentheses are 95% CIs 
† Number of new cases globally in the year 2008 is the sum of new cases in children residing in the six WHO 
regions; data in parentheses are 95% CIs 
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Table 12: Comparison of the estimated number of hospitalisations due to influenza-associated 
ALRI in young children aged below 5 years in 2008 using the incidence and prevalence-based 
approaches 
Region 
Estimated number of hospitalisations 
due to seasonal influenza-associated 
ALRI in 2008 using prevalence–
based approach (thousands) * 
Estimated number of 
hospitalisations due to seasonal 
influenza-associated ALRI in 2008 
using incidence–based approach 
(thousands)* 
Africa 141 (42 to 469) 134 (113, 159) 
Americas 49 (25 to 97) 95 (73, 126) 
Eastern 
Mediterranean 
19 (6 to 64) NA † 
Europe 32 (10 to 102) 55 (37, 82) 
South-East Asia 306 (139 to 673) 257 (65, 1020) 
Western Pacific 225 (122 to 416) 255 (105, 620) 
Global 772 (343 to 1821) 911 (617, 1356) 
 
                                                 
* Data in parentheses are 95% CIs 
† NA- Data not available 
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3.2. Influenza-associated ALRI mortality in 2008 
3.2.1. Method 
There are no global / regional estimates of the mortality attributable to seasonal influenza-
associated ALRI in young children (0-59 months).  Various modelling approaches have been 
used previously to estimate seasonal influenza-associated mortality (Simonsen et al., 1998, 
Simonsen et al., 2005, Thompson et al., 2003, Wong et al., 2004). These are described in 
detail in section 1.4. In order to precisely estimate the deaths due to influenza-associated 
ALRI in young children, two different data are required: good quality mortality data from 
vital registration / verbal autopsy studies; and good quality year round virological 
surveillance data for seasonal influenza and RSV as in many settings both viruses are known 
to co-circulate during the influenza season. Various studies have shown that the majority of 
ALRI deaths in developing countries occur at home, and vital registration data are incomplete 
(Adazu et al., 2005, Sacarlal et al., 2009, Sutanto et al., 2002, Rudan et al., 2005). Since data 
related to influenza-associated ALRI deaths were scarce, therefore modelling a point estimate 
for influenza-associated ALRI mortality was not attempted. Instead two approaches were 
used to assess the likely upper and lower boundary of ALRI mortality that could plausibly be 
attributed to influenza. 
3.2.1.1. Approach 1 (hospitalised cases) 
Studies reporting in-hospital case fatality ratio (CFR) for influenza-associated ALRI in 
hospitalised cases were identified from literature review and from unpublished data available 
with the Influenza Study Group. A meta-analysis of the in-hospital CFR was conducted using 
the random effects model to account for between-study heterogeneity. The pooled estimates 
and 95% confidence intervals were reported for industrialised and developing countries. 
These in-hospital CFR meta-estimates of influenza-associated ALRI were applied to the 
number of new cases of hospitalised influenza-associated ALRI (calculated individually for 
developing and industrialised countries) for the year 2008. Since access to hospital care in 
most developing countries is typically limited, it would be fair to assume that this result 
represents a lower bound for influenza-associated ALRI mortality. 
3.2.1.2. Approach 2 (all cases) 
The second approach was similar to the method used to estimate mortality due to RSV-
associated ALRI in children (Nair et al., 2010). First, the definition for influenza season 
provided by Izurieta and colleagues was modified for tropical / subtropical settings as data on 
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influenza positivity were only available by month (Izurieta et al., 2000). Any month in which 
at least 10 samples were analysed, and influenza virus was detected in more than 5% of 
specimens was considered to be within the “influenza season”. It was assumed that all excess 
mortality due to ALRI in children younger than 5 years during the “influenza season” was 
due to seasonal influenza virus, and that non-influenza mortality is equal within and between 
influenza epidemic periods. Since this approach represents an extreme case scenario, it was 
assumed that this method yielded an upper bound for influenza-associated ALRI mortality. 
The duration (in months) of the “influenza season” for each calendar year of the study 
(MonFLU) was defined. For each year, the average number of total ALRI deaths in the 
community that occurred per month during (AvgFLU) and outside (AvgOTHER) the 
“influenza season”, as well the total number of deaths (TOTAL) during the year was 
computed. The proportion of yearly deaths due to influenza was then calculated as: 
(AvgFLU – AvgOTHER) x MonFLU 
TOTAL 
 Population-based data to define “influenza season” and monthly death records (with cause of 
death attribution based on verbal autopsy data) from the same population for a period of three 
years were available from Ballabgarh, Haryana in India and Nairobi, Kenya (Nongkynrih et 
al., 2003, Ye et al., 2009). However, the Kenyan data were not suitable for this analytic 
approach as influenza virus was circulating throughout the years 2003-05 making it 
impossible to clearly delineate an “influenza season” (Figure 16). Application of this 
approach to the estimated mortality of children younger than 5 years due to ALRI in India in 
2008 (Black et al., 2010) provided an estimate of all ALRI deaths attributable to influenza if 
community-based case ascertainment (to identify all severe cases of influenza-associated 
ALRI) was used. The ratio of influenza-associated ALRI deaths (using this approach) 
compared to the influenza-associated ALRI deaths in hospitalised cases (using the first 
approach) in India was then applied to the lower bound of influenza-associated ALRI 
mortality in developing countries to estimate the upper bound of global ALRI mortality 
attributable to influenza in children younger than 5 years.  
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Figure 16: Seasonal pattern of laboratory confirmed influenza activity in Nairobi, Kenya from 
2003 to 2005. The number of influenza positive samples is indicated using a blue line and the 
proportion (%) of samples positive for influenza is indicated using red bars. The continuous 
circulation of the influenza virus in 2005 made it difficult to delineate an influenza season 
3.2.2. Results 
3.2.2.1. Approach 1 (In-hospital mortality due to influenza-
associated ALRI) 
Twelve published and 8 unpublished studies providing in-hospital CFR data for deaths in 
children (aged 0-59 months) with influenza-associated ALRI admitted to hospital were 
identified (Figure 5). Eleven studies reported in-hospital CFR data from developing countries 
(Table 10). The data from developing countries demonstrated some heterogeneity (I2 for 
heterogeneity=46.5%). However, there was no heterogeneity in the in-hospital CFR data 
from 8 studies in industrialised countries (I2 for heterogeneity=0%). The in-hospital CFR 
meta-estimate for developing countries was roughly 8 times that for industrialised countries. 
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Table 13: In-hospital case fatality ratio in children aged below 5 years with an admission 
diagnosis of ALRI and positive for seasonal influenza 
Location (Reference) Study period 





Paraná State, Brazil (Coelho et al., 2007) 1996-2001 6. 7 (3/45) 
Hong Kong (Nelson et al., 2007) 1997-1999 0.1 (7/5471) 
Soweto, South Africa (Madhi and colleagues, unpublished) 1998-2004 5.6 (10/178) 
Bohol, Philippines (Lucero and colleagues, 
unpublished) * † ‡ 2000-2004 7.5 (3/40) 
Kuala Lumpur, Malaysia (Sam et al., 2010) 2002-2007 2.6 (3/116) 
Hong Kong SAR, China (Kwong et al., 2009) 2005 1.2 (1/86) 
Sa Kaeo and Nakhon Phanom, Thailand (Simmerman and 
colleagues, unpublished) 2005-2008 0.2 (1/430) 
Kilifi, Kenya (Berkley and colleagues, unpublished) 2007 2.4 (1/41) 
Bondo district, Kenya (Ope and colleagues, unpublished) 2007-2009 4.5 (3/67) 
SARI Sentinel sites, Jordan, Oman, Egypt (Dueger and 
colleagues, unpublished) 2008 2.5 (2/80) 
Santa-Rosa, Guatemala (Lindblade and colleagues, 
unpublished) §§ 2008 28.6 (2/7) 
Takeo town, Cambodia (Vong and colleagues, unpublished) 2008 5 (1/20) 






South Australia, Australia (D'Onise and Raupach, 2008)  1996-2006 0.6 (4/626) 
Philadelphia (PA), USA (Coffin et al., 2007) 2000-2004 0.9 (5/573) 
Leicester, United Kingdom (Nicholson et al., 2006) ** 2001-2002 0 (0/33) 
Gipuzoka, Spain (Montes et al., 2005) 2001-2004 0 (0/70) 
Salt Lake County (UT), USA (Ampofo et al., 2006) 2001-2004 0.3 (1/325) 
Sydney, Australia (Milne et al., 2004)* 2003 6.3 (1/16) 
                                                 
* CFR meta-estimates if this study were excluded- 2.75% 
† CFR meta-estimates if Philippines and Guatemala study are excluded- 2.71% 
‡ This study was in children aged 0-23 months  
§ CFR meta-estimates if this study were excluded- 2.92% 
** CFR meta-estimates if these studies were excluded- 0.3% 
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Location (Reference) Study period 




Canada (Moore et al., 2006) 2003-2004 0.2 (1/424) 
Multicentre, United States (Dawood et al., 2010) 2003-2008 0.2 (7/2998) 





The in-hospital mortality due to influenza-associated ALRI was calculated using the 
estimated number of new cases of influenza-associated hospitalised ALRI in the year 2008 
(Table 6) and the in-hospital CFRs from children admitted with severe disease reported in 
hospital-based studies calculated separately for developing and industrialised countries 
(Table 13). Using this approach, it is estimated that approximately 21532 (95% CI 3958 to 
55702) young children (aged 0-59 months) died in hospitals in 2008 because of influenza-
associated ALRI (Panel 5). Ninety nine percent of all in-hospital deaths occurred in 
developing countries. There were insufficient data to calculate in-hospital CFR estimates in 
children in smaller age categories than 0-59 months.  
3.2.2.1.1. Proportional contribution of influenza to all-cause in-
hospital ALRI mortality  
To estimate the proportional contribution of influenza to all-cause in-hospital ALRI 
mortality, the overall in-hospital CFR in young children aged 0-59 months was estimated 
using data from 24 published studies and 10 unpublished studies (Figure 14).  Thirty one 
studies were from developing countries and three were from industrialised countries.  
                                                 
†† CFR meta-estimates are from random effects model. In case of industrialised countries CFR meta-estimates 
from random and fixed effects models were identical 
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Table 14: In-hospital case fatality ratios for ALRI in children than 5 years (n=34 studies)  
Location (reference) Study Period Case fatality 




Kassena-Nankana District, Ghana (Morris and colleagues, 
unpublished) 
1990-1991 3.3 (1/30) 
Soweto, South Africa (Madhi and colleagues, unpublished) 1998-2005 6.2 
(170/2722) 
Bondo district, Kenya (Tornheim et al., 2007)  2001-2003 11.0 
(120/1088) 
Kilifi District, Kenya (Moisi and colleagues, unpublished) 2002-2008 9.5 
(481/5041) 
Upper River Division and Central River Division, The Gambia 
(Zaman and colleagues, unpublished) 
2002-2004 12.0 (17/142) 
Manhiça district, Mozambique (Roca and colleagues, 
unpublished) 
2004-2006 8.7 (46/526) 
Bondo district, Kenya (Ope and colleagues, unpublished) 2007-2009 4.3 (42/985) 
Lwak, Kisumu, Kenya (Breiman and colleagues, unpublished) 2008-2009 1.5 (7/453) 
Kibera, Nairobi, Kenya (Breiman and colleagues, unpublished) 2008-2009 1.4 (4/285) 
Upper River region, The Gambia (Mackenzie and colleagues, 
unpublished) 
2008-2009 3.7 (33/898) 
CFR meta-estimate (95% CI) *  5.9 (4.4 to 7.8) 
                                                 
* Data are in-hospital CFR meta-estimates (%) from random effects model 
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Location (reference) Study Period Case fatality 
ratio (%) for 
hospitalised 
ALRI (n) 
   
Americas 
USA (Grijalva et al., 2010)  1997-2004 0.2 
Paysandú and Salto, Uruguay (Hortal and colleagues, 
unpublished) 
2000-2004 0.3 (7/2137) 
Goiânia, Brazil (Andrade and colleagues, unpublished)  2000-2001 1.1 (3/281) 
Colorado, USA (Simoes and colleagues, unpublished) 2000-2008 0.6 
(298/50469) 
Concordia and Parana, Argentina (Ruvinsky and colleagues, 
unpublished)  
2002-2005 1.1 (17/1601) 
Pilar, Argentina (Gentile and colleagues, unpublished) 2003-2005 0.2 (2/856) 
Goiânia, Brazil (Andrade and colleagues, unpublished)  2007-2009 0.3 (12/4388) 
Santa Rosa, Guatemala (McCracken and colleagues, unpublished) 2007-2008 4.8 (9/187) 
Multicentre, El Salvador (Clara and colleagues, unpublished)  2007 1.1 
(741/69140) 
CFR meta-estimate (95% CI) 0.8 (0.5 to 1.6) 
   
Eastern Mediterranean 
Sana'a, Yemen (Banajeh, 1998)  1991-1995 8.7 
(221/2554) 
Karachi, Pakistan (Owais et al., 2010)  2007-2008 3.7 (2/54) 
CFR meta-estimate (95% CI) 7.6 (4.1 to 13.9) 
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Location (reference) Study Period Case fatality 
ratio (%) for 
hospitalised 
ALRI (n) 
   
Europe 
Spain (Monge and Gonzalez, 2001) 1995-1996 0.4 
(64/15877) 
   
South East Asia 
Matlab, Bangladesh (Zaman et al., 1997)  1988-1989 7.4 (2/27) 
Lombok, Indonesia (Gessner and colleagues, unpublished) 1999-2002 11.0 
(656/5942) 
Mirzapur, Bangladesh (Arifeen and colleagues, unpublished) 2004-2008 2.2 (17/780) 




Patan, Nepal(Williams et al., 2009)  2005-2006 2.2 (8/360) 
Multicentre, India (Chandran and colleagues, unpublished) 2005-2007 0.3 (2/695) 
Nakhon Phanom and Sa Kaeo provinces, Thailand (Baggett and 
colleagues, unpublished)  
2006-2008 0.8 
(122/14782) 
Bangalore, India (Shah et al., 2009b)  2006 5.8 (56/967) 
Kamalapur, Bangladesh (Brooks and colleagues, unpublished) 2008  0.9 (1/109) 
CFR meta-estimate (95% CI) 2.9 (1.5 to 5.5) 
   
Western Pacific 
Bohol, Philppines (Lucero and colleagues, unpublished) 2000-2004 1.6 (12/736) 
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Location (reference) Study Period Case fatality 
ratio (%) for 
hospitalised 
ALRI (n) 
NhaTrang district, Vietnam (Anh et al., 2009)  2005-2006 2.6 (21/794) 
Suva, Fiji (Magree et al., 2005) 2001-2002 2.8 (7/248) 
CFR meta-estimate (95% CI) 2.3 (1.7 to 3.2) 
   
CFR meta-estimate for Developing countries †                    2.6 (1.8 to 3.9)%                      P<0.0005, 
I2=99% 
CFR meta-estimate for Industrialised countries†                 0.5 (0.3 to 0.7)%                       P=0.004, 
I2=87.8% 
 
The in-hospital CFR in young children aged 0-59 months with hospitalised ALRI was about 
2.6 (95% CI 1.8 to 3.9) percent in developing countries in 2008, with the highest CFRs being 
reported by studies from Africa (Table 14). By contrast, the estimated CFR in industrialised 
countries was 0.5 (95% CI 0.3 0.7) percent (Table 14). When the in-hospital CFR meta-
estimates for the developing and industrialised regions were applied to the incidence meta-
estimates for the respective regions, it was estimated that worldwide in 2008, ALRI resulted 
in about 283,000 (95% CI 164,000 to 504,000) in-hospital deaths in children younger than 
five years. Ninety-nine percent of these deaths occurred in developing countries.  
Thus, about 7.6% (21532/282602) (95% CI 2.4 to 11.1) percent of all in-hospital ALRI 
deaths are attributable to influenza. It is well recognised that 54 to 90% of all ALRI deaths in 
under-five children in developing countries occur outside health facilities (Adazu et al., 2005, 
Sacarlal et al., 2009, Sutanto et al., 2002). Therefore, the estimated 21532 in-hospital deaths 
represent only a proportion of the overall ALRI mortality at attributable to influenza. At best, 
this (1.4% of the estimated overall all-cause ALRI mortality in under-five children – 1.6 
                                                 
† Data in parentheses are 95% CIs 
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(95% CI 1.1 to 1.9) million (Black et al., 2010) ) can be considered to represent a plausible 
lower bound of influenza-associated ALRI mortality.  
3.2.2.2. Approach 2 (Overall mortality due to influenza-associated 
ALRI) 
This approach used cause of death data in children not admitted to hospital, assigned by 
verbal autopsy, and influenza virus isolations in the same population during the same period. 
Such cause of death data were available only from one site- Ballabgarh (Haryana) in India for 
a three year period from 2006-2008 (Nongkynrih et al., 2003). Influenza isolation data from a 
sample of the same population (all age groups) accessing outpatient services for ILIs were 
available from the All India Institute of Medical Sciences (AIIMS) run referral hospital at 
Ballabgarh (Figure 17).  
 
Figure 17: Pattern of verbal autopsy confirmed ALRI deaths in children younger than 5 years 
by circulation of influenza virus in the community in Ballabgarh, India (2006-08) 
Month 1 corresponds to January 2006 and month 36 corresponds to December 2008 
The ALRI deaths attributable to influenza (using mortality data in the community from verbal 
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applied to the published estimates of all-cause ALRI deaths in young children (0-59 months) 
in India in 2008 – 371605 (Black et al., 2010) Furthermore,  the abovementioned estimated 
number of childhood ALRI deaths in India attributable to influenza (24179) was over 5 times 
higher than was estimated with approach 1 (step l, Panel 5). Available data from this site 
indicate that RSV circulated entirely outside the “influenza season” with no overlap (Broor, 
personal communication). Additionally the site has low malaria activity (AIIMS, 2010). If 
these data are assumed to be broadly representative of India, then 6.5% (24179/371605) of all 
paediatric ALRI deaths in India are associated with influenza from 2006-2008. If 
extrapolated to other developing countries, this approach yields a crude estimate (for 
developing countries) of approximately 114,450 (95% CI 21,000 to 300,000) deaths 
attributable to influenza-associated ALRI in young children in 2008 (Panel 5). Black and 
colleagues estimated that globally 1575257 ALRI deaths occurred in young children (0-59 
months) in 2008 (Black et al., 2010). Therefore, the 114,450 influenza-associated ALRI 
deaths estimated above represents about 7.3% (114447/1575257) (95% CI 2.0 to 15.8) 
percent of overall all-cause ALRI mortality in young children. However, this method is likely 
to overestimate deaths because it assumes that all excess ALRI mortality during the 
“influenza season” is due to influenza. This assumption is not likely to be true, in view of 
other respiratory pathogens having a shared seasonality and the likelihood that influenza 
deaths occur outside the defined influenza season (especially in tropical and sub-tropical 
regions where the influenza virus circulates throughout the year) (Chiu et al., 2009, Sam et 
al., 2010).  Additionally, this estimate is based on data from a single study in a small rural 
area in north India and is therefore unlikely to be generalizable. At best, this estimate can be 
considered to represent the plausible upper bound of mortality attributable to influenza-
associated ALRI.  
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Table 15: Estimated influenza-associated ALRI deaths in India based on verbal autopsy 





























ALRI deaths  
attributable  






2006 3 2.33 2.22 27 0.01 4588 
2007 7 1.70 1.60 20 0.04 14864 
2008 5 2.60 1.86 26 0.14 53086 
Average  influenza-associated ALRI  deaths per year 24179 
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Panel 5: Estimated mortality due to influenza-associated ALRI in children younger than 5 years 
Approach 1: In-hospital case fatality ratios and incidence of influenza-associated hospitalised 
ALRI  
Estimated new cases (in children younger than 5 years) of influenza-associated hospitalised ALRI 
in industrialised countries in 2008, a= 66685 (95% CI 50434 to 87419) 
Estimated in-hospital case fatality ratio (CFR; for children younger than 5 years) due to influenza-
associated ALRI yearly in industrialised countries, b= 0.27 (95% CI 0.10 to 0.44) % 
Estimated in-hospital mortality due to influenza-associated ALRI in children (younger than 5 
years) in industrialised countries in 2008, c= a x b= 180 (50 to 385) 
Estimated new cases (in children younger than 5 years) of influenza-associated hospitalised ALRI 
in developing countries in 2008, d= 843952 (95% CI 566411 to 1268761) 
Estimated in-hospital case fatality ratio (CFR; for children younger than 5 years) due to influenza-
associated ALRI yearly in developing countries, e= 2.53 (95% CI 0.69 to 4.36) % 
Estimated in-hospital mortality due to influenza-associated ALRI in children (younger than 5 
years) in developing countries in 2008, f= d x e= 21352 (3908 to 55317) 
Estimated global in-hospital mortality due to influenza-associated ALRI in children (younger than 
5 years) in 2008, g= c + f= 21532 (95% CI 3958 to 55702) 
 
Approach 2: ALRI mortality during influenza season based on data from Ballabgarh, India 
Average proportion of ALRI mortality attributable to influenza during 3 years= 0.06 
Estimated mortality due to ALRI in Indian children younger than 5 years= 371605 (Black et al., 
2010) 
Estimated mortality due to influenza-associated ALRI in children younger than 5 years, h= 24179 
(mean of the three yearly estimates) 
Estimated number of hospitalised cases of influenza-associated ALRI in children younger than 5 
years in India in 2008 (applying the incidence of influenza-associated hospitalised ALRI in South-
East Asia (Table 6) to under-five population in India in 2008), i= 178263 
Estimated in-hospital mortality due to influenza-associated ALRI in Indian children, j= i x e= 4510 
Proportion of mortality from this approach compared to approach 1, j=h / i= 5.36 
Estimated global mortality due to influenza-associated ALRI (by extrapolating Indian model), k= j 
x f= 114447 (95% CI 20947 to 296450)
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In summary, insufficient data are available to make precise estimates of global mortality from 
influenza-associated ALRI. Two independent approaches with differing assumptions and 
limitations were adopted to obtain a rough data-derived estimate of the plausible lower and 
upper bound for influenza -associated ALRI mortality in young children. The estimates of 
mortality are consistent with influenza being associated with approximately 7% (uncertainty 
range 2 to 16%) of deaths from ALRI in children. Data from India and Kenya show 
substantial yearly variation in magnitude of influenza epidemic activity and associated ALRI 
deaths (Table 15, Figure 16, Figure 17). This finding suggests that national, regional and 
global influenza mortality could also vary widely from year to year.
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Chapter 4. Influenza disease burden estimation 
using severe acute respiratory infection (SARI) 
Sentinel Surveillance data 
4.1. Background 
Although virological surveillance for influenza has been conducted through the global 
influenza surveillance network (GISN) over the last six decades, the data collected through 
the approximately 130 national influenza centres around the world are primarily aimed at 
monitoring changes in the antigenicity of influenza virus and guide the selection of strains for 
the annual influenza vaccine, rather than assessing severity of disease. This gap in 
epidemiological data became evident during the influenza pandemic of 2009. The lack of any 
established surveillance for severe disease in most countries and the resulting absence of 
historical data limited the ability of the WHO member states to evaluate the severity of the 
event in the context of previous seasons. Even where the data were available, they were not 
collected using a standardised approach, which meant that the data could not be interpreted 
outside the local context. Thus, the WHO suggested using standardised case definitions for 
influenza surveillance in 2010 and have now updated these with guidelines for influenza 
surveillance in WHO member states (WHO Global Influenza Programme, 2012). The “WHO 
interim global epidemiological surveillance standards for influenza” focuses on mild 
influenza like illness (ILIs) as well as on severe acute respiratory infections (SARI). One of 
the aims of the revised surveillance guidelines was to enable data collection for influenza 
disease burden estimation. The WHO issued a request for proposals (RFP) for developing a 
manual (aimed at low and middle-income countries) for estimating influenza disease burden 
in a population using locally available data using basic mathematical methods accessible to 
an individual with basic epidemiological training. A detailed proposal was prepared in 
response to this RFP and the project was awarded jointly to the author and his supervisor 
(Prof Harry Campbell). 
4.2. Methods 
Prior to the development of the final draft of the manual, the following preparatory activities 
were undertaken: 
1. Needs assessment through survey of end-users in low and middle-income countries 
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2. Consultation with experts working in influenza disease burden estimation in low and 
middle-income countries 
3. Engaging the services of an educational consultant for instructional design and 
content delivery 
4. Engaging the services of a software developer for developing an electronic tool for 
disease burden estimation using the methods outlined in the manual 
5. Selection of possible sites for a desktop pilot of the methods and tools outlined in the 
draft manual 
6. Desktop pilot of the draft manual at three SARI surveillance sites in two developing 
countries 
7. Undertaking appropriate revisions based on feedback from end-users, independent 
technical experts, and internal reviewers at the WHO (WHO Steering Committee). 
 
4.2.1. Needs assessment 
A questionnaire (Appendix A6) was developed by the author to consult end-users in 
developing countries in order to understand their perceived needs so as to appropriately 
inform the design and content of the manual. This questionnaire was circulated to influenza 
focal points in 40 low and middle-income countries through the Global Influenza 
Programme, WHO. Twenty seven end-users in 24 countries (24 respondents in developing 
and three in industrialised countries) responded to the survey (Table 16).  
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Table 16: Location of respondents to the end-user survey for informing design and content of 
the influenza disease burden manual 
Africa Americas Eastern 
Mediterranean 








Cameroon Cuba Oman Belarus  Singapore 
Côte d’Ivoire Mexico  Georgia   
Ethiopia   Israel   
Ghana   Kyrgyzstan   
Madagascar   Portugal   
Uganda (2 
respondents) 
  Russia   
South Africa   Ukraine   
 
All respondents were MDs/ Ph.Ds/Masters in Public Health and working as epidemiologists 
in the Influenza Division in the Ministry of Health in the above countries. A majority of the 
respondents (48%) had ≥ 10 years’ experience as an epidemiologist and 30% had experience 
ranging between 6 and 10 years. Almost all (93%) felt that seasonal influenza was an 
important public health problem in their country. The respondents were asked to indicate 
what, in their opinion, were the best data sources that could contribute to influenza disease 
burden estimation. Eighty one percent (22/27) of the respondents indicated that, in their 
opinion, population-based data from sentinel sites were the best data source that could 
contribute to influenza disease burden estimation. Other sources of data that were indicated as 
being useful for disease burden estimation were: 
a. data on hospitalised children with ALRI positive for influenza where the denominator 
population (for the hospital catchment area) can be estimated using healthcare 
utilisation surveys- 59% (16/27) 
b. data on hospitalised children with ALRI positive for influenza where the denominator 
population (for the hospital catchment area) cannot be estimated- 41% (11/27) 
With regard to availability of influenza related data in their respective countries, 96% of the 
respondents indicated that they had data from sentinel surveillance for ILI/SARI (Table 17). 
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Exclusion of the three industrialised countries (Israel, Portugal and Singapore) from the 
analysis did not alter the results.  
Table 17: Current availability of influenza-related data in the WHO member states responding 
to the survey (N=24 respondents) 
Data source Overall availability (n) Availability in 21 
developing countries (n) 
Sentinel surveillance for ILI / SARI 96% (23) 95% (20) 
Hospital surveillance for respiratory 
infections 
67% (16) 66% (14) 
Laboratory surveillance for influenza virus 54% (13) 48% (10) 
ARI/pneumonia surveillance 29% (7) 19% (4) 
 
The survey indicated that while 85% of the respondents routinely analysed and monitored the 
timeliness of reporting of influenza surveillance data, they were not using it appropriately for 
either improving influenza surveillance or for assessing influenza-associated morbidity 
(Table 18). 
Table 18: Current patterns of action on influenza surveillance data in WHO member states 
(N=27 respondents) 
Activity Overall respondents 
utilizing  data for the 
activity (n) 
Developing country 
respondents utilizing data for 
the activity (n) 
Analyse data and monitor 
timeliness of  reporting 
85% (23) 83% (20) 
Update influenza surveillance 
database 
59% (16) 58% (14) 
Provide data to Ministry of 
Health  
48% (13) 46% (11) 
Assess influenza-associated 
morbidity 
48% (13) 50% (12) 
Alert unusual influenza activity 26% (7) 25% (6)  
Estimate influenza seasonality 22% (6) 21% (5) 
Improve influenza surveillance 22% (6) 21% (5) 
 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
Disease burden estimation using SARI sentinel surveillance data  105 
The majority (63%) of respondents indicated that the main limiting factor for influenza 
disease burden estimation was the lack of relevant / reliable data on influenza cases (Table 
19).  About a third (37%) of the respondents indicated the lack of a clear denominator 
(population at risk) as another reason which did not permit disease burden estimation.  
Table 19: Perceived gaps in the capacity to conduct disease burden estimation in the WHO 
member states (N=27 respondents) 
Factor  Overall Response (n) Response  from respondents 
in developing countries (n) 
Lack of reliable / relevant data on 
influenza cases 
63% (17) 54% (13) 
Shortage of trained manpower 44% (12) 46% (11) 
Lack of denominator data  37% (10) 33% (8) 
Lack of laboratory facilities and 
equipment 
30% (8) 33% (8) 
Lack of political commitment  26% (7) 29% (7) 
Lack of a dedicated influenza section 
in Ministry of Health 
15% (4) 17% (4) 
Lack of awareness amongst policy 
makers 
15% (4) 13% (3) 
 
 
Overall 74% (20/27) of the respondents and 79% (19/24) of the respondents from developing 
countries thought it was essential / very useful in the context of their country to have a 
manual providing generic guidelines for influenza disease burden estimation. 
  
“We don’t have any similar manual in our country. The burden estimate is needed to make 
decisions regarding organizing necessary organizational and prevention activities, and also to 
make a decision regarding the finances distribution in order to implement those activities.” 
      (Respondent from Eastern European country) 
“This manual will enable us to study on the socioeconomic impact of influenza in our country. 
This is an important incentive for the politician to get involved in influenza surveillance. For over 
a decade that we monitor flu we are not able to answer these questions. What is the burden of the 
flu? flu is it a major public health concern?” 
      (Respondent from African country 1) 
 
There was however, some concern that this may prove to be a double-edged sword especially 
if the estimated burden was lower than what is perceived generally.  
 
“It will give an idea of how important influenza is as a contributor to overall respiratory disease.  
My concern is that if it’s not found to have a significant share in the overall disease burden (after 
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reviewing several years systematically collected data), there will be less interest to continue with 
generating flu disease burden estimates.” 
      (Respondent from African country 2) 
Only one respondent from an industrialised country felt that there was no need for a manual 
in their national context.  
“I not sure if a manual will be something that GP will read. There is too many paper work and 
formularies in order to make a manual for influenza a really instrument of work. Could be 
theoretically useful. Perhaps a small manual (more operative) with main boxes with resume of 
action in each chapter could be considered for practical use.  The main challenge will be a manual 
that people will really read and put to practical!  Guidelines are different concept from manual and 
people usually give more attention!” 
      (Respondent from industrialised country) 
 
Eighty nine percent (24/27) of the respondents (78% in developing countries) felt that the 
manual should be aimed at epidemiologists. Health care planners and decision makers were 
identified as another important target group for the manual (74% overall and 67% in 
developing countries). Although a spread sheet based model to assist in disease burden 
estimation was not part of the RFP and the approved project proposal, the author felt that this 
would be a useful adjunct to the manual in low and middle income countries where users 
have limited access to statistical packages. Ninety six percent (26/27) of the respondents 
overall (identical proportion from developing countries) affirmed this proposal.  
“Yes, it could be more useful than a complete and meticulous manual with a lot of guidelines and 
complex methods difficult to understand and follow.” 
      (Respondent from Latin American Country) 
 
4.2.1.1. Expected outcomes 
The respondents had varied expectations of the manual. While the majority felt that the 
manual would assist in implementation of SARI sentinel surveillance, a few of the 
respondents expected the manual to: 
• improve case reporting 
• assist in assessing the economic impact of influenza 
• improve surveillance in order to have quality data 
• provide guidance on how to interpret and communicate results 
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The respondents were provided with the proposed content for the manual and were asked to 
indicate how useful this would be in their local context (Table 20). They were also requested 
to provide some any additional content which was likely to be useful. Eighty-nine percent 
(24/27) of the respondents felt that the proposed table of contents was useful in their 
individual countries settings. Specifically, the majority of the respondents felt that the 
chapters on data management; use of simple mathematical methods to estimate disease 
burden; standardisation of case definitions; and use of healthcare utilisation surveys to 
supplement available data were the highlights of the manual. Some of the respondents were 
of the opinion that the chapter on communicating data should include a section on 
communicating results to the general public. One respondent felt that the manual should 
detail the procedure for setting up a national surveillance system. Three proposed content 
items: namely using other data sources to check the plausibility of the estimates; data-sharing 
with neighbouring countries; and taking action to promote local ownership of the data scored 
low on the priority list of the respondents (less than 50% of the respondents considered these 
to be essential). None of the respondents felt that any of the proposed content was not 
relevant for inclusion in the manual.  
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Table 20: Results of the survey regarding proposed content for the manual 
Content 





Uncertain Essential Useful to include Uncertain 
Background 63 (17) 30 (8) 7 (2) 71 (17) 21 (5) 8 (2) 
Rationale and need for 
influenza burden estimate 
78 (21) 19 (5) 4 (1) 79 (19) 17 (4) 4 (1) 
Meaning of disease burden 
(definitions and descriptions 
of various ways to describe 
burden) 
93 (25) 7 (2) 0 (0) 100 (24) 0 (0) 0 (0) 
Description of target 
audience 
44 (12) 41 (11) 15 (4) 46 (11) 38 (9) 17 (4) 
Identifying the various 
sources of data for influenza 
74 (20) 26 (7) 0 (0) 79 (19) 21 (5) 0 (0) 
Critical review of data for 
quality and relevance 
74 (20) 26 (7) 0 (0) 83 (20) 17 (4) 0 (0) 
Selecting appropriate data 
sources 
85 (23) 15 (4) 0 (0) 88 (21) 13 (3) 0 (0) 
Mapping case definitions / 
data to appropriate ICD 
codes to aid interpretation of 
data 
59 (16) 37 (10) 4 (1) 63 (15) 33 (8) 4 (1) 
Adjusting for incomplete 
data (accounting for 
sampling variation) 
59 (16) 37 (10) 4 (1) 58 (14) 38 (9) 4 (1) 
Utilizing data from health 
utilization surveys to 
improve burden estimates 
59 (16) 30 (8) 11 (3) 58 (14) 29 (7) 13 (3) 
Adjusting for incomplete 
data on denominator 
74 (20) 22 (6) 4 (1) 75 (18) 21 (5) 4 (1) 
                                                 
* Data are proportion (%) of respondents; data in parentheses indicate actual numbers 
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Content 





Uncertain Essential Useful to include Uncertain 
population 
Estimating incidence, 
number of new episodes and 
mortality range in a calendar 
year 
81 (22) 19 (5) 0 (0) 83 (20) 17 (4) 0 (0) 
Delineating influenza season 56 (15) 44 (12) 0 (0) 58 (14) 42 (10) 0 (0) 
Expressing a confidence 
range for estimates 
63 (17) 33 (9) 4 (1) 63 (15) 33 (8) 4 (1) 
Carrying out a plausibility 
check with other available 
data 
37 (10) 56 (15) 7 (2) 38 (9) 54 (13) 8 (2) 
Looking at time trends over 
the years 
63 (17) 37 (10) 0 (0) 67 (16) 33 (8) 0 (0) 
Presenting the data in an 
appropriate format for local 
decision makers 
73 (19) 23 (6) 4 (1) 79 (19) 17 (4) 4 (1) 
Considering strategies to 
make appropriate use of 
these data in health services 
planning and priority setting      
63 (17) 37 (10) 0 (0) 71 (17) 29 (7) 0 (0) 
Taking actions to promote 
local ownership of these data 
37 (10) 48 (13) 15 (4) 42 (10) 46 (11) 13 (3) 
Encouraging data sharing 
with neighbouring countries 
to compare influenza burden 
37 (10) 48 (13) 15 (4) 42 (10) 46 (11) 13 (3) 
How seasonal patterns of 
influenza relate to seasonal 
patterns in ALRI hospital 
admission and how to 
interpret these findings 
74 (20) 22 (6) 4 (1) 75 (18) 21 (5) 4 (1) 
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4.2.2. Technical advisory panel (TAP) 
A technical advisory panel of six international experts who are familiar with influenza 
surveillance data and disease burden estimation studies in low and middle-income countries 
was constituted.  These experts included representatives from United States Centres for 
Disease Control and Prevention (US CDC); the Afriflu Alliance, which has been 
strengthening influenza surveillance in sub-Saharan Africa (Steffen et al., 2011); the WHO; 
and health professionals from low and middle-income country sites with relevant local 
influenza data. The TAP met in Edinburgh on May 26, 2011 under the chairpersonship of the 
author and Prof Harry Campbell and discussed the availability of data, possible approaches to 
data assembly, data interpretation and disease burden estimation based on the nature of the 
target audience and their requirements. The following were the main decisions agreed upon in 
the meeting: 
• The manual is not meant to contribute to global influenza burden estimation directly 
but rather give countries tools to better understand data and produce their own 
estimates; and appreciate the importance of influenza in relation to other health 
problems. 
• The manual should be structured like an “instructional cookbook” giving guidance on 
what can be done with available data (explain with examples). 
• The manual should be targeted at those with basic epidemiological training; and the 
output should be focused on those in the Ministry of Health (MOH). 
• A simple spread sheet-based model which will allow countries to calculate national 
disease burden estimates should accompany the manual. 
• The manual should guide the end-user on how to interpret data and present results to 
policy makers. This should include a discussion on limitations of these data and 
caution not to over-interpret data. 
 
4.2.3. External educational consultant  
The majority of the respondents of the initial survey were of the view that while the proposed 
content of the manual was comprehensive, it would be challenging to summarise all the 
information in a user-friendly manner in a single manual. 
“The content is sufficient and well organized. The advice will be to be concise during the writing 
process and avoid long paragraph.” 
      (Respondent from South East Asian Country) 
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Therefore, Agence de Médicine Préventive (AMP), an educational consultancy with proven 
technical expertise and experience in development of learning materials and tools was 
engaged to assist with instructional design and content delivery. While the technical content 
would be provided by the author, AMP were required to help clarify goals and objectives of 
the manual, advise on the instructional design, help develop some activities (including 
assessments) within the manual, assist in the editing of the final text for clarity and coherence 
and produce a ready-for-publication master copy.  
4.2.4. External software developer 
MDigital, a software developer was sub-contracted the task of developing the electronic tool 
(spread sheet based model) based on the methods outlined in the manual. They were required 
to work in co-ordination with the author.  
4.2.5. Selection of developing country sites for desktop pilot 
of the manual 
It was decided that the manual should be desktop piloted † in at least two developing country 
sites with good quality SARI surveillance-preferably one in Africa and another in Asia. The 
choice of the countries would depend on the type of surveillance sites (i.e. nested within a 
demographic surveillance site (DSS) / or secondary hospital with a known catchment area / or 
secondary or tertiary care facility where a catchment area cannot be defined); availability of 
data (sites with year-round surveillance with data for at least a couple of years); working 
language (desktop pilot was to be restricted to Anglophone countries); and an expression of 
interest by member states to participate in this exercise. Eight nine percent (24/27) of the 
respondents to the initial survey were enthusiastic regarding participation in the desktop pilot 
of the draft manual. After extensive consultation with experts at the WHO, India and Ghana 
were selected as the sites for desktop pilot of the manual. One technical expert (leading 
influenza work) from each of these countries was invited to be part of the TAP. After 
informal consultations with these experts during the TAP Meeting, a formal request for the 
desktop pilot was sent to the Ministry of Health in Ghana and the National Institute of 
Virology in India.  
                                                 
† Desktop pilot is defined as testing the methods and tools outlined in the manual using retrospective data at a 
field site 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
Disease burden estimation using SARI sentinel surveillance data  112 
In the case of India, two sites (nested within a DSS), which were part of the US CDC funded 
Influenza Disease Burden India (IDBI) project were selected for the desktop pilot. Both sites 
had different characteristics. While one site (Ballabgarh) had been operational as a field 
practice area for a large teaching hospital (All India Institute of Medical Sciences) in New 
Delhi for over 40 years and had a number of large healthcare facilities within a 10 km radius, 
the other site (Vadu) was only 10 years old and was a relatively remote rural site with the 
sentinel site being the only nearby healthcare facility for the denominator population. The 
Ballabgarh site additionally had outpatient facilities where influenza like illness (ILI) 
surveillance was conducted. It was decided that the desktop pilot would be conducted on-site 
rather than at a central location in India.  
In the case of Ghana, there were four SARI sentinel sites. Three of the four sites were such 
that a catchment area could be defined. The fourth site was a tertiary care centre in the capital 
city, Accra, where the patients from across the country sought healthcare. The desktop pilot 
was to be conducted at a central location in Accra.  
For the desktop pilot at both locations a common format was followed. The two-day desktop 
pilot at both locations was led by the author was accompanied by an expert from the WHO. 
After the introductory talks outlining the context for the manual and how the manual was 
structured, the participants were required to read the manual (although a copy of the manual 
had been shared in advance with the participants). Each chapter was then discussed in detail 
and feedback was provided to the author. Thereafter, on the second day of the workshop, the 
participants were introduced to the electronic tool (spread sheet model). A general talk by the 
author was followed by an introductory video demonstration prepared by the external 
software developers. The participants then tested the electronic tool using their own data and 
identified operational issues with the model. 
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4.3. Results 
4.3.1. The manual  
Based on the feedback from the prospective users of the manual and the recommendations by 
the experts in the TAP, a “Draft Manual for Estimating Disease Burden associated with 
Seasonal Influenza in a Population” was prepared. The manual was prepared using a bottom-
up approach i.e. the manual is mainly focused on an end-user based at a sentinel site rather 
than an epidemiologist at the national level. After the introductory chapters outlining the key 
concepts in influenza disease burden estimation, the users are provided with a detailed 
chapter on identifying and selecting data sources. This chapter provides the users with 
detailed concepts relating to reviewing their data for quality and relevance using the 
parameters of completeness, representativeness, accuracy, and bias. At the end of each 
concept, the users are provided with worked examples and are then required to review their 
own data using the checklist provided in the appendix. The subsequent sections on disease 
burden estimation are structured according to the three different data sources- SARI sentinel 
site; hospital not designated as a SARI sentinel site; and ILI sentinel site.  
The chapter on SARI sentinel sites provides users with guidelines on adjusting case counts 
when clinical specimens are collected in only a proportion of eligible SARI cases. Since the 
majority of SARI sentinel sites are secondary care facilities where the denominator 
population is not known a priori, but can be estimated with some effort, this chapter provides 
detailed guidelines on estimating the catchment population. Previously, the US CDC have 
used healthcare utilisation surveys (HUS) for estimating the denominator population for a 
sentinel site. HUS though robust, are resource intensive and not very straightforward 
(Lindblade et al., 2011, Breiman et al., 2011, Jordan et al., 2009, Clara et al., 2012, Azziz-
Baumgartner et al., 2012). Therefore, in this manual, the author has proposed an alternative 
method (Hospital Admission Survey) for estimating the denominator population using an 
administrative review of the inpatient records of the various healthcare facilities in the 
catchment area of the SARI sentinel site. In this method, the catchment area of the SARI 
sentinel site is assumed to be the lowest (i.e. most peripheral) administrative unit (in which 
the sentinel site is located), for which population data are available. Once the proportion of 
pneumonia cases seeking care at the sentinel site has been estimated after reviewing hospital 
admission records (at all likely points of care) for the past 3 to 5 years, this can be applied to 
the population of the lowest administrative unit, to estimate the catchment population of the 
SARI sentinel site. Identification of the catchment population by age group and gender would 
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enable the sentinel site to estimate the gender and / or age -specific incidence rate due to 
influenza-associated SARI. In the scenario where the denominator population cannot be 
estimated (e.g. tertiary care centres catering to patients from all over the country / large 
teaching hospitals), the chapter provides guidelines on estimating the disease burden 
associated with seasonal influenza by estimating the proportion of SARI cases positive for 
seasonal influenza.  
The other chapters provide guidance on estimating disease burden using data from hospitals 
not designated as SARI sentinel sites (and therefore requiring mapping the case 
definition/ICD code to the SARI case definition); estimating disease burden in specific risk 
groups; and estimating disease burden using ILI sentinel surveillance data. One chapter on 
estimating disease burden using data from multiple sentinel sites is aimed solely at 
epidemiologists working at the national level. The manual concludes with detailed guidance 
on interpreting the results and key aspects to bear in mind when communicating findings to 
the appropriate audience (policymakers/health professionals/general public/surveillance 
sites).  
4.3.2. Desktop pilot  
The draft manual was reviewed by the Steering Group at the WHO and the independent panel 
of experts (TAP) in October and November 2011. The experts provided detailed comments 
for consideration by the author. Based on their feedback, a revised version was prepared for 
the desktop pilot. The desktop pilot of the manual was conducted at two sites (Ballabgarh and 
Vadu) in India and at one site (Accra) in Ghana in December, 2011 and January 2012 
respectively. The participants were varied in terms of their background and experience in 
influenza surveillance. Overall, 18 participants (10 in India and 8 in Ghana) participated in 
this exercise. Twelve of the participants were epidemiologists and six were data analysts or 
program managers. While four of the participants were senior epidemiologists (more than 10 
years of experience), four were relatively new to influenza surveillance. This diversity was 
important as the manual was targeted at professional audiences (with similar abilities and 
experience). 
At the end of the desktop pilot, the participants were asked to provide feedback on a 
structured questionnaire (and score each question on a scale of 0 to 5 with 5 being consistent 
with complete agreement). The feedback has been summarised in Table 21. Overall, the 
participants expressed satisfaction with the content and delivery of the manual. The feedback 
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from all three sites was largely similar except that in Ballabgarh the participants examined the 
manual more critically than at the other two sites, which is reflected in the overall scores 
from this site. This is not surprising as the participants at Ballabgarh were MDs with a 
Master’s degree in Public Health and were working at the premier medical school in India. 
Overall, all participants felt that the manual provided useful background information on 
essential epidemiological concepts for someone (with a minimal training in epidemiology) 
attempting to undertake influenza disease burden estimation.  
 
“With the training I have received in public health, this was essentially a repeat (concise one) of 
the training.” 
     (Participant from India trained in Public Health)  
“Good step-by-step approach. Was helpful”  
     (Participant from India working as Data Analyst) 
All participants felt that the manual was a good starting point for someone not previously 
trained in influenza disease burden estimation.  
“I have been involved in influenza disease burden related activities since last three years already 
and did not learn anything new from this manual. However, I do believe that people who haven't 
been as involved as I am would greatly benefit.”  
     (Participant from India working as Epidemiologist)  
However, some of the participants felt that the manual was too detailed. They advised that 
inclusion of more pictures and flowcharts would make it less daunting for the reader.  
“I was overwhelmed in a positive sense. The information was good but with much repetition.” 
      (Participant from Ghana working as Data Analyst) 
“Pictures, more flowcharts and text boxes could be included”      
     (Another participant from Ghana working as Epidemiologist)
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Table 21: Feedback regarding the technical content and organization of the manual during the 
Desktop Pilot in India and Ghana (n=18 participants) 
Question Proportion (%) of participants in agreement 
(score) 
 Ballabgarh Vadu India total Ghana 
total 
Purpose/objectives      
The rationale and the global introduction 
to the manual were clear and easy to 
understand 
78.3 (23.5) 100 (20) 87 (43.5) 92.5 (37) 
The objectives of the manual were 
clearly stated   
81.7 (24.5) 100 (20) 89 (44.5) 95 (38)  
Technical content      
The technical content was consistent 
with the manual’s objectives 
81.7 (24.5) 95 (19) 87 (40.5) 97.5 (39) 
The technical content extended your 
knowledge on what burden of disease is 
73.3 (22) 90 (18) 80 (40) 95 (38) 
The technical content extended your 
knowledge on how to estimate disease 
burden 
73.3 (22) 90 (18) 80 (40) 100 (40) 
More specifically, the technical content 
extended your knowledge on using your 
surveillance data for influenza cases 
73.3 (22) 95 (19) 82 (41) 92.5 (37) 
More specifically, the technical content 
extended your knowledge on assessing 
the quality of the numerator and 
denominator data 
76.7 (23) 95 (19) 84 (42) 92.5 (37)  
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Question Proportion (%) of participants in agreement 
(score) 
 Ballabgarh Vadu India total Ghana 
total 
More specifically, the technical content 
extended your knowledge on making any 
necessary adjustment to these data 
70.0 (21) 90 (18) 78 (39) 92.5 (37) 
More specifically, the technical content 
extended your knowledge on combining 
data from multiple sites 
66.7 (20) 75 (15) 70 (35) 85 (34) 
More specifically, the technical content 
extended your knowledge on how to 
estimate influenza disease burden at the 
national level 
68.3 (20.5) 75 (15) 71 ((35.5) 95 (38) 
The technical content could be easily 
applied in real-work situations  
78.3 (23.5) 90 (18) 83 (41.5) 90 (36) 
The language used in the manual to 
explain technical content was clear and 
easy to understand 
83.3 (25) 100 (20) 90 (45) 95 (38) 
Flow      
The content was organized in a manner 
that allowed each technical concept to 
build upon the previous one 
83.3 (25) 95 (19) 88 (44) 90 (36) 
Your attention was sustained throughout 
the manual 
90.0 (27) 92.5 
(18.5) 
91 (45.5) 85 (34) 
As a reader you don’t feel overwhelmed 
by information 
78.3 (23.5) 100 (20) 87 (43.5) 77.5 (31) 
Content presentation and layout      
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Question Proportion (%) of participants in agreement 
(score) 
 Ballabgarh Vadu India total Ghana 
total 
The presentation of the technical content 
extended the learning experience 
80 (24) 100 (20) 88 (44) 97.5 (39) 
The layout of the manual supported the 
learning experience 
83.3 (25) 95 (19) 88 (44) 90 (36) 
Instructions on how to use the manual 
were clear and easy to understand 
80 (24) 95 (19) 86 (43) 90 (36) 
Information could be rapidly found 
within the manual 
76.7 (23) 95 (19) 84 (42) 90 (36) 
The page design, which includes text, 
fonts, icons and background, was visually 
pleasing 
75 (22.5) 95 (19) 83 (41.5) 82.5 (33) 
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Based on this feedback, the manual was revised after extensive consultations with the 
instructional designers (AMP). Illustrations to explain new concepts were developed and a 
system of colour coding and symbols was used to segregate the sections and highlight 
important concepts respectively. The revised manual was sent again to the experts at WHO 
and the TAP members for their comments. All reviewers felt that the revised version was 
much improved and that their initial concerns had been addressed. 
4.3.3. Spread sheet model 
Following a video demonstration of the electronic tool, the participants were provided with a 
copy of the spread sheet model on their laptops and an instruction booklet. At all three sites, 
the participants utilised the second day of the workshop for familiarising themselves with the 
tool and using their influenza surveillance data to identify outstanding issues with the tool. 
Although there was not enough time for them to estimate disease burden associated with 
influenza at their sentinel site, they were able to input data for at least three months in each of 
the categories (SARI sentinel site with known population denominator, SARI sentinel site 
with an unknown population denominator, ILI sentinel site without a known population 
denominator). All participants found the tool to be extremely helpful and appreciated the 
accompanying video demonstration as an instructional tool.  
“This is a useful tool. Could be extended to other disease burden estimation aside from influenza.” 
        (Participant from Ghana ) 
They however expressed concerns regarding the ease of navigation between the different 
months within the tool.  
“The start screen can include navigation instructions.”      
        (Participant from India) 
“Cannot move between the months freely.”        
        (Participant from Ghana) 
The general feedback from 17 participants (one participant from India did not attend the 
second day of the workshop) is summarised in Table 22.
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Table 22: Feedback from seventeen participants during the desktop pilot of the spread sheet 
model in India and Ghana  
Item Proportion (%) of respondents (n) 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
Directions for navigating within the spread 
sheet model were clear and easy to 
understand 
35.3 (6) 52.9 (9) 11.8 (2) 0 (0) 
Instruction booklet on how to use the 
spread sheet model was clear and easy to 
understand 
17.6 (3) 82.4 (14) 0 (0) 0 (0) 
The video demonstration of the model was 
clear and easy to understand 
29.4 (5)  64.7 (11) 0 (0) 5.9 (1) 
The video demonstration is an useful 
adjunct to the instruction booklet 
29.4 (5)  70.6 (12) 0 (0) 0 (0) 
Selecting input options (based on type of 
data available) occurs easily within the 
spread sheet model 
29.4 (5)  70.6 (12) 0 (0) 0 (0) 
Calculating data occurs easily within the 
spread sheet model 
52.9 (9) 47.1 (8) 0 (0) 0 (0) 
Compiling data occurs easily within the 
spread sheet model 
29.4 (5) 70.6 (12) 0 (0) 0 (0) 
Getting required output for burden 
estimates occurs easily within the spread 
sheet model 
35.3 (6) 64.7 (11) 0 (0) 0 (0) 
This tool is a useful complementary tool of 
the manual 
47.1 (8) 52.9 (9) 0 (0) 0 (0) 
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Based on the feedback from the participants, the spread sheet model was revised 
considerably. Specifically, navigation bars were added to make navigation from one month to 
another easy without having to return to the main screen and new graphical outputs were 
added. The beta version of the model 
(http://www.homepages.ed.ac.uk/eseodora/flu/index.php) was circulated amongst 
International Emerging Infections Program (IEIP) field sites of the US CDC and country 
offices of the WHO European Region to conduct further tests which would assist in 
identifying and fixing any bugs in the program. 
4.3.4. Evaluation 
The draft manual has been submitted to the WHO for official clearance (Appendix A9). 
Meanwhile, Eastern Mediterranean Regional Office of the WHO expressed an interest in 
undertaking influenza disease burden estimation in the member states in their region. To this 
end, the author was invited for a Consultation Meeting (15-17 May, 2012) to discuss the 
possibility of using this manual for the disease burden estimation. Apart from officers from 
the WHO, representatives from US CDC (NAMRU-III) and academics working on influenza 
surveillance participated in the meeting. After extensive discussions, the WHO Regional 
Office decided to adopt the manual. All participants agreed that influenza surveillance in the 
member states in the region was of variable quality and not all member states would be in a 
position to undertake disease burden estimation in the first instance. Rather, the most 
pragmatic approach would be to initiate this in those countries in the region that had good 
quality data for at least 12 consecutive months.  In order to identify the member states most 
likely to have such data, the author was invited to present the manual and the spread sheet 
model to the member states at an Inter-Country Meeting from 27-29 August, 2012. The 
author outlined to the participants the minimum data requirements for undertaking disease 
burden estimation. Based on this, eight countries (namely Egypt, Iran, Jordan, Oman, 
Morocco, Pakistan, Palestine and Qatar) were identified for participation in a disease burden 
estimation workshop to be held in Egypt in December, 2012. All eight countries agreed to 
collect and prepare data for at least one sentinel site (in the format outlined in the manual) 
prior to the meeting.  
The WHO Eastern Mediterranean Regional Office’s decision to undertake influenza disease 
burden estimation is timely as there are hardly any data from this region. Even though the 
manual is being translated in Arabic, the implementation is likely to be very challenging 
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given the lack of trained epidemiologists and general civil unrest in the region. The workshop 
will assist in evaluating the implementation of the tools proposed in the manual in a variety of 
developing country settings. 
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Chapter 5. Discussion 
This body of work estimates that about 1 million young children aged 0-59 months were 
hospitalised due to influenza-associated ALRI in 2008. It is also estimated that in the same 
year, about 22,000 to 115,000 deaths in children aged 0-59 could be attributable to influenza 
associated ALRI. This indicates that influenza contributes to about 8% of all hospitalised 
ALRI cases and about 7% of all ALRI deaths in children aged 0-59 months.   
5.1. Strengths 
This work included herein is the first to estimate the number of hospitalised influenza-
associated ALRI cases and the mortality attributable to influenza-associated ALRI in children 
younger than five years. The author utilised different data sources and methods to triangulate 
the estimates and demonstrated that the estimates using different approaches are consistent 
with each other and with previously published ALRI estimates The main strength of the 
thesis lies in the use of extensive amounts of unpublished data (especially from developing 
countries) to supplement data from published literature. The author successfully established 
and led three large international collaborative groups (first the RSV Study Group, then the 
Influenza Study Group, and finally the Severe ALRI Working Group) each of which 
demonstrated progressive expansion in terms of numbers and representation of geographical 
sites. The members of these international consortia are leading experts in paediatric 
pneumonia and influenza. The author also established close working relationships with US 
CDC (a global leader in influenza research) and the WHO (policy-making body on influenza 
vaccines and research). The methods and tools developed by the author for estimating disease 
burden using SARI Sentinel surveillance data would be useful in providing disease burden 
information in high risk groups (e.g. pregnant women, young children, those with 
comorbidities etc.). Such information is vital for prioritising the use of vaccines in resource 
limited settings and for planning healthcare services (augmenting hospital beds, use of 
antivirals, and delivery of supplemental oxygen) in developing countries where access to 
healthcare is likely to improve in the next 5 to 10 years. Additionally, the morbidity and 
mortality data could contribute to future Global Burden of Disease estimates (especially in 
computing aetiology specific estimates of years of life lost).  
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5.2. Limitations 
The data sources and the methodology used for estimating the disease burden have several 
limitations. Estimates are very variable within countries or regions and between regions. 
These variations could be partially attributable to variation in influenza epidemiology 
between study populations and yearly variations in influenza severity (Thompson et al., 
2010). It was not possible to make global incidence estimates by type/subtype of influenza 
virus because of insufficient studies conducted in the same year with the same subtype and 
often mixed strains circulating. The limited data available indicate that influenza A has a 
higher incidence compared to influenza B. Indeed, the virulence and severity of disease is 
known to vary by the type/subtype of the influenza virus – influenza A (particularly H3N2 
subtype) has been shown to result in higher morbidity and mortality than influenza B 
(Thompson et al., 2010, Johnson et al., 2009). However, the majority of the variation in the 
data presented in this study may be artefactual (a result of chance, potential bias and / or 
confounding) and therefore these limitations should be borne in mind while interpreting the 
results. 
5.2.1. Incidence-based estimates  
5.2.1.1. Study population and duration of study 
The population at risk in the included studies varied from about 250 to 5.6 million children 
younger than 5 years. While the studies with population denominators less than thousand 
children were cohort studies in developing countries, the studies from industrialised countries 
were mostly retrospective studies using discharge diagnosis from hospital records and 
laboratory data, and had large denominator population. The individual incidence estimates in 
the included studies having a smaller population denominator are likely to have wider 95% 
confidence intervals, thus affecting the precision of the estimates.  
Although all included studies had to satisfy the minimum eligibility criteria for study duration 
(12 consecutive months), the duration of included studies varied from one year to 25 years. 
The epidemiology of seasonal influenza virus suggests considerable variation in the severity 
of disease episodes from year to year. Therefore, any incidence estimate based on study 
duration of one year while indicative of the incidence in the given year, is unlikely to reflect 
the average disease burden associated with seasonal influenza. However, the incidence meta-
estimates for developing and industrialised countries were based on 39 studies and thus 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
Discussion  125 
reflect the average incidence of seasonal influenza-associated ALRI rather than the estimate 
for an individual year.  
5.2.1.2. Case ascertainment 
These estimates are based on hospital-based studies using passive case ascertainment 
(wherein a child with ALRI is brought to a healthcare facility). Therefore, these incidence 
estimates are influenced by the healthcare seeking behaviour of the population and the 
admission practices / policies of the attending physician / hospital respectively. The estimates 
for industrialised countries (where access to healthcare and healthcare seeking behaviour are 
good and decisions for hospital admission are based on objective clinical criteria) are likely to 
reflect the true burden of severe disease. On the other hand, estimates for hospitalisations in 
resource-poor settings in developing countries are unlikely to be reflective of the true burden 
of severe disease because healthcare seeking behaviour is poor and access to healthcare is 
limited (Nokes et al., 2009, Sutanto et al., 2002). Previous studies in Kenya and the Gambia 
have shown two-fold to 10 fold decreases in hospital pneumonia admissions in areas farthest 
from the hospital (Nokes et al., 2009, Weber et al., 2002, Bigogo et al., 2010). Recent data 
from Bangladesh and Kenya have also shown a marked decrease in hospitalisation rates out 
with a 4 km radius from the hospital (Nair et al., 2013) (Figure 18). In one study, 
investigators attempted to reduce this distance decay effect through provision of 
reimbursement for travel costs; nonetheless about 25% of referred children did not attend the 
hospital (Nokes et al., 2009). Therefore, while these estimates are an underestimate of the 
severe disease due to influenza-associated ALRI, it is not possible to quantify the degree of 
underestimation. However, these estimates are indicative of the burden on hospital inpatient 
services in developing countries. 
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Figure 18: Variation in incidence (per 1000 children per year) of hospitalised ALRI in children 
younger than 5 years by distance from hospital 
 
5.2.1.3. Case definition 
The thirty nine included studies did not use the same case definition for hospitalised 
influenza-associated ALRI. The variability in case definitions was more in the case of 
developing countries. While six of the 21 studies from developing countries used a case 
definition of laboratory confirmed influenza in a child hospitalised for ALRI based on a 
physician's diagnosis, six studies required presence of lower chest wall indrawing in addition 
to a physician's diagnosis of ALRI, and the remaining nine studies required an additional 
criteria (like presence of WHO specified danger signs (Department of Child and Adolescent 
Health, 2005), or clinical or laboratory signs of acute infection). Similarly, in the case of 
industrialised countries too, the case definitions were variable ̶  10 of the 18 studies used 
laboratory confirmed influenza in a child hospitalised for  ALRI based on a physician's 
diagnosis, six studies used a mixture of ICD codes (for influenza and pneumonia) and two 
studies required radiological confirmation of ALRI.  
The absence of a standardised case definition resulting in substantial variability in case 
definitions in the included studies is likely to have contributed to some of the variation in the 
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by encouraging sites contributing unpublished data to reanalyse their data using common case 
definitions. In spite of this, studies that have used a more stringent case definition are 
unlikely to have collected clinical specimens, and conducted diagnostic tests in children who 
did not fulfil their initial eligibility criteria and therefore reported lower estimates compared 
to those studies that used a more broad-based case definition.  
5.2.1.4. Laboratory diagnosis  
Five studies identified infection with influenza virus either by rapid tests such as EIA or 
immunofluorescence alone and 11 used them in combination with either PCR or viral culture. 
Immunofluorescence assays have shown variable and lower sensitivity and specificity 
compared to PCR which have very high sensitivity and specificity (Espy et al., 1986, 
Rawlinson et al., 2004, Stockton et al., 1998, Grijalva et al., 2007a, Yoo et al., 2007). It is not 
possible to estimate the overall effect of this bias as it depends on relative sensitivity and 
specificity of the individual assays, which were unknown for most studies. However, this has 
not resulted in a significant difference in the final estimates as a sensitivity analysis 
conducted using only PCR-based studies demonstrated consistency in the incidence estimates 
(Table 23). 
Table 23: Results of a sensitivity analysis on the incidence of hospitalised influenza-
associated ALRI in young children after including only PCR-based studies 
 
Children aged below 1 
year 
Children aged below 5 
years 
Developing countries   
Incidence rates after including only PCR-based studies * 
No. of studies 12 12 
Incidence (per 1000 children per year)  3.1 (95% CI 1.9 to 5.0 ) 1.6 (95% CI 0.9 to 2.7) 
Incidence rates from all studies satisfying eligibility criteria 
No. of studies 21 21 
Incidence (per 1000 children per year) 2.7 (95% CI 1.8 to 4) 1.5 (95% CI 1 to 2.3) 
   Industrialised countries  
Incidence rates after including only PCR-based studies 
No. of studies 14 14 
Incidence (per 1000 children per year) 2.1 (95% CI 1.6 to 2.9) 1.0 (95% CI 0.7 to 1.5) 
Incidence rates from all studies satisfying eligibility criteria 
No. of studies 18 18 
Incidence (per 1000 children per year) 2.4 (95% CI 1.7 to 3.2) 1.3 (95% CI 1 to 1.8) 
                                                 
* Includes studies where PCR was used in combination with viral culture  
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Thirteen of the 39 included studies collected clinical specimens for diagnostic assays using 
nasopharyngeal / nasal / throat swabs. Although, nasopharyngeal aspirate is considered to be 
the best specimen for detection of influenza viruses (Zambon, 1998), recent research has 
shown that specimens collected using the less invasive nasal swab / nasopharyngeal swab in 
combination with molecular diagnostic techniques like PCR and time-resolved 
fluoroimmunoassay (monoclonal antibodies) have a sensitivity of 91 to 92% compared to 
nasopharyngeal aspirates which are difficult to collect in low resource settings (Heikkinen et 
al., 2001, Lambert et al., 2008b). However, nasopharyngeal aspirates have been demonstrated 
to be more sensitive for detecting influenza B virus (Sung et al., 2008). Since available data 
from included studies demonstrate that influenza A was the predominantly circulating virus, 
use of nasopharyngeal/nasal swabs are unlikely to have resulted in a substantial difference in 
incidence estimates. 
Many of the included studies have collected clinical specimens in a proportion of the eligible 
cases (i.e. systematically collected samples in only a proportion of eligible hospitalised ALRI 
cases). In other studies, even though the study protocol recommended collection of clinical 
specimens in all eligible cases, a proportion of eligible children were excluded for various 
reasons (Table 24). Although in both scenarios, the estimated number of hospitalised 
influenza positive ALRI cases has been adjusted by scaling for the proportion sampled 
(assuming that influenza positivity rate is similar in both groups), this is unlikely to be true 
and would have contributed to some bias in the estimates. If it is assumed that disease 
severity is correlated to influenza positivity, the hospitalised ALRI cases where clinical 
specimens were not collected (e.g. critically ill, died before sample collection, were intubated 
etc.) are more likely to be influenza positive, and would have thus resulted in an 
underestimation of the incidence estimates. 
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Table 24: Reasons (from three unpublished studies) for not collecting clinical specimens from 
all eligible hospitalised ALRI cases 
Location 
(reference) 
Study period Proportion of 
eligible children 
with hospitalised 
for ALRI in who 
clinical specimens 







2006-2007 7.6% (67/874) Admitted late at night or 
on weekends, no physical 
presentation of severity, 
critically ill or died 
before sample collection  




2007 18% (163/922) Child was critically ill, or 
was discharged before 






2008 11.1% Refused nasopharyngeal 
swab or were intubated 
 
Nasopharyngeal carriage of a pathogen presents a major challenge while attributing a causal 
association in ALRI cases. Previous studies in the Gambia have shown that influenza virus 
can be isolated from asymptomatic children (Adegbola et al., 1994). However, recent well-
designed case-control studies reveal that the proportion of asymptomatic children who are 
positive for influenza virus is very low (Berkley et al., 2010, Singleton et al., 2010). 
Nevertheless, disease burden estimates based solely on laboratory identification of influenza 
virus in a nasal / nasopharyngeal clinical specimen should be interpreted with caution. In this 
study, this may have resulted in overestimation of the true incidence of influenza-associated 
hospitalised ALRI. Ideally, identification of influenza virus in clinical specimens collected 
using lung aspiration could be used to confirm a causal association (Scott and Hall, 1999). 
Lung aspirates in combination with PCR significantly increases diagnostic yield in children 
with both bacterial as well as viral ALRIs (Carrol et al., 2011). However, for disease burden 
estimation, a simpler approach like vaccine probe studies such as those conducted for 
Streptococcus pneumoniae, and Haemophilus influenzae type B (Lucero and Williams, 2005, 
Lucero et al., 2009, Gessner et al., 2005, Cutts et al., 2005, Madhi et al., 2005) is being 
advocated since an effective influenza vaccine is available. However, adopting this approach 
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would be challenging as the effectiveness of the influenza vaccine varies from year to year 
(depending on the circulating strain of circulating viruses) (Jefferson et al., 2012).   
5.2.1.5. Methodological issues 
5.2.1.5.1. Study period 
There are two possible criticisms of the methodology used in this study.  First, this study 
included only papers published since January 1995. This was done because studies prior to 
the latter half of 1990s primarily used serology or virus culture for diagnosis and results from 
the former are not really comparable with those from modern molecular techniques. The 
second and more important point is that the estimates for the year 2008 are based on data that 
spans a period of about 15 years (1 January 1995 to 31 October 2010). As has been already 
noted, there is substantial variability in the severity of influenza-associated ALRI from year 
to year in a given setting. The median period of the data included in this study is 2004. This 
method of estimating disease burden captures the underlying uncertainty in the true disease 
burden estimates, and is likely to reflect the seasonal influenza-associated hospitalised ALRI 
burden in 2008.  
5.2.1.5.2. Data imputation 
Only 24 of the 39 studies included for estimating the incidence of influenza-associated 
hospitalised ALRI reported data for the full age range (i.e. both for age 0 to 11 months as 
well as 0 to 59 months). For the remaining 15 studies missing data were imputed using 
median incidence rate ratio. In order to assess the validity of data after imputation, a 
sensitivity analysis was carried out by including only studies which had data for the full age 
range. The incidence rates for influenza-associated hospitalised ALRI (using data with and 
without imputation) for industrialised and developing countries were comparable for both 
infants (aged less than one year) and young children (aged less than five years). However, at 
the regional level, the incidence rates (from the two analyses) for infants in Americas were 
significantly different because 10 studies did not have data for the full age range (Table 25).  
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Table 25: Results of sensitivity analysis for incidence (per 1000 children per year) of influenza-







hospitalised ALRI in 
infants < 1 year (95% 
CI) per thousand 






hospitalised ALRI in 
young children <5 
years (95% CI) per 
thousand children per 
year 
Analysis with data imputation  
Africa  6 2.3 (1.6 to 3.4) 6 1.0 (0.9 to 1.2) 
Americas 16 2.5 (1.8 to 3.6) 16 1.2 (1.0 to 1.6) 
Europe 6 1.9 (1.3 to 2.8) 6 1.1 (0.7 to 1.6) 
South-east Asia 4 2.2 (0.7 to 6.8) 4 1.4 (0.4 to 5.6) 
Western Pacific 7 3.6 (1.7 to 7.4) 7 2.1 (0.9 to 5.1) 
     
Developing countries 20 2.8 (2.0 to 4.1) 20 1.5 (1.0 to 2.3) 
Industrialised countries 19 2.3 (1.7 to 3.0) 19 1.2 (0.9 to 1.6) 
     
Analysis without data imputation 
Africa  6 2.3 (1.6 to 3.4) 6 1.0 (0.9 to 1.2) 
Americas 6 1.9 (1.1 to 3.1) 13 1.2 (0.8 to 1.9) 
Europe 4 2.1 (1.7 to 2.6) 5 1.2 (0.9 to 1.6) 
South-east Asia 2 2.3 (0.3 to 16.3) 3 1.5 (0.3 to 7.1) 
Western Pacific 8 3.3 (1.7 to 6.4) 6 2.3 (0.9 to 6.0) 
     
Developing countries 14 2.9 (1.9 to 4.4) 16 1.5 (0.9 to 2.3) 
Industrialised countries 12 2.1 (1.5 to 2.8) 17 1.2 (0.9 to 1.8) 
 
There are other overarching limitations related to methods employed in the study and are 
discussed later in section 5.2.4.   
 
5.2.2. Prevalence-based estimates  
5.2.2.1. Study population and duration of study 
The population at risk in the studies included for estimating the incidence of hospitalised 
ALRI in young children varied from about 500 to about 48 million. While the studies with 
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population denominators less than thousand children were cohort studies, the larger studies 
from industrialised countries were mostly retrospective studies using discharge diagnosis 
from hospital records. The individual incidence estimates in the included studies having a 
smaller population denominator are likely to have wider 95% confidence intervals, thus 
affecting the precision of the estimates. Although all included studies had to satisfy the 
minimum eligibility criteria for study duration (12 consecutive months), the duration of 
included studies varied from one year to 25 years. The available data suggest considerable 
variation in the severity of ALRI episodes from year to year. Therefore, any incidence 
estimate based on study duration of one year while indicative of the incidence in the given 
year, is unlikely to reflect the average disease burden associated with hospitalised ALRI. 
However, the incidence meta-estimates for developing and industrialised countries were 
based on 85 studies (median year 2005) and thus reflect the average incidence of hospitalised 
ALRI rather than the estimate for an individual year.  
5.2.2.2. Case ascertainment 
These estimates are based on hospital-based studies using passive case ascertainment 
(wherein a child with ALRI is brought to a healthcare facility). Therefore, these incidence 
estimates are influenced by the healthcare seeking behaviour of the population and the 
admission practices / policies of the attending physician / hospital respectively. Since this 
study attempted to estimate the incidence of hospitalised ALRI in young children, and 
thereby the burden of ALRI on hospital inpatient services, rather than the (total) burden of 
severe ALRI, and all included studies had a well-defined catchment population, the 
ascertainment bias has been minimised. 
5.2.2.3. Case definition 
Estimates of hospitalised ALRI are very variable within and between countries and regions 
and across different study periods.  The 85 included studies did not use the same (standard) 
case definition for hospitalised ALRI. The variability in case definitions was more in the case 
of developing countries. While 17 of the 61 studies from developing countries used a case 
definition of physician diagnosed ALRI, 33 studies used the WHO case definition of severe 
pneumonia (based on lower chest wall indrawing) (Department of Child and Adolescent 
Health, 2005), and four studies used either of these. Additionally, one study used a case 
definition based on more specific clinical signs and symptoms suggestive of acute infection, 
while six others used hospital discharge diagnosis. Similarly, in the case of industrialised 
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countries too, the case definitions were variable – nine of the 24 studies used a case definition 
of hospitalisation for  ALRI based on a physician's diagnosis, 14 studies used a mixture of 
ICD codes (for pneumonia and bronchiolitis), and one study included only children with 
bronchiolitis.  
The absence of a standardised case definition resulting in substantial variability in the case 
definitions in the included studies is likely to have contributed to some of the variation in the 
incidence estimates across different sites. However, this bias was attempted to be minimised 
by encouraging sites contributing unpublished data to reanalyse their data using common case 
definitions. In spite of this, studies that have used a more stringent case definition (excluding 
cases not fulfilling their stringent clinical criteria for inclusion) may not have included all the 
excluded cases during the re-analysis and therefore underestimated the true incidence of 
hospitalised ALRI. Estimates from developing and industrialised countries are not strictly 
comparable as case definitions in the former tend to be based on simpler clinical syndromic 
criteria with no requirement for results of investigations. 
The case definitions employed by the 23 studies reporting the proportion of hospitalised 
ALRI cases in children positive for seasonal influenza were less variable. While 15 of the 19 
studies from developing countries used a simple case definition of hospitalisation for ALRI 
(based on a physician’s diagnosis), three required additional radiological confirmation, and 
one used the SARI case definition. Similarly, three of the four studies from industrialised 
countries used the simple case definition of hospitalised ALRI, while one used a mixture of 
ICD codes from hospital records. 
5.2.2.4. Laboratory diagnosis 
Similar issues relating to clinical specimens, and diagnostic assays (as discussed for the 
studies reporting incidence of influenza-associated hospitalised ALRI) were present in studies 
estimating the proportion of hospitalised ALRI cases positive for seasonal influenza. Only six 
of the 19 studies from developing countries used PCR-based assays and four used either viral 
culture alone or in combination with immunofluorescence assays. The meta-estimates of 
proportion of hospitalised ALRI cases positive for seasonal influenza were highest in PCR-
based studies (Table 26). 
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Table 26: Sensitivity analysis (based on diagnostic assays) comparing the meta-estimates of 
the proportion of hospitalised ALRI cases positive for seasonal influenza in children younger 
than five years residing in developing countries 
No. of studies 
Meta-estimate of proportion (%) of hospitalised 
ALRI cases positive for seasonal influenza (95% 
CI) 
PCR-based studies only 
6 7.8 (4.9 to 12.4) 
  
PCR and viral culture-based studies only 
10 7.1 (5.1 to 9.9) 
  
All eligible studies 
19 5.0 (3.6 to 7.0) 
 
Thirteen of the 19 studies from developing countries used nasopharyngeal aspirates or nasal 
wash to collect clinical specimens while two others used these in combination with nasal / 
nasopharyngeal swabs. This is perhaps one of the reasons why the overall influenza positivity 
rate is consistent with what is seen from incidence-based studies (7.8 percent compared with 
8.5 percent), even though the proportion of studies using PCR-based assays was higher in the 
incidence based studies (57% compared to 32% in prevalence-based studies). 
Detailed data regarding the eligible cases where clinical specimens were not collected have 
not been provided in the included studies. Since the denominator in these cases are all 
children hospitalised for ALRI and fulfilling the case definition, it is assumed that clinical 
specimens were collected in all these cases. However, if certain children were excluded from 
specimen collection (a likely scenario) because they were very sick, or if the parents refused 
to provide consent or the child died before specimen collection, the resulting estimates would 
be biased, and if these cases were more likely to be influenza positive, then the estimated 
proportion is likely to be an underestimate. 
5.2.2.5. Methodological issues 
5.2.2.5.1. Data imputation 
Only 43 of the 85 studies included for estimating the incidence of hospitalised ALRI in 
young children reported data for the full age range (i.e. both for age 0 to 11 months as well as 
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0 to 59 months). For the remaining 42 studies missing data were imputed using median 
incidence rate ratio. In order to assess the validity of data after imputation, a sensitivity 
analysis was carried out by including only studies which had data for the full age range. The 
incidence rates for hospitalised ALRI (using data with and without imputation) for 
industrialised and developing countries were comparable for young children (aged 0-59 
months) (Table 27). However, the incidence rates were not comparable in infants (0-11 
months) for the industrialised region (because 11 studies with missing data were excluded). 
For the same reason, the meta-estimates for Europe and South-east Asia were not comparable 
in infants.  
Table 27: Results of sensitivity analysis for incidence (per 1000 children per year) of 






hospitalised ALRI in 
infants < 1 year (95% 
CI) per thousand 





hospitalised ALRI in 
young children <5 
years (95% CI) per 
thousand children per 
year 
Analysis with data imputation  
Africa  13  49.3 (30.4 to 79.8) 13  21.1(13.6 to 32.8) 
Americas 18  38.7 (30.0 to 50.0)         18  17.4 (12.0 to 25.3) 
Eastern Mediterranean 2  27.9 (14, 55.5) 2  12.1 (8.6 to 17.2) 
Europe 14  14.2 (8.1, 25) 14  7.3 (4.6 to 11.6) 
South-east Asia 13  49.8 (33.6 to 73.8)        13  18.6 (11.4 to 30.3) 
Western Pacific 25  43 (32.3, 57.3) 25  17.3 (13.4 to 22.3) 
     
Developing countries 61  48.6 (41.0 to 57.6) 61  18.9 (15.9 to 22.4) 
Industrialised countries 24  19.1 (15.7 to 23.4) 24  9.6 (7.1 to 13.0) 
     
Analysis without data imputation 
Africa  11 51.3 (28.6 to 92.1) 10 24.7 (14.7 to 41.2) 
Americas 17 38.6 (29.7 to 50.2) 9 16.0 (10.1 to 25.5) 
Eastern Mediterranean 2 27.9 (14.0 to 55.5) 2 12.1 (8.6 to 17.2) 
Europe 5 17.7 (3.6 to 87.8) 8 5.7 (5.0 to 6.5) 
South-east Asia 7 78.6 (73.0 to 83.6) 9 18.3 (8.4 to 40.0) 
Western Pacific 9 47.6 (37.8 to 60.0) 24 16.8 (13.0 to 21.8) 
     
Developing countries 38 54.5 (46.5 to 63.9) 48 18.7 (15.1 to 23.3) 
Industrialised countries 13 42.5 (35 to 51.5) 14 8.3 (5.9 to 11.8) 
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5.2.3. Mortality estimates 
5.2.3.1. Influenza-associated in-hospital case fatality 
The in-hospital CFR meta-estimates for influenza-associated ALRI reported in this study are 
for a broad age range (0-59 months). There were insufficient data to report in-hospital CFR 
for influenza-associated ALRI for narrower age ranges (e.g. 0 to 11 months, or 0 to 23 
months) having the highest incidence rates for influenza-associated hospitalised ALRI. Even 
for this broad age range, substantial uncertainty surrounds the in-hospital CFR estimates from 
developing countries. First, as has been pointed out earlier, many studies only obtained 
clinical specimens from and carried out diagnostic test in a random sample of the proportion 
of eligible cases. Some sites have reported that clinical specimens were not collected from a 
proportion of eligible children because they were either critically ill, or refused participation 
or were discharged or died before clinical specimens could be collected. The absence of 
clinical specimen collection in all children hospitalised for ALRI introduces a bias towards 
falsely low reported estimates because mortality tends to be higher in these groups. Second, 
although the in-hospital CFR has been estimated separately for broad developing and 
industrialised country categories, the degrees to which the included studies are representative 
of these broad categories are unknown. Though in this instance, it has been attempted to 
reduce the selection bias by combining the incidence of hospitalised cases with the in-
hospital CFR data, the studies might be from settings with above average resources, and thus 
the reported in-hospital CFR would be an underestimate of the true CFR in hospital settings 
in developing countries. Finally, infection with influenza virus has been shown to predispose 
to bacterial infection, particularly pneumococcal pneumonia (Klugman et al., 2009, O'Brien 
et al., 2000, Zaman et al., 2008, McCullers, 2006, McCullers et al., 2010). Results from a 
nine-valent pneumococcal vaccine probe study in South Africa indicates that a minimum 
45% of the cases with influenza-associated severe ALRI have co-infection with 
Streptococcus pneumoniae (Klugman et al., 2009). While bacterial infections are reported to 
have higher CFR (at least in developing country settings), the sensitivity of the diagnostic 
tests to identify bacterial infection remains poor (Sutanto et al., 2002, Isaacs, 1989, Lankinen 
et al., 1997). While attempting to fairly interpret childhood pneumonia deaths, it may be 
worthwhile to co-attribute mortality to both influenza and bacterial pneumonia in cases with 
influenza and bacterial co-infection. 
This study documents a more than 8-fold difference in the in-hospital CFR meta-estimates for 
influenza-associated ALRI for the developing regions compared to the industrialised regions. 
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This could be attributable to epidemiological factors such as population immunity; circulation 
of Streptococcus pneumoniae; circulating type/subtype of influenza virus; clinical factors 
such as availability of oxygen, mechanical ventilation, antivirals, trained nursing staff; and 
access to care. The estimates based on in-hospital CFR have been regarded as the lower 
bound of the influenza-associated ALRI mortality estimates. There are two key reasons why 
this estimate should be considered as an underestimate. First, the estimates of influenza-
associated hospitalised ALRI are likely to be an underestimate of the true burden of 
influenza-associated severe ALRI. Second, in-hospital CFRs from included studies cannot be 
regarded as representative of whole population groups. In the most resource poor settings, the 
true CFR for influenza-associated ALRI would be much higher than these reported estimates 
as the resources and quality of care in study hospitals are likely to above average.  
On the other hand, it is possible that the true in-hospital influenza-associated ALRI mortality 
for 2008 is lower than what has been estimated here. Data available from published and 
unpublished studies demonstrate that there has been a general decrease in the in-hospital CFR 
for ALRI over the last decade (Figure 19). This is consistent with the reported decrease in 
childhood pneumonia mortality during this period (Liu et al., 2012). Since the in-hospital 
mortality for influenza-associated ALRI in 2008 has been based on in-hospital CFR data for a 
period ranging from 1996 to 2008 (median year 2003), the true in-hospital mortality for that 
year is perhaps lower than what has been estimated. However, the proportion of in-hospital 
ALRI mortality attributable to seasonal influenza is likely to be consistent with what has been 
estimated in this study. More significantly, these data demonstrate that 99% of influenza-
associated ALRI mortality occurs in developing countries. 
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Figure 19: In-hospital case fatality ratio for young children with ALRI by WHO regions from 
2000 to 2010 
There were no data from developing countries to validate the estimated lower bound for 
influenza-associated ALRI mortality. However, in the case of industrialised countries, the 
estimated influenza-associated ALRI mortality for US (76 deaths) was consistent with that 
reported by Thompson and colleagues (92 deaths) for American children (aged 0-59 months) 
for 1992 to 1999 (Thompson et al., 2003). 
5.2.3.2. Influenza-associated ALRI mortality in the community 
This study utilised population-based data on cause of death in children not admitted to 
hospital, assigned by verbal autopsy, and concurrent seasonal influenza virus isolation in the 
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same population, to estimate the excess ALRI mortality during the “influenza season”. This 
estimate has been considered as the upper bound of influenza-associated ALRI mortality in 
children. The site at Ballabgarh in North India is typical of most developing countries with 
high infant and child mortality, with majority of deaths occurring at home (Nongkynrih et al., 
2003, AIIMS, 2010). The mortality rate is lower than many African countries and other 
Indian states but is higher than many other developing countries in South / South East Asia 
and Latin America. Due to paucity of data, data on deaths in community from this site have 
been used to predict the likely upper bound for influenza-associated ALRI mortality in 
developing region. Since the upper bound is based only on one study in a small rural 
population in one country, this method needs to be replicated in other settings. Additionally, 
although all excess ALRI mortality during the influenza season has been attributed to 
influenza, RSV is known to co-circulate during the influenza season (Zambon et al., 2001). 
The acute respiratory infections in which RSV and seasonal influenza are identified are 
clinically indistinguishable although influenza appears to result in more febrile illness (Bosis 
et al., 2005). Since RSV is a leading pathogen identified in cases with ALRI, it is important 
to identify the periods of RSV transmission while delineating the “influenza season”. In the 
case of data from Ballabgarh, a random sample of about 10% of the clinical specimens for the 
period 2006-2008 was tested for RSV and it was observed that there was no overlap in the 
periods of peak activity for both viruses (Broor, personal communication). However, several 
other viral pathogens (e.g. parainfluenza virus and human metapneumovirus) causing ALRI 
have (unknown) seasonal patterns. These pathogens could, in some areas, account for as 
much as a third of the ALRI hospital admissions and may have a similar, if not higher, CFR 
to influenza (Foulongne et al., 2006, Madhi et al., 2007, Hamelin et al., 2004, Wolf et al., 
2006, Nascimento-Carvalho et al., 2010). Also, unlike in Ballabgarh, in many developing 
countries, seasonal influenza and RSV are likely to co-circulate. Therefore, the estimated 
upper bound of influenza-associated ALRI mortality in children is likely to be an 
overestimate.  
On the other hand, the assumption that no influenza mortality in young children occurs 
outside the “influenza season” is unlikely to be true in developing countries located in 
tropical and subtropical areas which have typically demonstrated a year round circulation of 
the virus with one or two peaks annually (Sam et al., 2010, Nicholson et al., 2006). 
Additionally, a substantial proportion of ALRI mortality in the three to four weeks after an 
infection with seasonal influenza virus may be the result of subsequent infection with a 
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bacterial pathogen (where influenza may have predisposed the child to bacterial infection) 
(McCullers, 2006, McCullers et al., 2010). Both these factors are likely to result in an under-
estimation of the upper bound of influenza-associated mortality.  
The estimated upper bound of influenza-associated ALRI mortality indicates that about 7% of 
all ALRI mortality in children younger than five years is associated with influenza. This 
estimate is consistent with the estimated proportion of influenza-associated ALRI mortality 
that occurs in hospitals (7.6 percent). More importantly, this indicates that about 81% 
(93095 †/ 114627) of all influenza-associated ALRI deaths in young children occur outside 
hospitals or health facilities. This finding is consistent with the recent estimate that only 19% 
of all ALRI deaths in young children occur in hospitals (Nair et al., 2013) and other published 
estimates (Sutanto et al., 2002, Sacarlal et al., 2009, Adazu et al., 2005).  
5.2.4. Overarching limitations 
5.2.4.1. Location of study sites 
This study has utilised data from published literature and unpublished data available with the 
Influenza Study Group and the Severe ALRI Working Group to estimate the number of 
hospitalised influenza-associated ALRI cases in young children in the year 2008. The 
included studies span a 15 year period from 1995 to 2010. About 54 to 82% of included data 
are from developing countries. In spite of these efforts, there are large parts of the world for 
which no data are available (e.g. Russia, Central Asia, Middle East, and North Africa). 
Similarly, data on influenza-associated ALRI were scarce from mainland China. The only 
study from mainland China was identified in English language databases. To supplement data 
from mainland China, three Chinese language databases were extensively searched to identify 
studies reporting population-based data on incidence of influenza-associated ALRI in 
Chinese literature. Additionally, the Chinese Centre for Disease Control and Prevention was 
contacted to identify any unpublished data reporting incidence of influenza-associated ALRI 
in China. However, despite these efforts, no additional studies reporting incidence of 
influenza-associated ALRI in children younger than five years were identified. Chinese 
language databases could not be searched for identifying studies reporting proportion of 
hospitalised ALRI cases positive for seasonal influenza (as the services of a Chinese 
                                                 
† Estimated in-hospital deaths due to influenza associated ALRI= 21532. Therefore, the out-of hospital 
influenza-associated ALRI deaths= (114627-21532)= 93095 
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language researcher was no longer available). Although literature search in English language 
databases identified two studies in Chinese language, data from these studies could not be 
included in the meta-analysis as the two studies could not be translated using Google 
translator. 
5.2.4.2. Methodological issues 
5.2.4.2.1. Confidence intervals 
There are two methodological issues related to confidence intervals for the results presented 
in this study. First, the 95% confidence intervals for the point estimates are asymmetric. This 
is because where possible, the 95% CIs for the included studies were calculated using 
Poisson distribution rather than binomial distribution (Kirkwood and Sterne, 2006). In the 
case of studies with small sample sizes, the 95% CI are likely to be asymmetric. Second and 
more importantly, the 95% confidence intervals of the meta-estimates are narrower than the 
conference intervals of the individual studies. It is known that meta-analyses appear to give 
results that are more precise and more conclusive than are unwarranted (Egger et al., 1998). 
The large number of subjects contributing to the meta-analysis will often lead to very narrow 
confidence intervals for effect estimate. This is because while the 95% CI of individual study 
represents the underlying sampling variability (random error), the meta-estimates represent 
an average value after combining the individual studies using different weights (assuming 
they all are measuring the same effect), and the 95% confidence interval represents the 
probability that the interval includes the true value (Henmi and Copas, 2010). Also it is 
crucial to remember that these endeavours do not account for the various biases across 
studies; rather they take account of only between-study variation in effect, or bias only under 
restrictive assumptions. When uncertainties about bias sources are included in the meta-
analysis, the interval estimates will expand dramatically (Eddy et al., 1992, Greenland, 2005). 
While the sources of bias have been discussed qualitatively in this study (and the likely 
direction and scale have been discussed), it has not been possible to conduct a formal bias 
analysis (for quantitatively adjusting the estimates) because such analyses require data on 
quantitative assessment of systematic errors which are not available in published studies. In 
the absence of such data, either educated guesses can be made, which in the current scenario 
(absence of accepted convention regarding the specifications), leave the input judgements 
entirely to the analyst, thus opening avenues for manipulation to produce desired results; or 
data can be obtained from validation studies which may themselves be subject systematic 
errors beyond those present in the main studies (Greenland and Lash, 2008).  
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5.2.4.2.2. Random effects meta-analysis 
Random effects model assumes a hypothetical random distribution of effects, thus 
incorporating real differences in effect in each study as well as sampling variability (chance). 
This generalisation more accurately reflects uncertainty about unaccounted for sources of 
variation in study results.  However, the summary estimate obtained from a random effects 
model has no population specific interpretation. It does not correspond to an average effect in 
an actual population, but instead represents the mean of a distribution of effects across 
included studies (Greenland and O'Rourke, 2008). The random effects meta-analysis weights 
the studies by the inverse of the variance within studies as well as the between study 
variance. Thus, here the study weights are assigned with the goal of minimizing both sources 
of variance. The model gives proportionally greater weight to smaller studies than do fixed 
effects estimates. As a consequence, the random effects summaries will be more affected by 
biases that more strongly affect small studies (Thompson and Pocock, 1991, Poole and 
Greenland, 1999). If the number of studies is very small, as in the case of in-hospital CFR 
meta-estimates for influenza-associated ALRI (section 3.2.2.1), the estimate of the between 
studies variance will have poor precision (Borenstein et al., 2009). In such situations, while 
the random effects model is still the most appropriate, there are a few alternatives ̶  a simple 
descriptive analysis without reporting summary effect; or a fixed-effects analysis; or a 
Bayesian meta-analysis- none of which have been accepted as standard. 
5.2.4.2.3. Study specific factors  
The hospitalisation for influenza-associated ALRI is likely to be influenced by environmental 
factors relating to the study setting (like altitude, rainfall, humidity, and temperature); study 
design (such as median year of study, mean cohort size, duration of study, duration of 
surveillance); and cultural factors and access to healthcare.  Rudan and colleagues in their 
paper on the incidence of clinical pneumonia in young children assessed the association 
between these factors and the incidence of clinical pneumonia and made several adjustments 
in their final estimates (Rudan et al., 2004). However, this study has not undertaken any 
formal assessment of association between the above-mentioned factors and incidence of 
influenza-associated hospitalised ALRI and made post-hoc assessment for the reasons given 
below: 
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• Since the environmental factors relate to the true incidence at the study site, they do 
not warrant adjustment. This approach is consistent with the findings and conclusions by 
Rudan and colleagues (Rudan et al., 2004). 
• The majority of the factors relating to study design were accounted for either through 
the inclusion criteria ̶  limiting the included studies to those published after 1995 (rather than 
1960 onwards as was done by Rudan), duration of study, duration of influenza surveillance 
etc. ̶  or through the use of random effects meta-analysis (rather than a median estimate 
approach used by Rudan).  
• Since this study aims to estimate the burden of paediatric seasonal influenza-
associated ALRI on hospital inpatient services, rather than the overall disease burden, it was 
not necessary to adjust the incidence estimates based on cultural factors (determining 
healthcare seeking behaviour) and access to healthcare. 
5.2.4.2.4. Confounding by RSV  
Clinically, RSV-associated ALRI are indistinguishable from influenza-associated ALRI 
although influenza appears to result in more febrile illness (Bosis et al., 2005). As discussed 
earlier, the peak transmission periods of RSV and seasonal influenza are known to overlap in 
many settings. The estimates reported in this study have not been adjusted for confounding 
by RSV activity. This is because clinical signs and symptoms have not been used as the sole 
criteria to define hospitalised influenza-associated ALRI cases. Laboratory confirmation 
using valid diagnostic test has been used to attribute the illness to influenza (as was done in 
the estimates for RSV-associated ALRI). Thus, RSV is unlikely to be a confounder for 
incidence estimates for influenza-associated hospitalised ALRI. Some studies in the past 
(Izurieta et al., 2000, Mullooly et al., 2007, Thompson et al., 2003) which have analysed both 
RSV and influenza together have tried to adjust for the co-circulation using mathematical 
models. However, these studies were not estimating true rates based on virologically 
confirmed cases. Since this study only includes hospitalised ALRI cases with laboratory 
confirmed diagnosis of seasonal influenza, the estimated rates reflect the true rates and thus 
do not require statistical adjustments. 
5.2.5. Disease burden estimation using SARI surveillance data 
The manual developed for estimating disease burden associated with seasonal influenza is 
targeted at developing countries and uses certain broad assumptions in order to assist WHO 
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member states for estimating their national seasonal influenza-associated SARI disease 
burden. There are several key limitations to the methods outlined in the manual: 
• The manual focuses primarily on morbidity. To estimate mortality, only one approach 
(i.e. in-hospital case fatality ratio) has been used. Data from vital registration are 
scarce in resource poor settings at which this manual is targeted. However, in certain 
middle-income countries (e.g. Russia, Chile, Argentina and Venezuela), vital 
registration of deaths is more than 90% complete (Rudan et al., 2005). In these 
countries, modelling approaches using cause of death data from vital registration and 
data on influenza activity from virological surveillance can be used to estimate the 
influenza-associated mortality. 
• The manual proposes a rather simplistic method of estimating the catchment 
population for a SARI sentinel site. While this method is likely to suffice for a stable 
population where care seeking for pneumonia (preference for healthcare provider) 
does not change over time, this is unlikely to be true, in situations where the 
population is mobile, and healthcare provider preference changes from year to year 
and season to season (depending on accessibility issues). 
• There are various sources of uncertainty in the disease burden estimates generated 
using surveillance data. The manual only deals with one of the sources of uncertainty 
– random error due to variation in sampling – and provides the reader with the 
methods for calculating the 95% confidence intervals. Although the other sources of 
uncertainty (biases) are discussed qualitatively, in the absence of quantification of this 
uncertainty, the average reader may be led to believe that the true uncertainty in the 
estimates have been captured in a standard 95% confidence interval.  
• For estimating disease burden at the national level, the manual describes combining 
data from different SARI sentinel sites that are representative of the national 
population using a median approach. This method, though simple, is very crude and 
does not capture the variation within and between the various SARI sentinel sites 
included in the analysis.  
• The methods outlined in the manual assume that vaccination for seasonal influenza is 
non-existent in the low and middle-income countries which are targeted in the 
manual. However, while this may be the case at present, this assumption is unlikely to 
be true in the future. Therefore, ideally the manual should have outlined techniques 
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for estimating disease burden after adjusting for the coverage of seasonal influenza 
vaccines. 
• The manual only deals with disease burden estimation using laboratory confirmed 
influenza. The methods outlined in the manual do not incorporate data from 
serologically determined influenza incidence (e.g. studies like FluWatch) (Research 
Department of Infection and Population Health, 2012). 
• The manual focuses on disease burden due to influenza-associated SARI. While this 
would reflect the burden on hospital inpatient services, the majority of the disease 
burden associated with seasonal influenza is at the milder end of the spectrum (Nair et 
al., 2011). The mild influenza like illnesses and the non-severe influenza-associated 
ALRI that do not result in hospitalisation nevertheless pose a significant burden on 
hospital / clinic outpatient services and result in significant economic costs due to 
workplace absences, reduce productivity and school closures (during outbreaks / 
pandemics). 
• The manual focuses solely on the “medical burden” due to seasonal influenza-
associated SARI. While the data on hospitalisation is useful for planning purposes, 
such data coupled with costs associated with hospitalisation make a powerful 
argument for introducing interventions against seasonal influenza (e.g. vaccines, anti-
virals etc.). Therefore, the manual should have included a toolkit for economic 
analysis for seasonal influenza-associated SARI. 
• The manual focuses solely on seasonal influenza. While the burden of seasonal 
influenza in itself is an important public health problem, it cannot be viewed in 
isolation against the larger burden associated with respiratory viruses. Most countries 
presently use modern molecular techniques which can identify multiple respiratory 
pathogens from a single sample (e.g. multiplex PCR). Ideally, the manual should have 
been expanded to include disease burden estimation for other major respiratory 
viruses. 
• The manual does not provide details on how to compare the seasonal influenza-
associated disease SARI burden estimates with the estimates for other diseases. 
• The manual assumes that the average reader is trained in basic epidemiology and 
therefore would not require any formal training. This is unlikely to be true in most 
developing countries settings and therefore this manual should be accompanied by a 
trainer’s manual.  
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5.3. Public health impact of influenza 
Using data from hospital-based studies with a clear population denominator and an incidence 
rate-based approach, it was estimated that in 2008 approximately 911,000 (95% CI 617,000 
to 1.4 million) hospitalisations due to influenza-associated ALRI occurred in children under 
the age of five years.  Using data from studies (without a known population denominator) 
reporting the proportion of hospitalised ALRI cases positive for seasonal influenza using 
laboratory diagnosis and the global and regional estimates of hospitalised all-cause ALRI 
cases, it was estimated that in the same year, about 772,000 (95% CI 343,000 to 1.8 million) 
hospitalisations due to influenza-associated ALRI occurred in children younger than five 
years. Thus, seasonal influenza was associated with about 8% of all hospitalised ALRI in 
children younger than 5 years in 2008.  
In-hospital CFRs in influenza-associated ALRI cases were utilised to estimate the lower 
boundary of ALRI deaths in children younger than five years that would be attributable to 
influenza. These data indicate that about 21530 (95% CI 3960 to 55700) in-hospital ALRI 
deaths (translating to about 7.6% of all in-hospital ALRI deaths) occurred in children younger 
than five years with laboratory confirmed influenza. Only one site reported cause of death 
data (in children not admitted to hospital), assigned by verbal autopsy and concurrent 
isolation of influenza virus in the same population for a period of three consecutive years. 
Using these data and a comparative model, it was estimated that globally 114,450 (95% CI 
20,950 to 296,450) deaths in under-five children (about 7.2% of all childhood ALRI deaths in 
2008) could be attributed to influenza-associated ALRI. These findings are summarised in 
Figure 20 and demonstrate the internal consistency of the results derived using different 
approaches and independent data sources. Approximately 92% of hospitalisations due to 
influenza-associated ALRI and 99% of influenza-associated ALRI deaths occurred in 
developing countries.  
Available data indicate that the incidence of influenza-associated hospitalised ALRI was 
highest in infants, especially those in the first six months of life. There is substantial 
variability in the incidence of influenza-associated hospitalised ALRI between regions and 
from year to year within a country / or region. This variability can be explained partly by the 
circulating type/subtype of the influenza virus- with influenza A(H3N2) resulting in more 
severe disease. Secondary bacterial pneumonia commonly caused by Streptococcus 
pneumoniae and Staphylococcus aureus is a frequent complication of influenza-associated 
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ALRI (Klugman et al., 2009, Reed et al., 2009, van der Sluijs et al., 2010, Foulongne et al., 
2006). Insufficient data were available to estimate the burden of co-infections (especially 
with a bacterial pathogen) in children hospitalised for ALRI.  
These estimates indicate that seasonal influenza is the second most common viral pathogen 
identified in young children with ALRI when placed in context with disease burden estimates 
for other respiratory pathogens (Streptococcus pneumoniae, Haemophilus influenzae type B, 
and RSV) that are associated with 49% of severe episodes likely to result in hospitalisation 
and 61% of deaths (O'Brien et al., 2009, Watt et al., 2009, Nair et al., 2010). However, these 
estimates are not directly comparable because:  
• The estimates for the bacterial pathogens were based on a small number of vaccine 
probe studies and were for the year 2000.  
• The RSV estimates were based on a similar approach (though with fewer data points), 
and were for the year 2005.  
Nonetheless, these estimates indicate that seasonal influenza is an important contributor to 
childhood pneumonia morbidity and mortality.  
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Figure 20: Hospitalizations and mortality due to influenza-associated ALRI in children aged 0-
59 months estimated using two different approaches and independent data sources  
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5.4. Implications for vaccination policies and 
strategies using existing vaccines 
There are two broad categories of existing influenza vaccines- trivalent inactivated vaccines 
(TIV) and live attenuated influenza vaccines (LAIV) - both containing two influenza A 
strains and one influenza B strain. In order to ensure optimal vaccine efficacy against 
prevailing strains of influenza virus, the antigenic composition of the influenza vaccine is 
revised annually (once each for the Northern and Southern hemispheres) depending on the 
virological data obtained from the WHO global influenza surveillance and response system 
(GISRS).  
The majority of currently available TIVs are split-virion vaccines, sometimes adjuvanted to 
enhance the immunogenicity (Waddington et al., 2010, Vesikari et al., 2009). Only 
unadjuvanted TIVs are currently licensed for use in children older than six months of age. 
Antibody responses to TIV are related to the age of the infant with decreased antibody 
responses noted stepwise in children 6 to 23 months of age (Walter et al., 2010). A recent 
Cochrane review reported that TIVs have an efficacy of 59 (95% CI 41 to 71) percent, and 
vaccine effectiveness of 36 (95% CI 24 to 46) percent in children aged 24-59 months 
(Jefferson et al., 2012). However, there were insufficient data to estimate the efficacy and 
effectiveness in children aged 6 to 23 months. TIVs are in general considered to be safe in 
young children and although transient local reactions at the injection site may occur 
frequently, no evidence of important medically attended adverse events following 
immunisation have been noted (Neuzil et al., 2001, Vellozzi et al., 2009, France et al., 2004). 
TIVs are the only vaccines licensed for immunisation against influenza in pregnant women. It 
has been demonstrated previously that maternal antibodies transferred transplacentally confer 
protection against influenza during the neonates’ first months of life (Englund et al., 1993, 
Glezen, 2003, Reuman et al., 1987, Puck et al., 1980). However, there are no vaccine 
effectiveness studies in pregnant women that have used laboratory confirmed influenza 
outcomes in vaccine recipients (Ortiz et al., 2011). Results from three vaccine trials in 
pregnant women have demonstrated that laboratory confirmed influenza virus infections are 
lower among young infants whose mothers received the TIV (Eick et al., 2011, Zaman et al., 
2008, Poehling et al., 2011). Randomised controlled trials in pregnant women in USA and 
Bangladesh have not reported any significant adverse outcomes in the pregnant women or 
their offspring (from foetal period through infancy) (Englund et al., 1993, Zaman et al., 
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2008). Therefore, maternal vaccination against influenza using platforms like the maternal 
and neonatal tetanus (MNT) elimination initiative which exist in all resource poor countries 
has been recommended for protecting young infants (Ortiz et al., 2012). Currently, there are 
several large trials in low resource settings (e.g. Nepal, Mali and South Africa) assessing the 
impact of maternal vaccination against influenza, both on the pregnant woman as well as the 
young infant (Adegbola et al., 2012). 
LAIVs are currently licenced for use in in healthy adults and children above two years of age 
in North America, European Union, South Korea, Hong Kong, Macau and Israel. Jefferson 
and colleagues in their recent review report that LAIVs have a good vaccine efficacy (80; 
95% CI 68 to 87) percent in children aged more than 2 years (Jefferson et al., 2012). A meta-
analyses comparing the immunogenicity of intranasally administered LAIV with egg-based 
TIV in children (6 months to 17 years old) demonstrated the superior efficacy of the LAIV 
compared to TIV (Rhorer et al., 2009). Apart from transient febrile reactions in less than one 
percent of children immediately after immunisation, no serious adverse events following 
immunisation with LAIVs have been reported (Rudenko et al., 1996). Presently, none of the 
vaccine trials using TIV or LAIV have used laboratory confirmed influenza-associated 
pneumonia as an endpoint. In order to bridge this gap, four large vaccine trials (in 
Bangladesh, India, Kenya and Senegal) funded by US CDC are currently underway that are 
using influenza-associated SARI as an endpoint (Centres for Disease Control and Prevention, 
2012). 
This body of work demonstrates that seasonal influenza is a major pathogen identified in 
young children hospitalised for acute lower respiratory infections. The majority of the disease 
burden occurs in children younger than two years of age (Nair et al., 2011). The burden of 
influenza-associated ALRI on hospital inpatient services is disproportionately higher in 
infants particularly those in the first six months of life. Therefore, young children (aged less 
than five years), particularly young infants (aged below six months) are one of the high risk 
groups for immunisation against seasonal influenza.  Brooks suggests that integration of 
seasonal influenza vaccine into routine immunisation programmes (along with the vaccines 
against bacterial pneumonia) remains the key to decreasing childhood pneumonia morbidity 
and mortality (Brooks, 2009). The WHO now recommends that immunising pregnant women 
against influenza should be accorded the highest priority (World Health Organization, 2012). 
Universal immunisation of children aged 6-59 months using existing influenza vaccines has 
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also been recommended as a priority intervention (World Health Organization, 2012). 
However, implementing such a recommendation in resource limited setting is likely to be 
challenging and contestable for the following reasons: 
i. the existing public health infrastructure in developing countries is 
already overburdened and routine administration of seasonal influenza 
vaccine by EPI or maternal and child health (MCH) services would 
most likely be opposed by policy makers and health workers 
ii. recent evidence demonstrates that repeated immunization with 
seasonal influenza vaccine may not be effective (Ohmit et al., 2013). 
This could be due partly to antigenic interference and partly to 
confounding (Treanor and Szilagyi, 2013) 
iii. a recent randomised controlled trial in children aged 6-15 years has 
demonstrated that children immunized with TIV were more likely to 
be infected with non-influenza respiratory virus compared to the 
placebo group (Cowling et al., 2012) 
iv. recent data from Europe suggest that in the elderly and clinical high 
risk groups, the vaccine effectiveness is lower than that estimated by 
Osterholm and colleagues (Nicoll and Sprenger, 2013) 
The burden of seasonal influenza is under recognised in developing countries owing to 
paucity of good quality data on the role of influenza in childhood pneumonia (Brooks et al., 
2010). In the absence of such data, uptake of the seasonal influenza vaccine has been poor 
(especially in high influenza burden developing countries). This is linked to the limited 
vaccine production capacity in low resource settings and ultimately impairs the much needed 
surge in influenza vaccine production capacity during pandemics. The WHO now considers 
production and uptake of seasonal influenza vaccines as an integral part of pandemic 
influenza preparedness planning (World Health Organisation, 2011). To this end, there is an 
urgent need to increase the production and uptake of seasonal influenza vaccine especially in 
high burden settings in low income countries. National governments in developing countries 
with high disease burden of influenza-associated ALRI need to recognise the role of seasonal 
influenza as a major contributor to childhood ALRI morbidity and mortality. In order to meet 
the demands for a surge in vaccine production during pandemics, technology transfer and 
establishment of regional centres for vaccine manufacture in resource poor settings have 
already been incorporated as part of the Global Action Plan (GAP) for influenza vaccines 
(World Health Organisation, 2011). However, national level disease burden estimates using 
SARI sentinel surveillance data would assist national policy makers and health programme 
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partners in identifying risk groups, estimating cost effectiveness, so as to make an informed 
decision regarding introducing influenza vaccines into their immunisation programmes.  
5.5. Proposals for improving future estimates 
The current body of work has identified several gaps in data which need to be addressed in 
future studies estimating the disease burden due to influenza-associated respiratory 
infections: 
• The estimates of hospitalisations and mortality due to influenza-associated ALRI are 
limited by the geographical representation of study sites. There are certain areas of the 
world from where no data were available (e.g., North Africa, Middle East, Central 
Asia and Russia). Limited data were available from large countries like India and 
China that contribute to about 40% of the global population. Rudan and colleagues 
demonstrated a similar gap in data (in the year 2000) for ALRI morbidity and 
mortality (Rudan et al., 2005). While funding future studies, funding agencies need to 
ensure geographical representation of study sites so that the findings from similar 
meta-analyses are more generalisable. 
• Although, several studies have reported a higher incidence rate for hospitalised ALRI 
in young children, existing studies on influenza-associated ALRI do not report 
gender-based incidence estimates. Future studies need to consider reporting gender-
specific data for morbidity and mortality. 
• The majority of the existing studies do not report incidence rates and case fatality 
ratios for narrow age ranges (e.g. 0-5 months, 6-11 months, 12-23 months). In order 
to precisely identify the age groups at the highest risk (for influenza related morbidity 
and mortality), and make informed policy decisions for targeted interventions 
(particularly maternal vaccination to protect young infants), there is an urgent need to 
report data by narrow age bands at least in the first two years of life. 
• Post-mortem diagnostic testing for influenza in children with acute lower respiratory 
infections who die in hospital before clinical specimens can be collected for 
diagnostic testing would assist in estimating the true in-hospital CFR for influenza-
associated ALRI. 
• In order to precisely estimate the mortality due to influenza-associated ALRI in young 
children, studies where good quality mortality data (either from vital registration or 
confirmation using verbal autopsy) along with concurrent isolation of respiratory 
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viruses (like RSV, seasonal influenza, human meta-pneumovirus, and parainfluenza 
virus) in the same population need to be carefully planned and implemented. 
• In order to estimate disease burden due to influenza-associated ALRI in young 
children, vaccine probe studies (using a similar approach as was done for estimating 
the disease burden for Streptococcus pneumoniae and Haemophilus influenzae type 
B) should be considered. Such studies would help estimate disease burden due to non 
severe illnesses as well. 
• Studies included in this meta-analysis did not report data on hypoxaemia in children 
hospitalised for ALRI and positive for influenza. Hypoxaemia has been shown to be 
an important predictor of mortality in children with severe pneumonia (Djelantik, 
2003, Onyango et al., 1993, Duke et al., 2001). Availability of data on hypoxaemia as 
a specific risk factor for influenza-associated ALRI mortality would assist in 
advocacy and planning for pulse oximeters and oxygen concentrators in hospitals in 
resource constrained settings (Dobson et al., 1996, Duke et al., 2008). 
• With the introduction and scaling up of pneumococcal conjugate vaccines (PCVs), 
future studies should record and report influenza incidence separately in PCV 
recipients and PCV recipients immunised against influenza.  
• There are scarce data regarding co-infections with other viruses and bacteria in 
children hospitalised for influenza-associated ALRI. As newer molecular techniques 
capable of identifying multiple pathogens (like TAC) become available, well-
designed case-control studies in combination with sero-epidemiology are likely to 
inform disease burden estimates (Laurie et al., 2012). 
• There are scarce data on the milder influenza-associated respiratory infections that do 
not result in hospitalisation (i.e. influenza like illness and non-severe influenza-
associated ALRI). Although per capita hospitalisations present a higher burden on 
healthcare systems, the economic burden resulting from workplace absences, loss of 
productivity and school closures (during outbreaks) due to the milder infections 
should not be underestimated. Population-based studies to estimate the incidence and 
costs related to non-severe influenza-associated respiratory infections should be 
considered perhaps as an extension to hospital-based studies in a well-defined 
catchment population. 
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5.6. Implementation of the disease burden manual 
The generic guidelines to estimate disease burden associated with seasonal influenza using 
data from SARI sentinel surveillance has been prepared and the final draft is now being 
reviewed by the WHO for final clearance. While introducing this manual to member states, it 
would need to be emphasised that this manual is an adjunct to the “WHO interim global 
epidemiological surveillance standards for influenza” (WHO Global Influenza Programme, 
2012) and that member states need to ensure availability of quality data conforming to at least 
the minimum requirements for undertaking disease burden estimation. The revised WHO 
surveillance guidelines provide detailed guidance on selection of appropriate sentinel sites for 
SARI surveillance. Although ideally, data from at least 3 to 5 years from multiple sites are 
required for robust disease burden estimates, at a minimum, the following data (for the age 
groups specified in the manual) must be available from at least one sentinel site for a 
continuous period of 12 months: 
• total number of new SARI cases admitted to the sentinel site (by month) 
• total number of new SARI cases where clinical specimens were collected for 
virological diagnosis (by month) 
• number of new SARI cases positive for influenza (by month) 
The experience from the inter-country meeting of the WHO Eastern Mediterranean Region in 
Marrakech in August 2012 demonstrates that the quality of SARI sentinel surveillance is 
highly variable within the region. While some countries like Egypt, Oman, Jordan and Iran 
have good quality SARI surveillance data, SARI sentinel surveillance is virtually non-
existent in countries like Somalia, Sudan and Afghanistan. This is likely to be the scenario in 
most other developing country regions.  
Since this is the first attempt to use sentinel surveillance data to generate disease burden 
estimates, it is expected that many of the steps which in theory appear to be very simple 
might be challenging in resource constrained settings. Therefore, the disease burden manual 
must now be evaluated in practice in different low and middle income countries before the 
final widespread adoption of the methods proposed in the manual. Initially, the countries 
chosen for introduction of the manual (evaluation phase) will require support in the form of 
training and supervision by technical experts trained in using the tool. Disease burden 
estimation using the methods outlined in the manual will require adequate support from 
academia, policymakers and healthcare planners at the national level. This is only possible 
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with repeated advocacy with academia and policymakers during the initial phase so as to 
ensure support for such a resource-intensive exercise. The disease burden estimates generated 
using the methods outlined in the manual would require validation against estimates from 
research studies (both published and on-going). There are numerous countries where the US 
CDC is supporting SARI surveillance through their IEIP field sites or collaborative 
cooperative agreements. Estimates from other SARI sentinel sites in the same country can be 
validated against the estimates from the IEIP study sites. Validation against routine data 
would be more challenging as countries with good routine data (e.g. USA, Australia and 
Western Europe) are not the targeted end-users of the manual. However, the results would 
need to be interpreted with caution- influenza disease burden can vary substantially from site 
to site within a country in any given year. During the evaluation phase, it is important to 
document carefully the best practices and challenges faced while implementing the tools 
outlined in the manual so that appropriate revisions can be made in the future versions and 
subsequent users can learn from the experience of previous users. 
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Chapter 6. Conclusions 
This body of work demonstrates that influenza-associated ALRI confers substantial burden 
on hospital inpatient services, with approximately 1 (95% CI 0.6 to 1.4) million episodes of 
influenza-associated hospitalised ALRI (accounting for about 8 (95% CI 5.3 to 12.4) percent 
of all hospitalised ALRI) in children younger than five years in 2008. This study also 
demonstrates that about 7.6 (95% CI 2.4 to 11.1) percent of all childhood in-hospital ALRI 
mortality and about 7.3 (95% CI 2.0 to 15.8) percent of all ALRI deaths in young children are 
associated with seasonal influenza. Nonetheless, the evidence to support valid and precise 
estimates of global influenza-associated ALRI mortality is sparse and of low quality.  
Research investment to gather further data is clearly needed. There are large gaps in data on 
influenza-associated ALRI hospitalizations from many regions of the world (particularly the 
Middle East, North Africa, Central Asia and Eastern Europe including Russia). Development 
and consistent application of standardised case definitions and study protocols (at least 
regionally) would make an important contribution towards addressing gaps in the data and 
substantially improving these estimates. The evidence base could be improved by a three 
pronged strategy. First, more research studies need to be initiated in low income countries 
(especially those in Africa and West Asia). Second, data systems in middle income countries 
(e.g. Brazil) can be strengthened by appropriate investments in hospital and other routine 
health information systems. Third, further evaluation of the WHO “Manual for Estimating 
Disease Burden Associated with Seasonal Influenza in a Population” through coordinated 
assessments in a variety of country settings should contribute towards standardising the case 
definition and data collection tools for improved disease burden estimates in the future. The 
disease burden estimates thus generated would require validation against estimates from 
research studies in the same country / region. Mortality estimates can be improved by 
gathering influenza and other respiratory viral pathogens isolation data from ALRI patients in 
sites where demographic surveillance records community-based pneumonia mortality. 
Further large-scale unselected case series reporting age specific in-hospital CFRs from many 
well described clinical settings in developing countries and large-scale post-mortem studies 
of ALRI cases that include investigation of seasonal influenza virus as a possible cause would 
also substantially improve the evidence base for the mortality estimate.  
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
Conclusions  158 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  159 
References 
Adazu, K., Lindblade, K. A., Rosen, D. H., Odhiambo, F., Ofware, P., Kwach, J., 
Van Eijk, A. M., Decock, K. M., Amornkul, P., Karanja, D., et al. 2005. 
Health and demographic surveillance in rural western Kenya: a platform for 
evaluating interventions to reduce morbidity and mortality from infectious 
diseases. Am J Trop Med Hyg, 73, 1151-8. 
Adegbola, R., Nesin, M. & Wairagkar, N. 2012. Immunogenicity and efficacy of 
influenza immunization during pregnancy: recent and ongoing studies. Am J 
Obstet Gynecol, 207, S28-32. 
Adegbola, R. A., Falade, A. G., Sam, B. E., Aidoo, M., Baldeh, I., Hazlett, D., 
Whittle, H., Greenwood, B. M. & Mulholland, E. K. 1994. The etiology of 
pneumonia in malnourished and well-nourished Gambian children. Pediatr 
Infect Dis J, 13, 975-82. 
AIIMS. 2010. 53rd AIIMS Annual Report 2008-09 [Online]. New Delhi: All India 
Institute of Medical Sciences. Available: http://www.aiims.edu/aiims/annual-
report/AIIMS%20Annual%20Repront%202008-2009.pdf [Accessed 26 
August 2010]. 
Ajayi-Obe, E. K., Coen, P. G., Handa, R., Hawrami, K., Aitken, C., McIntosh, E. D. 
G. & Booy, R. 2008. Influenza A and respiratory syncytial virus hospital 
burden in young children in East London. Epidemiol Infect, 136, 1046-58. 
Ampofo, K., Gesteland, P. H., Bender, J., Mills, M., Daly, J., Samore, M., Byington, 
C., Pavia, A. T. & Srivastava, R. 2006. Epidemiology, complications, and 
cost of hospitalization in children with laboratory-confirmed influenza 
infection. Pediatrics, 118, 2409-17. 
Anh, D. D., Kilgore, P. E., Slack, M. P., Nyambat, B., Tho, L. H., Yoshida, L. M., 
Nguyen, H. A., Nguyen, C. D., Chong, C. Y., Nguyen, D., et al. 2009. 
Surveillance of pneumococcal-associated disease among hospitalized 
children in Khanh Hoa Province, Vietnam. Clin Infect Dis, 48 S57-64. 
Ansaldi, F., Sticchi, L., Durando, P., Carloni, R., Oreste, P., Vercelli, M., Crovari, P. 
& Icardi, G. 2008. Decline in pneumonia and acute otitis media after the 
introduction of childhood pneumococcal vaccination in Liguria, 
Italy.[Erratum appears in J Int Med Res. 2009 Mar-Apr;37(2):594]. J Int Med 
Res, 36, 1255-60. 
Aranda-Romo, S., Comas-Garcia, A., Garcia-Sepulveda, C. A., Hernandez-Salinas, 
A. E., Pina-Ramirez, M. & Noyola, D. E. 2010. Effect of an immunization 
program on seasonal influenza hospitalizations in Mexican children. Vaccine, 
28, 2550-5. 
Azziz-Baumgartner, E., Alamgir, A., Rahman, M., Homaira, N., Sohel, B. M., 
Sharker, M. Y., Zaman, R. U., Dee, J., Gurley, E. S., Al Mamun, A., et al. 
2012. Incidence of influenza-like illness and severe acute respiratory 
infection during three influenza seasons in Bangladesh, 2008-2010. Bull 
World Health Organ, 90, 12-9. 
Bakir, T. M., Halawani, M. & Ramia, S. 1998. Viral aetiology and epidemiology of 
acute respiratory infections in hospitalized Saudi children. J Trop Pediatr, 44, 
100-3. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  160 
Banajeh, S. M. 1998. Outcome for children under 5 years hospitalized with severe 
acute lower respiratory tract infections in Yemen: a 5 year experience. 
Journal of Tropical Pediatrics, 44, 343-6. 
Baqui, A. H., Rahman, M., Zaman, K., El Arifeen, S., Chowdhury, H. R., Begum, 
N., Bhattacharya, G., Chotani, R. A., Yunus, M., Santosham, M., et al. 2007. 
A population-based study of hospital admission incidence rate and bacterial 
aetiology of acute lower respiratory infections in children aged less than five 
years in Bangladesh. Journal of Health, Population & Nutrition, 25, 179-88. 
Barakat, A., Ihazmad, H., Benkaroum, S., Cherkaoui, I., Benmamoun, A., Youbi, M. 
& El Aouad, R. 2011. Influenza surveillance among outpatients and 
inpatients in Morocco, 1996-2009. PLoS One, 6, e24579. 
Barker, W. H. & Mullooly, J. P. 1980. Impact of epidemic type A influenza in a 
defined adult population. Am J Epidemiol, 112, 798-811. 
Bellei, N., Benfica, D., Perosa, A. H., Carlucci, R., Barros, M. & Granato, C. 2003. 
Evaluation of a rapid test (QuickVue) compared with the shell vial assay for 
detection of influenza virus clearance after antiviral treatment. J Virol 
Methods, 109, 85-8. 
Berkley, J. A., Munywoki, P., Ngama, M., Kazungu, S., Abwao, J., Bett, A., 
Lassauniere, R., Kresfelder, T., Cane, P. A., Venter, M., et al. 2010. Viral 
Etiology of Severe Pneumonia Among Kenyan Infants and Children. JAMA, 
303, 2051-2057. 
Bigogo, G., Audi, A., Aura, B., Aol, G., Breiman, R. F. & Feikin, D. R. 2010. 
Health-seeking patterns among participants of population-based morbidity 
surveillance in rural western Kenya: implications for calculating disease 
rates. Int J Infect Dis, 14, e967-73. 
Black, R. E., Cousens, S., Johnson, H. L., Lawn, J. E., Rudan, I., Bassani, D. G., Jha, 
P., Campbell, H., Walker, C. F., Cibulskis, R., et al. 2010. Global, regional, 
and national causes of child mortality in 2008: a systematic analysis. Lancet, 
375, 1969-87. 
Borenstein, M., Hedges, L. V., Higgins, J. P. T. & Rothstein, H. R. 2009. 
Introduction to Meta-analysis, West Sussex, United Kingdom, John Wiley & 
Sons Ltd. 
Bosis, S., Esposito, S., Niesters, H. G., Crovari, P., Osterhaus, A. D. & Principi, N. 
2005. Impact of human metapneumovirus in childhood: comparison with 
respiratory syncytial virus and influenza viruses. J Med Virol, 75, 101-4. 
Breiman, R. F., Olack, B., Shultz, A., Roder, S., Kimani, K., Feikin, D. R. & Burke, 
H. 2011. Healthcare-use for major infectious disease syndromes in an 
informal settlement in Nairobi, Kenya. J Health Popul Nutr, 29, 123-33. 
Brooks, W. A. 2009. A four-stage strategy to reduce childhood pneumonia-related 
mortality by 2015 and beyond. Vaccine, 27, 619-23. 
Brooks, W. A., Goswami, D., Rahman, M., Nahar, K., Fry, A. M., Balish, A., 
Iftekharuddin, N., Azim, T., X, X., Klimov, A., et al. 2010. Influenza is a 
major contributor to childhood pneumonia in a tropical developing country. 
Pediatr Infect Dis J, 29, 216-21. 
Brooks, W. A., Santosham, M., Naheed, A., Goswami, D., Wahed, M. A., Diener-
West, M., Faruque, A. S. G. & Black, R. E. 2005. Effect of weekly zinc 
supplements on incidence of pneumonia and diarrhoea in children younger 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  161 
than 2 years in an urban, low-income population in Bangladesh: randomised 
controlled trial. Lancet, 366, 999-1004. 
Broor, S. 1 November, 2010 personal communication. RE: Seasonality of 
Respiratory Syncytial Virus in Ballagrah, 2006-08. Type to Nair, H. 
Brotherton, J., McIntyre, P., Puech, M., Wang, H., Gidding, H., Hull, B., Lawrence, 
G., MacIntyre, R., Wood, N. & Armstrong, D. 2004. Vaccine preventable 
diseases and vaccination coverage in Australia 2001 to 2002. Commun Dis 
Intell, 28, vii-S116. 
Bueving, H. J., van der Wouden, J. C., Berger, M. Y. & Thomas, S. 2005. Incidence 
of influenza and associated illness in children aged 0-19 years: a systematic 
review. Rev Med Virol, 15, 383-91. 
Buss, B. F., Shinde, V. M., Safranek, T. J. & Uyeki, T. M. 2009. Pediatric influenza-
associated myositis - Nebraska, 2001-2007. Influenza Other Respi Viruses, 3, 
277-85. 
Campbell, J. D., Sow, S. O., Levine, M. M. & Kotloff, K. L. 2004. The causes of 
hospital admission and death among children in Bamako, Mali. J Trop 
Pediatr, 50, 158-63. 
Carballal, G., Videla, C. M., Espinosa, M. A., Savy, V., Uez, O., Sequeira, M. D., 
Knez, V., Requeijo, P. V., Posse, C. R. & Miceli, I. 2001. Multicentered 
study of viral acute lower respiratory infections in children from four cities of 
Argentina, 1993-1994. J Med Virol, 64, 167-174. 
Carrol, E. D., Mankhambo, L. A., Guiver, M., Banda, D. L., Denis, B., Dove, W., 
Jeffers, G., Molyneux, E. M., Molyneux, M. E., Hart, C. A., et al. 2011. PCR 
improves diagnostic yield from lung aspiration in Malawian children with 
radiologically confirmed pneumonia. PLoS One, 6, e21042. 
Carroll, K. N., Gebretsadik, T., Griffin, M. R., Wu, P., Dupont, W. D., Mitchel, E. F., 
Enriquez, R. & Hartert, T. V. 2008. Increasing burden and risk factors for 
bronchiolitis-related medical visits in infants enrolled in a state health care 
insurance plan. Pediatrics, 122, 58-64. 
Centres for Disease Control and Prevention. 2012. Influenza Research [Online]. 
Atlanta: Centres for Disease Control and Prevention. Available: 
http://www.cdc.gov/flu/pdf/international/program/research.pdf [Accessed 15 
October 2012]. 
Cevey-Macherel, M., Galetto-Lacour, A., Gervaix, A., Siegrist, C. A., Bille, J., 
Bescher-Ninet, B., Kaiser, L., Krahenbuhl, J. D. & Gehri, M. 2009. Etiology 
of community-acquired pneumonia in hospitalized children based on WHO 
clinical guidelines. Eur J Pediatr, 168, 1429-36. 
Chandyo, R. K., Shrestha, P. S., Valentiner-Branth, P., Mathisen, M., Basnet, S., 
Ulak, M., Adhikari, R. K., Sommerfelt, H. & Strand, T. A. 2010. Two weeks 
of zinc administration to Nepalese children with pneumonia does not reduce 
the incidence of pneumonia or diarrhea during the next six months. J Nutr, 
140, 1677-1682. 
Che, D., Caillere, N., Brosset, P., Vallejo, C. & Josseran, L. 2010. Burden of infant 
bronchiolitis: data from a hospital network. Epidemiology & Infection, 138, 
573-5. 
Chen, P. 1996. Effect of acute respiratory infections management to reduce mortality 
in children with pneumonia (运用ARI管理适宜技术降低婴幼儿肺炎死亡
率). Jiangsu Journal of Preventive Medicine (江苏预防医学), 2. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  162 
Chen, W., Zhao, M. R., Zhao, Y. Y. & Ma, B. J. 1997. Analysis of acute respiratory 
infections surveillance in children in rural Henan (河南农村婴幼儿急性呼吸
道感染监测结果分析). Chinese Journal of Rural Medicine (中国农村医学), 
25. 
Chi, X. X., Chen, X., Ouyang, Y. & Xue, X. L. 1996. Preliminary analysis of acute 
respiratory infections surveillance in children under 5 years in Fujian (福建省
ARI项目县5岁以下儿童监测结果初步分析). Strait Journal of Preventive 
Medicine (海峡预防医学杂志), 2. 
Chiu, S. S., Chan, K., Chen, H., Young, B. W., Lim, W., Wong, H., Lau, Y. & Peiris, 
J. S. M. 2009. Virologically confirmed population-based burden of 
hospitalization caused by influenza A and B among children in Hong Kong. 
Clin Infect Dis, 49, 1016-1021. 
Chiu, S. S., Tse, C. Y. C., Lau, Y. & Peiris, M. 2001. Influenza A infection is an 
important cause of febrile seizures. Pediatrics, 108, 993. 
Choi, K. & Thacker, S. B. 1981. An evaluation of influenza mortality surveillance, 
1962-1979. I. Time series forecasts of expected pneumonia and influenza 
deaths. Am J Epidemiol, 113, 215-26. 
Chonmaitree, T., Revai, K., Grady, J. J., Clos, A., Patel, J. A., Nair, S., Fan, J. & 
Henrickson, K. J. 2008. Viral upper respiratory tract infection and otitis 
media complication in young children. Clin Infect Dis, 46, 815-23. 
Cilla, G., Onate, E., Perez-Yarza, E. G., Montes, M., Vicente, D. & Perez-Trallero, 
E. 2008. Viruses in community-acquired pneumonia in children aged less 
than 3 years old: High rate of viral coinfection. J Med Virol, 80, 1843-9. 
Cilla, G., Onate, E., Perez-Yarza, E. G., Montes, M., Vicente, D. & Perez-Trallero, 
E. 2009. Hospitalization rates for human metapneumovirus infection among 
0- to 3-year-olds in Gipuzkoa (Basque Country), Spain. Epidemiol Infect, 
137, 66-72. 
Clara, W., Armero, J., Rodriguez, D., de Lozano, C., Bonilla, L., Minaya, P., 
Chacon, R., Jara, J., Blanco, N., Widdowson, M. A., et al. 2012. Estimated 
incidence of influenza-virus-associated severe pneumonia in children in El 
Salvador, 2008-2010. Bull World Health Organ, 90, 756-63. 
Coelho, M. C., Tsuchiya, L. R. R. V., Nogueira, M. B., Pereira, L. A., Takahashi, G. 
A., Cruz, C. R. & Raboni, S. M. 2007. Impact of respiratory infections by 
influenza viruses A and B in pediatrics patients from Federal University of 
Parana, Brazil. Braz J Infect Diseases, 11, 220-3. 
Coffin, S. E., Zaoutis, T. E., Rosenquist, A. B. W., Heydon, K., Herrera, G., Bridges, 
C. B., Watson, B., Localio, R., Hodinka, R. L. & Keren, R. 2007. Incidence, 
complications, and risk factors for prolonged stay in children hospitalized 
with community-acquired influenza. Pediatrics, 119, 740-8. 
Collins, S., Frost, W., Gover, M. & Sydenstricker, E. 1930. Mortality from Influenza 
and Pneumonia in 50 large cities of the United States 1910-1929. Public 
Health Rep, 45, 2277-2328. 
Comes Castellano, A. M., Lluch Rodrigo, J. A., Portero Alonso, A., Pastor Villalba, 
E. & Sanz Valero, M. 2005. Development of the incidence of pneumonia in 
the autonomous community of Valencia throughout the 1995-2001 period. A 
retrospective study. Anales de Medicina Interna, 22, 118-23. 
Cowling, B. J., Fang, V. J., Nishiura, H., Chan, K. H., Ng, S., Ip, D. K., Chiu, S. S., 
Leung, G. M. & Peiris, J. S. 2012. Increased risk of noninfluenza respiratory 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  163 
virus infections associated with receipt of inactivated influenza vaccine. Clin 
Infect Dis, 54, 1778-83. 
Cox, N. J. & Subbarao, K. 1999. Influenza. Lancet, 354, 1277-82. 
Cutts, F. T., Zaman, S. M. A., Enwere, G., Jaffar, S., Levine, O. S., Okoko, J. B., 
Oluwalana, C., Vaughan, A., Obaro, S. K., Leach, A., et al. 2005. Efficacy of 
nine-valent pneumococcal conjugate vaccine against pneumonia and invasive 
pneumococcal disease in The Gambia: randomised, double-blind, placebo-
controlled trial.[Erratum appears in Lancet. 2005 Jul 2-8;366(9479):28]. 
Lancet, 365, 1139-46. 
D'Onise, K. & Raupach, J. C. A. 2008. The burden of influenza in healthy children in 
South Australia. Med J Aust., 188, 510-3. 
Dawood, F. S., Fiore, A., Kamimoto, L., Bramley, A., Reingold, A., Gershman, K., 
Meek, J., Hadler, J., Arnold, K. E., Ryan, P., et al. 2010. Burden of Seasonal 
Influenza Hospitalization in Children, United States, 2003 to 2008. J Pediatr, 
157, 808-14. 
Dawood, F. S., Iuliano, A. D., Reed, C., Meltzer, M. I., Shay, D. K., Cheng, P. Y., 
Bandaranayake, D., Breiman, R. F., Brooks, W. A., Buchy, P., et al. 2012. 
Estimated global mortality associated with the first 12 months of 2009 
pandemic influenza A H1N1 virus circulation: a modelling study. Lancet 
Infect Dis. 
Department of Child and Adolescent Health 2005. Handbook: IMCI integrated 
management of childhood illness. Geneva: World Health Organization. 
DerSimonian, R. & Laird, N. 1986. Meta-analysis in clinical trials. Control Clin 
Trials, 7, 177-88. 
Djelantik, I. G., Gessner B.D., Sutanto A., Steinhoff M., Linehan M., Moulton L.H., 
Arjoso S. 2003. Case Fatality Proportions and Predictive Factors for 
Mortality among Children Hospitalised with Severe Pneumonia in a Rural 
Developing Country Setting. J Trop Pediatr, 49, 327-332. 
Do, A. H., van Doorn, H. R., Nghiem, M. N., Bryant, J. E., Hoang, T. H., Do, Q. H., 
Van, T. L., Tran, T. T., Wills, B., Nguyen, V. C., et al. 2011. Viral etiologies 
of acute respiratory infections among hospitalized Vietnamese children in Ho 
Chi Minh City, 2004-2008. PLoS One, 6, e18176. 
Dobson, M., Peel, D. & Khallaf, N. 1996. Field trial of oxygen concentrators in 
upper Egypt. Lancet, 347, 1597-9. 
Donaldson, G. C. & Keatinge, W. R. 2002. Excess winter mortality: influenza or 
cold stress? Observational study. BMJ, 324, 89-90. 
Duke, T., Mgone, J. & Frank, D. 2001. Hypoxaemia in children with severe 
pneumonia in Papua New Guinea. Int J Tuberc Lung Dis, 5, 511-9. 
Duke, T., Wandi, F., Jonathan, M., Matai, S., Kaupa, M., Saavu, M., Subhi, R. & 
Peel, D. 2008. Improved oxygen systems for childhood pneumonia: a 
multihospital effectiveness study in Papua New Guinea. Lancet, 372, 1328-
33. 
Eddy, D. M., Hasselblad, V. & Schachter, R. 1992. Meta-analysis by the confidence 
profile method, New York, Academic press. 
Egger, M., Schneider, M. & Davey Smith, G. 1998. Spurious precision? Meta-
analysis of observational studies. BMJ, 316, 140-4. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  164 
Eick, A. A., Uyeki, T. M., Klimov, A., Hall, H., Reid, R., Santosham, M. & O'Brien, 
K. L. 2011. Maternal influenza vaccination and effect on influenza virus 
infection in young infants. Arch Pediatr Adolesc Med, 165, 104-11. 
Englund, J. A., Mbawuike, I. N., Hammill, H., Holleman, M. C., Baxter, B. D. & 
Glezen, W. P. 1993. Maternal immunization with influenza or tetanus toxoid 
vaccine for passive antibody protection in young infants. J Infect Dis, 168, 
647-56. 
Esposito, S., Gasparini, R., Bosis, S., Marchisio, P., Tagliabue, C., Tosi, S., Bianchi, 
C., Crovari, P. & Principi, N. 2005. Clinical and socio-economic impact of 
influenza and respiratory syncytial virus infection on healthy children and 
their households. Clin Microbiol Infect, 11, 933-6. 
Espy, M. J., Smith, T. F., Harmon, M. W. & Kendal, A. P. 1986. Rapid detection of 
influenza virus by shell vial assay with monoclonal antibodies. J Clin 
Microbiol, 24, 677-9. 
Feikin, D. R., Olack, B., Bigogo, G. M., Audi, A., Cosmas, L., Aura, B., Burke, H., 
Njenga, M. K., Williamson, J. & Breiman, R. F. 2011. The burden of 
common infectious disease syndromes at the clinic and household level from 
population-based surveillance in rural and urban Kenya. PLoS One, 6, 
e16085. 
Fields, B. 5 February, 2012 personal communication. RE: Application of Taqman 
Array Cards (TAC) to the Diagnosis of Respiratory Diseases at International 
Emerging Infection Program Sites. Type to Nair, H. 
Forgie, I. M., O'Neill, K. P., Lloyd-Evans, N., Leinonen, M., Campbell, H., Whittle, 
H. C. & Greenwood, B. M. 1991. Etiology of acute lower respiratory tract 
infections in Gambian children: II. Acute lower respiratory tract infection in 
children ages one to nine years presenting at the hospital. Pediatr Infect Dis J, 
10, 42-7. 
Forster, J., Ihorst, G., Rieger, C. H. L., Stephan, V., Frank, H.-D., Gurth, H., Berner, 
R., Rohwedder, A., Werchau, H., Schumacher, M., et al. 2004. Prospective 
population-based study of viral lower respiratory tract infections in children 
under 3 years of age (the PRI.DE study). Eur J Pediatr, 163, 709-16. 
Foulongne, V., Guyon, G., Rodiere, M. & Segondy, M. 2006. Human 
metapneumovirus infection in young children hospitalized with respiratory 
tract disease. Pediatr Infect Dis J, 25, 354-9. 
France, E. K., Glanz, J. M., Xu, S., Davis, R. L., Black, S. B., Shinefield, H. R., 
Zangwill, K. M., Marcy, S. M., Mullooly, J. P., Jackson, L. A., et al. 2004. 
Safety of the trivalent inactivated influenza vaccine among children: a 
population-based study. Arch Pediatr Adolesc Med, 158, 1031-6. 
Gao, J. Y., Feng, B. & Li, L. 2004. Establishing respiratory monitoring network to 
reduce pneumonia mortality in children (建立儿童呼吸监测网控制肺炎降
低肺炎死亡率的研究). Chinese Journal of Maternal and Child Health (中国
妇幼保健), 19. 
Garces-Sanchez, M. D., Diez-Domingo, J., Ballester Sanz, A., Peidro Boronat, C., 
Garcia Lopez, M., Anton Crespo, V., Peris Vidal, A., Baldo Poblet, J. M. & 
Gallego Garcia, D. 2005. Epidemiology of community-acquired pneumonia 
in children aged less than 5 years old in the Autonomous Community of 
Valencia (Spain). An Pediatr (Barc), 63, 125-30. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  165 
Gessner, B. D., Sutanto, A., Linehan, M., Djelantik, I. G. G., Fletcher, T., Gerudug, 
I. K., Ingerani, Mercer, D., Moniaga, V., Moulton, L. H., et al. 2005. 
Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia 
and meningitis in Indonesian children: hamlet-randomised vaccine-probe 
trial. Lancet, 365, 43-52. 
Gibbs, M. J. & Gibbs, A. J. 2006. Molecular virology: was the 1918 pandemic 
caused by a bird flu? Nature, 440, E8; discussion E9-10. 
Gil, A., San-Martin, M., Carrasco, P. & Gonzalez, A. 2002. Epidemiology of 
pneumonia hospitalizations in Spain, 1995-1998. J Infect, 44, 84-7. 
Glezen, W. P. 1996. Emerging infections: pandemic influenza. Epidemiol Rev, 18, 
64-76. 
Glezen, W. P. 2003. Effect of maternal antibodies on the infant immune response. 
Vaccine, 21, 3389-92. 
Graham, N. M. 1990. The epidemiology of acute respiratory infections in children 
and adults: a global perspective. Epidemiol Rev, 12, 149-78. 
Grant, C. C., Scragg, R., Tan, D., Pati, A., Aickin, R. & Yee, R. L. 1998. 
Hospitalization for pneumonia in children in Auckland, New Zealand. J 
Paediatr Child Health, 34, 355-9. 
Greenland, S. 2005. Multiple-bias modelling for analysis of observational data (with 
discussion). J R Stat Soc Ser A, 168, 267-308. 
Greenland, S. & Lash, T. L. 2008. Bias Analysis. In: Rothman, K. J., Greenland, S. 
& Lash, T. L. (eds.) Modern Epidemiology. 3rd ed. Philadelphia: Lippincott 
Williams & Wilkins. 
Greenland, S. & O'Rourke, K. 2008. Meta-analysis. In: Rothman, K. J., Greenland, 
S. & Lash, T. L. (eds.) Modern Epidemiology. 3rd ed. Philadelphia: 
Lippincott, Williams & Wilkins. 
Grijalva, C. G., Craig, A. S., Dupont, W. D., Bridges, C. B., Schrag, S. J., Iwane, M. 
K., Schaffner, W., Edwards, K. M. & Griffin, M. R. 2006. Estimating 
influenza hospitalizations among children. Emerg Infect Dis, 12, 103-9. 
Grijalva, C. G., Nuorti, J. P., Zhu, Y. & Griffin, M. R. 2010. Increasing incidence of 
empyema complicating childhood community-acquired pneumonia in the 
United States. Clin Infect Dis, 50, 805-13. 
Grijalva, C. G., Poehling, K. A., Edwards, K. M., Weinberg, G. A., Staat, M. A., 
Iwane, M. K., Schaffner, W. & Griffin, M. R. 2007a. Accuracy and 
interpretation of rapid influenza tests in children. Pediatrics, 119, e6-e11. 
Grijalva, C. G., Weinberg, G. A., Bennett, N. M., Staat, M. A., Craig, A. S., Dupont, 
W. D., Iwane, M. K., Postema, A. S., Schaffner, W., Edwards, K. M., et al. 
2007b. Estimating the undetected burden of influenza hospitalizations in 
children. Epidemiol Infect, 135, 951-8. 
Hamano-Hasegawa, K., Morozumi, M., Nakayama, E., Chiba, N., Murayama, S. Y., 
Takayanagi, R., Iwata, S., Sunakawa, K., Ubukata, K. & Acute Respiratory 
Diseases Study Group 2008. Comprehensive detection of causative pathogens 
using real-time PCR to diagnose pediatric community-acquired pneumonia. J 
Infect Chemother, 14, 424-32. 
Hamelin, M. E., Abed, Y. & Boivin, G. 2004. Human metapneumovirus: a new 
player among respiratory viruses. Clin Infect Dis, 38, 983-90. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  166 
Hasan, K., Jolly, P., Marquis, G., Roy, E., Podder, G., Alam, K., Huq, F. & Sack, R. 
2006. Viral etiology of pneumonia in a cohort of newborns till 24 months of 
age in Rural Mirzapur, Bangladesh. Scand J Infect Dis, 38, 690-5. 
Heikkinen, T., Salmi, A. A. & Ruuskanen, O. 2001. Comparative study of 
nasopharyngeal aspirate and nasal swab specimens for detection of influenza. 
BMJ, 322, 138. 
Heikkinen, T., Thint, M. & Chonmaitree, T. 1999. Prevalence of various respiratory 
viruses in the middle ear during acute otitis media. N Engl J Med, 340, 260-4. 
Henmi, M. & Copas, J. B. 2010. Confidence intervals for random effects meta-
analysis and robustness to publication bias. Stat Med, 29, 2969-83. 
Henrickson, K. J., Hoover, S., Kehl, K. S. & Hua, W. M. 2004. National disease 
burden of respiratory viruses detected in children by polymerase chain 
reaction. Pediatr Infect Dis J, 23, Supplement, S11-S18. 
Ho, P.-L., Chiu, S. S., Chow, F. K. H., Mak, G. C. & Lau, Y. L. 2007. Pediatric 
hospitalization for pneumococcal diseases preventable by 7-valent 
pneumococcal conjugate vaccine in Hong Kong. Vaccine, 25, 6837-41. 
Hu, Y. C. & Lu, W. Y. 1996. Effect of acute respiratory infections management in 
children (小儿急性呼吸道感染管理效果分析). Shanghai Journal of 
Preventive Medicine (上海预防医学杂志) 8. 
Huang, W. H., Chen, L. N. & Shi, L. B. 1999. Analysis of acute respiratory 
infections surveillance in children aged 0-4 years old in Licheng (鲤城区0-4
岁儿童急性呼吸道感染监测结果分析). Strait Journal of Preventive 
Medicine (海峡预防医学杂志), 5. 
Isaacs, D. 1989. Problems in determining the etiology of community-acquired 
childhood pneumonia. Pediatr Infect Dis J, 8, 143-8. 
Iskander, M., Booy, R. & Lambert, S. 2007. The burden of influenza in children. 
Curr Opin Infect Dis, 20, 259-63. 
Iwane, M. K., Edwards, K. M., Szilagyi, P. G., Walker, F. J., Griffin, M. R., 
Weinberg, G. A., Coulen, C., Poehling, K. A., Shone, L. P., Balter, S., et al. 
2004. Population-based surveillance for hospitalizations associated with 
respiratory syncytial virus, influenza virus, and parainfluenza viruses among 
young children. Pediatrics, 113, 1758-64. 
Izurieta, H. S., Thompson, W. W., Kramarz, P., Shay, D. K., Davis, R. L., 
DeStefano, F., Black, S., Shinefield, H. & Fukuda, K. 2000. Influenza and the 
rates of hospitalization for respiratory disease among infants and young 
children. N Engl J Med, 342, 232-239. 
Jefferson, T., Rivetti, A., Di Pietrantonj, C., Demicheli, V. & Ferroni, E. 2012. 
Vaccines for preventing influenza in healthy children. Cochrane Database 
Syst Rev, 8, CD004879. 
Ji, W., Zhang, T., Zhang, X., Jiang, L., Ding, Y., Hao, C., Ju, L., Wang, Y., Jiang, 
Q., Steinhoff, M., et al. 2010. The epidemiology of hospitalized influenza in 
children, a two year population-based study in the People's Republic of 
China. BMC Health Serv Res. , 10, 82. 
Johnson, A. W., Osinusi, K., Aderele, W. I., Gbadero, D. A., Olaleye, O. D. & 
Adeyemi-Doro, F. A. 2008. Etiologic agents and outcome determinants of 
community-acquired pneumonia in urban children: a hospital-based study. J 
Natl Med Assoc, 100, 370-85. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  167 
Johnson, B. F., Wilson, L. E., Ellis, J., Elliot, A. J., Barclay, W. S., Pebody, R. G., 
McMenamin, J., Fleming, D. M. & Zambon, M. C. 2009. Fatal cases of 
influenza a in childhood. PLoS One, 4, e7671. 
Jokinen, C., Heiskanen, L., Juvonen, H., Kallinen, S., Karkola, K., Korppi, M., 
Kurki, S., Ronnberg, P. R., Seppa, A. & Soimakallio, S. 1993. Incidence of 
community-acquired pneumonia in the population of four municipalities in 
eastern Finland. Am J Epidemiol, 137, 977-88. 
Jordan, H. T., Prapasiri, P., Areerat, P., Anand, S., Clague, B., Sutthirattana, S., 
Chamany, S., Flannery, B. & Olsen, S. J. 2009. A comparison of population-
based pneumonia surveillance and health-seeking behavior in two provinces 
in rural Thailand. Int J Infect Dis, 13, 355-61. 
Juven, T., Mertsola, J., Waris, M., Leinonen, M., Meurman, O., Roivainen, M., 
Eskola, J., Saikku, P. & Ruuskanen, O. 2000. Etiology of community-
acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J, 19, 
293-8. 
Kabra, S. K., Lodha, R., Broor, S., Chaudhary, R., Ghosh, M. & Maitreyi, R. S. 
2003. Etiology of acute lower respiratory tract infection. Indian J Pediatr, 70, 
33-6. 
Karaivanova, G. M. 1995. Viral respiratory infections and their role as public health 
problem in tropical countries (review). Afr J Med Med Sci., 24, 1-7. 
Kasai, T., Togashi, T. & Morishima, T. 2000. Encephalopathy associated with 
influenza epidemics. Lancet, 355, 1558-9. 
Keren, R., Zaoutis, T. E., Saddlemire, S., Luan, X. Q. & Coffin, S. E. 2006. Direct 
medical cost of influenza-related hospitalizations in children. Pediatrics, 118, 
e1321-7. 
Kirkwood, B. R. & Sterne, J. A. C. 2006. Essentials of Medical Statistics, Oxford, 
Blackwell Science. 
Klugman, K. P., Chien, Y. W. & Madhi, S. A. 2009. Pneumococcal pneumonia and 
influenza: a deadly combination. Vaccine, 27, C9-C14. 
Kusel, M. M., de Klerk, N. H., Holt, P. G., Kebadze, T., Johnston, S. L. & Sly, P. D. 
2006. Role of respiratory viruses in acute upper and lower respiratory tract 
illness in the first year of life: a birth cohort study. Pediatr Infect Dis J, 25, 
680-6. 
Kwong, K. L., Lung, D., Wong, S. N., Que, T. L. & Kwong, N. S. 2009. Influenza-
related hospitalisations in children. J Paediatr Child Health, 45, 660-4. 
Lahti, E., Peltola, V., Waris, M., Virkki, R., Rantakokko-Jalava, K., Jalava, J., 
Eerola, E. & Ruuskanen, O. 2009. Induced sputum in the diagnosis of 
childhood community-acquired pneumonia. Thorax, 64, 252-7. 
Lambert, S. B., Allen, K. M., Carter, R. C. & Nolan, T. M. 2008a. The cost of 
community-managed viral respiratory illnesses in a cohort of healthy 
preschool-aged children. Respir Res, 9. 
Lambert, S. B., Whiley, D. M., O'Neill, N. T., Andrews, E. C., Canavan, F. M., 
Bletchly, C., Siebert, D. J., Sloots, T. P. & Nissen, M. D. 2008b. Comparing 
nose-throat swabs and nasopharyngeal aspirates collected from children with 
symptoms for respiratory virus identification using real-time polymerase 
chain reaction. Pediatrics, 122, e615-20. 
Lankinen, K. S., Salo, P., Rapola, S., Salo, E., Takala, A. K. & Leinonen, M. 1997. 
Pneumococcal Capsular Antigen Detection after Enrichment Culture: An 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  168 
Alternative to Culture Methods in Epidemiologic Research. Am J Trop Med 
Hyg, 56, 211-215. 
Laurie, K. L., Huston, P., Riley, S., Katz, J. M., Willison, D. J., Tam, J. S., Mounts, 
A. W., Hoschler, K., Miller, E., Vandemaele, K., et al. 2012. Influenza 
serological studies to inform public health action: best practices to optimise 
timing, quality and reporting. Influenza Other Respi Viruses. 
Lee, G. E., Lorch, S. A., Sheffler-Collins, S., Kronman, M. P. & Shah, S. S. 2010. 
National hospitalization trends for pediatric pneumonia and associated 
complications. Pediatrics, 126, 204-13. 
Lester-Smith, D., Zurynski, Y. A., Booy, R., Festa, M. S., Kesson, A. M. & Elliott, 
E. J. 2009. The burden of childhood influenza in a tertiary paediatric setting. 
Commun Dis Intell, 33, 209-15. 
Lindblade, K. A., Johnson, A. J., Arvelo, W., Zhang, X., Jordan, H. T., Reyes, L., 
Fry, A. M. & Padilla, N. 2011. Low usage of government healthcare facilities 
for acute respiratory infections in guatemala: implications for influenza 
surveillance. BMC Public Health, 11, 885. 
Liu, L., Johnson, H. L., Cousens, S., Perin, J., Scott, S., Lawn, J. E., Rudan, I., 
Campbell, H., Cibulskis, R., Li, M., et al. 2012. Global, regional, and national 
causes of child mortality: an updated systematic analysis for 2010 with time 
trends since 2000. Lancet, 379, 2151-61. 
Liu, Q., Fu, P., Zhao, S. & Zou, S. H. 1994. Analysis of acute respiratory infections 
surveillance in children aged 0-4 years old in Qingdao (青岛市0-4岁儿童急
性呼吸道感染监测结果分析). Acta Academiae Medicinae Qingdao (青岛医
学院学报), 30. 
Lou, L. Y., Cong, G. Q., Sun, S. X., Song, Y. H., Li, G. L. & Yang, S. 1995. 
Analysis of acute respiratory infections surveillance in children under 5 years 
in rural Heilongjiang (黑龙江省农村5岁以下儿童急性呼吸道感染监测分
析). Chinese Journal of Primary Health Care (中国初级卫生保健), 9. 
Lowther, S. A., Shay, D. K., Holman, R. C., Clarke, M. J., Kaufman, S. F. & 
Anderson, L. J. 2000. Bronchiolitis-associated hospitalizations among 
American Indian and Alaska Native children. Pediatr Infect Dis J, 19, 11-7. 
Lucero, M. G., Nohynek, H., Williams, G., Tallo, V., Simoes, E. A. F., Lupisan, S., 
Sanvictores, D., Forsyth, S., Puumalainen, T., Ugpo, J., et al. 2009. Efficacy 
of an 11-valent pneumococcal conjugate vaccine against radiologically 
confirmed pneumonia among children less than 2 years of age in the 
Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr 
Infect Dis J, 28, 455-62. 
Lucero, M. G. & Williams, G. 2005. Vaccine trial as "probe" to define the burden of 
pneumococcal pneumonia disease. Lancet, 365, 1113-4. 
Madhi, S. 19 July, 2011 2011. RE: HIV adjustment for S Africa Severe ALRI data. 
Type to Nair, H. 
Madhi, S. A., Kuwanda, L., Cutland, C. & Klugman, K. P. 2005. The impact of a 9-
valent pneumococcal conjugate vaccine on the public health burden of 
pneumonia in HIV-infected and -uninfected children. Clin Infect Dis, 40, 
1511-8. 
Madhi, S. A., Ludewick, H., Kuwanda, L., van Niekerk, N., Cutland, C. & Klugman, 
K. P. 2007. Seasonality, incidence, and repeat human metapneumovirus 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  169 
lower respiratory tract infections in an area with a high prevalence of human 
immunodeficiency virus type-1 infection. Pediatr Infect Dis J, 26, 693-9. 
Madhi, S. A., Schoub, B., Simmank, K., Blackburn, N. & Klugman, K. P. 2000. 
Increased burden of respiratory viral associated severe lower respiratory tract 
infections in children infected with human immunodeficiency virus type-1. J 
Pediatr, 137, 78-84. 
Magree, H. C., Russell, F. M., Sa'aga, R., Greenwood, P., Tikoduadua, L., Pryor, J., 
Waqatakirewa, L., Carapetis, J. R. & Mulholland, E. K. 2005. Chest X-ray-
confirmed pneumonia in children in Fiji. Bull World Health Organ, 83, 427-
33. 
Mahony, J. B. 2008. Detection of respiratory viruses by molecular methods. Clin 
Microbiol Rev, 21, 716-47. 
McCullers, J. A. 2006. Insights into the interaction between influenza virus and 
pneumococcus. Clin Microbiol Rev, 19, 571-82. 
McCullers, J. A., McAuley, J. L., Browall, S., Iverson, A. R., Boyd, K. L. & 
Henriques Normark, B. 2010. Influenza enhances susceptibility to natural 
acquisition of and disease due to Streptococcus pneumoniae in ferrets. J 
Infect Dis, 202, 1287-95. 
Miller, E. K., Griffin, M. R., Edwards, K. M., Weinberg, G. A., Szilagyi, P. G., Staat, 
M. A., Iwane, M. K., Zhu, Y., Hall, C. B., Fairbrother, G., et al. 2008. 
Influenza burden for children with asthma. Pediatrics, 121, 1-8. 
Milne, B. G., Williams, S., May, M. L. A., Kesson, A. M., Gillis, J. & Burgess, M. 
A. 2004. Influenza A associated morbidity and mortality in a Paediatric 
Intensive Care Unit. Commun Dis Intell., 28, 504-9. 
Mo, J. Z. 1998. Analysis of acute respiratory infections surveillance in 20867 
children aged 0-4 years old in Southern Jiangsu (苏南农村20867名0-4岁儿
童ARI监测研究). Chinese Journal of Primary Health Care (中国初级卫生
保健), 12. 
Monge, V. & Gonzalez, A. 2001. Hospital admissions for pneumonia in Spain. 
Infection, 29, 3-6. 
Montes, M., Vicente, D., Perez-Yarza, E. G., Cilla, G. & Perez-Trallero, E. 2005. 
Influenza-related hospitalisations among children aged less than 5 years old 
in the Basque Country, Spain: a 3-year study (July 2001-June 2004). Vaccine, 
23, 4302-6. 
Moore, D. L., Vaudry, W., Scheifele, D. W., Halperin, S. A., Dery, P., Ford-Jones, 
E., Arishi, H. M., Law, B. J., Lebel, M., Le Saux, N., et al. 2006. Surveillance 
for influenza admissions among children hospitalized in Canadian 
immunization monitoring program active centers, 2003-2004. Pediatrics, 
118, e610-9. 
Moore, H. C., de Klerk, N., Richmond, P. & Lehmann, D. 2010. A retrospective 
population-based cohort study identifying target areas for prevention of acute 
lower respiratory infections in children. BMC Public Health, 10, 757. 
Morishima, T., Togashi, T., Yokota, S., Okuno, Y., Miyazaki, C., Tashiro, M. & 
Okabe, N. 2002. Encephalitis and encephalopathy associated with an 
influenza epidemic in Japan. Clin Infect Dis, 35, 512-7. . 
Mounts, A. W. 9 February, 2012 personal communication. RE: Studies evaluating 
ILI and SARI case definitions for sensitivity, specificity and PPV. Type to 
Nair, H. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  170 
Mulholland, K., Hilton, S., Adegbola, R., Usen, S., Oparaugo, A., Omosigho, C., 
Weber, M., Palmer, A., Schneider, G., Jobe, K., et al. 1997. Randomised trial 
of Haemophilus influenzae type-b tetanus protein conjugate vaccine 
[corrected] for prevention of pneumonia and meningitis in Gambian 
infants.[Erratum appears in Lancet 1997 Aug 16;350(9076):524]. Lancet, 
349, 1191-7. 
Mullooly, J. P., Bridges, C. B., Thompson, W. W., Chen, J., Weintraub, E., Jackson, 
L. A., Black, S. & Shay, D. K. 2007. Influenza- and RSV-associated 
hospitalizations among adults. Vaccine, 25, 846-55. . 
Nair, H., Brooks, W. A., Katz, M., Roca, A., Berkley, J. A., Madhi, S. A., 
Simmerman, J. M., Gordon, A., Sato, M., Howie, S., et al. 2011. Global 
burden of respiratory infections due to seasonal influenza in young children: a 
systematic review and meta-analysis. Lancet, 378, 1917-30. 
Nair, H., Nokes, D., Gessner, B., Dherani, M., Madhi, S., Singleton, R., O'Brien, K., 
Roca, A., Wright, P., Bruce, N., et al. 2010. Global burden of acute lower 
respiratory infections due to respiratory syncytial virus in young children: a 
systematic review and meta-analysis. Lancet, 375, 1545-55. 
Nair, H., Simoes, E. A., Rudan, I., Gessner, B. D., Azziz-Baumgartner, E., Zhang, J. 
S., Feikin, D. R., Mackenzie, G. A., Moisi, J. C., Roca, A., et al. 2013. Global 
and regional burden of hospital admissions for severe acute lower respiratory 
infections in young children in 2010: a systematic analysis. Lancet. 
Nascimento-Carvalho, C. M., Cardoso, M. R., Barral, A., Araujo-Neto, C. A., 
Oliveira, J. R., Sobral, L. S., Saukkoriipi, A., Paldanius, M., Vainionpaa, R., 
Leinonen, M., et al. 2010. Seasonal patterns of viral and bacterial infections 
among children hospitalized with community-acquired pneumonia in a 
tropical region. Scand J Infect Dis, 42, 839-44. 
Nascimento-Carvalho, C. M., Ribeiro, C. T., Cardoso, M. R., Barral, A., Araujo-
Neto, C. A., Oliveira, J. R., Sobral, L. S., Viriato, D., Souza, A. L., 
Saukkoriipi, A., et al. 2008. The role of respiratory viral infections among 
children hospitalized for community-acquired pneumonia in a developing 
country. Pediatr Infect Dis J, 27, 939-41. 
Nelson, E. A., Tam, J. S., Yu, L. M., Li, A. M., Chan, P. K. & Sung, R. Y. 2007. 
Assessing disease burden of respiratory disorders in Hong Kong children 
with hospital discharge data and linked laboratory data. Hong Kong Med J, 
13, 114-21. 
Neuzil, K. M., Dupont, W. D., Wright, P. F. & Edwards, K. M. 2001. Efficacy of 
inactivated and cold-adapted vaccines against influenza A infection, 1985 to 
1990: the pediatric experience. Pediatr Infect Dis J, 20, 733-40. 
Neuzil, K. M., Mellen, B. G., Wright, P. F., Mitchel, E. F., Jr. & Griffin, M. R. 2000. 
The effect of influenza on hospitalizations, outpatient visits, and courses of 
antibiotics in children. N Engl J Med, 342, 225-31. 
Neuzil, K. M., Zhu, Y. W., Griffin, M. R., Edwards, K. M., Thompson, J. M., 
Tollefson, S. J. & Wright, P. F. 2002. Burden of interpandemic influenza in 
children younger than 5 years: a 25-year prospective study. J Infect Dis, 185, 
147-152. 
Nicholson, K. G., McNally, T., Silverman, M., Simons, P., Stockton, J. D. & 
Zambon, M. C. 2006. Rates of hospitalisation for influenza, respiratory 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  171 
syncytial virus and human metapneumovirus among infants and young 
children. Vaccine, 24, 102-8. 
Nicoll, A. & Sprenger, M. 2013. Low effectiveness undermines promotion of 
seasonal influenza vaccine. Lancet Infect Dis, 13, 7-9. 
Nizami, S. Q., Bhutta, Z. A. & Hasan, R. 2006. Incidence of acute respiratory 
infections in children 2 months to 5 years of age in periurban communities in 
Karachi, Pakistan. J Pak Med Assoc, 56, 163-7. 
Nokes, D. J., Ngama, M., Bett, A., Abwao, J., Munywoki, P., English, M., Scott, J. 
Anthony G., Cane, P. & Medley, Graham F. 2009. Incidence and Severity of 
Respiratory Syncytial Virus Pneumonia in Rural Kenyan Children Identified 
through Hospital Surveillance. Clin Infect Dis., 49, 1341-1349. 
Nongkynrih, B., Anand, K. & Kapoor, S. K. 2003. Use of verbal autopsy by health 
workers in under-five children. Indian Pediatr, 40, 766-71. 
O'Brien, K. L., Walters, M. I., Sellman, J., Quinlisk, P., Regnery, H., Schwartz, B. & 
Dowell, S. F. 2000. Severe pneumococcal pneumonia in previously healthy 
children: the role of preceding influenza infection. Clin Infect Dis, 30, 784-9. 
O'Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M., McCall, 
N., Lee, E., Mulholland, K., Levine, O. S. & Cherian, T. 2009. Burden of 
disease caused by Streptococcus pneumoniae in children younger than 5 
years: global estimates. Lancet, 374, 893-902. 
O'Brien, M. A., Uyeki, T. M., Shay, D. K., Thompson, W. W., Kleinman, K., 
McAdam, A., Yu, X. J., Platt, R. & Lieu, T. A. 2004. Incidence of outpatient 
visits and hospitalizations related to influenza in infants and young children. 
Pediatrics, 113, 585-93. 
Ohmit, S. E., Petrie, J. G., Malosh, R. E., Cowling, B. J., Thompson, M. G., Shay, D. 
K. & Monto, A. S. 2013. Influenza Vaccine Effectiveness in the Community 
and the Household. Clin Infect Dis. 
Okabe, N., Yamashita, K., Taniguchi, K. & Inouye, S. 2000. Influenza surveillance 
system of Japan and acute encephalitis and encephalopathy in the influenza 
season. Pediatr Int, 42, 187-91. 
Onyango, F. E., Steinhoff, M., Wafula, E. M., Wariua, S., Musia, J. & Kitonyi, J. 
1993. Hypoxaemia in young Kenyan children with acute lower respiratory 
infection. BMJ, 306, 612-15. 
Ortiz, J. R., Englund, J. A. & Neuzil, K. M. 2011. Influenza vaccine for pregnant 
women in resource-constrained countries: a review of the evidence to inform 
policy decisions. Vaccine, 29, 4439-52. 
Ortiz, J. R., Neuzil, K. M., Ahonkhai, V. I., Gellin, B. G., Salisbury, D. M., Read, J. 
S., Adegbola, R. A. & Abramson, J. S. 2012. Translating vaccine policy into 
action: A report from the Bill & Melinda Gates Foundation Consultation on 
the prevention of maternal and early infant influenza in resource-limited 
settings. Vaccine. 
Ortiz, J. R., Sotomayor, V., Uez, O. C., Oliva, O., Bettels, D., McCarron, M., Bresee, 
J. S. & Mounts, A. W. 2009. Strategy to enhance influenza surveillance 
worldwide. Emerg Infect Dis, 15, 1271-8. 
Owais, A., Tikmani, S. S., Sultana, S., Zaman, U., Ahmed, I., Allana, S. & Zaidi, A. 
K. 2010. Incidence of pneumonia, bacteremia, and invasive pneumococcal 
disease in Pakistani children. Trop Med Int Health, 15, 1029-36. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  172 
Pecchini, R., Berezin, E. N., Felicio, M. C. C., Passos, S. D., Souza, M. C., Lima, L. 
R. d. A. V. d., Ueda, M., Matsumoto, T. K. & Durigon, E. L. 2008. Incidence 
and clinical characteristics of the infection by the respiratory syncytial virus 
in children admitted in Santa Casa de Sao Paulo Hospital. Braz J Infect Dis, 
12, 476-9. 
Peck, A. J., Holman, R. C., Curns, A. T., Lingappa, J. R., Cheek, J. E., Singleton, R. 
J., Carver, K. & Anderson, L. J. 2005. Lower respiratory tract infections 
among american Indian and Alaska Native children and the general 
population of U.S. Children. Pediatr Infect Dis J, 24, 342-51. 
Poehling, K. A., Edwards, K. M., Weinberg, G. A., Szilagyi, P., Staat, M. A., Iwane, 
M. K., Bridges, C. B., Grijalva, C. G., Zhu, Y. W., Bernstein, D. I., et al. 
2006. The underrecognized burden of influenza in young children. N Engl J 
Med, 355, 31-40. 
Poehling, K. A., Szilagyi, P. G., Staat, M. A., Snively, B. M., Payne, D. C., Bridges, 
C. B., Chu, S. Y., Light, L. S., Prill, M. M., Finelli, L., et al. 2011. Impact of 
maternal immunization on influenza hospitalizations in infants. Am J Obstet 
Gynecol, 204, S141-8. 
Poole, C. & Greenland, S. 1999. Random-effects meta-analyses are not always 
conservative. Am J Epidemiol, 150, 469-75. 
Principi, N., Esposito, S., Gasparini, R., Marchisio, P. & Crovari, P. 2004. Burden of 
influenza in healthy children and their households. Arch Dis Child, 89, 1002-
1007. 
Principi, N., Esposito, S., Marchisio, P., Gasparini, R. & Crovari, P. 2003. 
Socioeconomic impact of influenza on healthy children and their families. 
Pediatr Infect Dis J, 22, S207-10. 
Puck, J. M., Glezen, W. P., Frank, A. L. & Six, H. R. 1980. Protection of infants 
from infection with influenza A virus by transplacentally acquired antibody. J 
Infect Dis, 142, 844-9. 
Qu, J. S., Li, L. & Wang, G. Y. 2009. The influence of acute respiratory infection 
administration on mortality of pnemonia in children under five years old (急
性呼吸道感染管理对5岁以下儿童肺炎死亡率的影响). Qilu Journal of 
Medicine (齐鲁医学杂志), 24. 
Rawlinson, W. D., Waliuzzaman, Z. M., Fennell, M., Appleman, J. R., Shimasaki, C. 
D. & Carter, I. W. 2004. New point of care test is highly specific but less 
sensitive for influenza virus A and B in children and adults. J Med Virol, 74, 
127-31. 
Reed, C., Kallen, A. J., Patton, M., Arnold, K. E., Farley, M. M., Hageman, J. & 
Finelli, L. 2009. Infection with community-onset Staphylococcus aureus and 
influenza virus in hospitalized children. Pediatr Infect Dis J, 28, 572-6. 
Rennels, M. B., Meissner, H. C. & Committee on Infectious Diseases 2002. 
Technical report: Reduction of the influenza burden in children. Pediatrics, 
110, e80. 
Research Department of Infection and Population Health. 2012. Flu Watch [Online]. 
London: University College London. Available: 
http://www.ucl.ac.uk/iph/research/cide/fluwatch [Accessed 1 November 
2012]. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  173 
Reuman, P. D., Ayoub, E. M. & Small, P. A. 1987. Effect of passive maternal 
antibody on influenza illness in children: a prospective study of influenza A 
in mother-infant pairs. Pediatr Infect Dis J, 6, 398-403. 
Rhorer, J., Ambrose, C. S., Dickinson, S., Hamilton, H., Oleka, N. A., Malinoski, F. 
J. & Wittes, J. 2009. Efficacy of live attenuated influenza vaccine in children: 
A meta-analysis of nine randomized clinical trials. Vaccine, 27, 1101-10. 
Riley, R. D., Higgins, J. P. & Deeks, J. J. 2011. Interpretation of random effects 
meta-analyses. BMJ, 342, d549. 
Robertson, S. E., Roca, A., Alonso, P., Simoes, E. A. F., Kartasasmita, C. B., 
Olaleye, D. O., Odaibo, G. N., Collinson, M., Venter, M., Zhu, Y., et al. 
2004. Respiratory syncytial virus infection: denominator-based studies in 
Indonesia, Mozambique, Nigeria and South Africa. Bulletin of the World 
Health Organization, 82, 914-22. 
Rojo, J. C., Ruiz-Contreras, J., Fernandez, M. B., Marin, M. A. & Folgueira, L. 2006. 
Influenza-related hospitalizations in children younger than three years of age. 
Pediatr Infect Dis J, 25, 596-601. 
Roxburgh, C. S. D., Youngson, G. G., Townend, J. A. & Turner, S. W. 2008. Trends 
in pneumonia and empyema in Scottish children in the past 25 years. Arch 
Dis Child, 93, 316-8. 
Rudan, I., Boschi-Pinto, C., Biloglav, Z., Mulholland, E. K. & Campbell, H. 2008. 
Epidemiology and etiology of clinical pneumonia. Bull World Health Organ, 
86, 408-416. 
Rudan, I., Lawn, J., Cousens, S., Rowe, A. K., Boschi-Pinto, C., Tomaskovic, L., 
Mendoza, W., Lanata, C. F., Roca-Feltrer, A., Carneiro, I., et al. 2005. Gaps 
in policy-relevant information on burden of disease in children: a systematic 
review. Lancet, 365, 2031-40. 
Rudan, I., Tomaskovic, L., Boschi-Pinto, C. & Campbell, H. 2004. Global estimate 
of the incidence of clinical pneumonia among children under five years of 
age. Bull World Health Organ, 82, 895-903. 
Rudenko, L. G., Lonskaya, N. I., Klimov, A. I., Vasilieva, R. I. & Ramirez, A. 1996. 
Clinical and epidemiological evaluation of a live, cold-adapted influenza 
vaccine for 3-14-year-olds. Bull World Health Organ, 74, 77-84. 
Russell, F. M., Fakakovi, T., Paasi, S., Ika, A. & Mulholland, E. K. 2009. Reduction 
of meningitis and impact on under-5 pneumonia after introducing the Hib 
vaccine in the Kingdom of Tonga. Ann Trop Paediatr, 29, 111-7. 
Ruuskanen, O., Arola, M., Putto-Laurila, A., Mertsola, J., Meurman, O., Viljanen, 
M. & Halonen, P. 1989. Acute otitis media and respiratory virus infections. 
Pediatr Infect Dis J, 8, 94-9. 
Sacarlal, J., Nhacolo, A. Q., Sigauque, B., Nhalungo, D. A., Abacassamo, F., Sacoor, 
C. N., Aide, P., Machevo, S., Nhampossa, T., Macete, E. V., et al. 2009. A 10 
year study of the cause of death in children under 15 years in Manhica, 
Mozambique. BMC Public Health, 9, 67. 
Sam, I. C., Abdul-Murad, A., Karunakaran, R., Rampal, S., Chan, Y. F., Nathan, A. 
M. & Ariffin, H. 2010. Clinical features of Malaysian children hospitalized 
with community-acquired seasonal influenza. Int J Infect Dis, 14 Suppl 3, 
e36-40. 
Samransamruajkit, R., Hiranrat, T., Chieochansin, T., Sritippayawan, S., 
Deerojanawong, J., Prapphal, N. & Poovorawan, Y. 2008. Prevalence, 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  174 
clinical presentations and complications among hospitalized children with 
influenza pneumonia. Jpn J Infect Dis, 61, 446-9. 
Schrag, S. J., Shay, D. K., Gershman, K., Thomas, A., Craig, A. S., Schaffner, W., 
Harrison, L. H., Vugia, D., Clogher, P., Lynfield, R., et al. 2006. Multistate 
surveillance for laboratory-confirmed, influenza-associated hospitalizations 
in children: 2003-2004. Pediatr Infect Dis J, 25, 395-400. 
Scott, J. A. & Hall, A. J. 1999. The value and complications of percutaneous 
transthoracic lung aspiration for the etiologic diagnosis of community-
acquired pneumonia. Chest, 116, 1716-32. 
Serfling, R. E. 1963. Methods for current statistical analysis of excess pneumonia-
influenza deaths. Public Health Rep, 78, 494-506. 
Shah, A. S., Knoll, M. D., Sharma, P. R., Moisi, J. C., Kulkarni, P., Lalitha, M. K., 
Steinhoff, M. & Thomas, K. 2009a. Invasive pneumococcal disease in Kanti 
Children's Hospital, Nepal, as observed by the South Asian Pneumococcal 
Alliance network. Clin Infect Dis, 48 S123-8. 
Shah, A. S., Nisarga, R., Ravi Kumar, K. L., Hubler, R., Herrera, G. & Kilgore, P. E. 
2009b. Establishment of population-based surveillance for invasive 
pneumococcal disease in Bangalore, India. Indian J Med Sci, 63, 498-507. 
Simmerman, J. M. & Uyeki, T. M. 2008. The burden of influenza in East and South-
East Asia: a review of the English language literature. Influenza Other Respi 
Viruses, 2, 81-92. 
Simoes, E. A. 1999. Respiratory syncytial virus infection. Lancet, 354, 847-52. 
Simonsen, L. 1999. The global impact of influenza on morbidity and mortality. 
Vaccine, 17, S3-10. 
Simonsen, L., Clarke, M. J., Schonberger, L. B., Arden, N. H., Cox, N. J. & Fukuda, 
K. 1998. Pandemic versus epidemic influenza mortality: a pattern of 
changing age distribution. J Infect Dis, 178, 53-60. 
Simonsen, L., Clarke, M. J., Williamson, G. D., Stroup, D. F., Arden, N. H. & 
Schonberger, L. B. 1997. The impact of influenza epidemics on mortality: 
introducing a severity index. Am J Public Health, 87, 1944-50. 
Simonsen, L., Reichert, T. A., Viboud, C., Blackwelder, W. C., Taylor, R. J. & 
Miller, M. A. 2005. Impact of influenza vaccination on seasonal mortality in 
the US elderly population. Arch Intern Med, 165, 265-72. 
Singleton, R. J., Bulkow, L. R., Miernyk, K., DeByle, C., Pruitt, L., Hummel, K. B., 
Bruden, D., Englund, J. A., Anderson, L. J., Lucher, L., et al. 2010. Viral 
respiratory infections in hospitalized and community control children in 
Alaska. J Med Virol, 82, 1282-90. 
Sivadon-Tardy, V., Orlikowsk, i. D., Porcher, R., Sharshar, T., Durand, M. C., 
Enouf, V., Rozenberg, F., Caudie, C., Annane, D., van der Werf, S., et al. 
2009. Guillain-Barre syndrome and influenza virus infection. Clin Infect Dis, 
48, 48-56. 
Sivadon-Tardy, V., Orlikowski, D., Rozenberg, F., Caudie, C., Sharshar, T., Lebon, 
P., Annane, D., Raphael, J. C., Porcher, R. & Gaillard, J. L. 2006. Guillain-
Barre syndrome, greater Paris area. Emerg Infect Dis, 12, 990-3. 
Smuts, H. 2008. Human coronavirus NL63 infections in infants hospitalised with 
acute respiratory tract infections in South Africa. Influenza Other Respi 
Viruses, 2, 135-8. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  175 
Steffen, C., Diop, O. M., Gessner, B. D., Hacen, M. M., Hassar, M., Katz, M. A., 
Miller, M. A., Paget, W. J., Schoub, B. D., Vernet, G., et al. 2011. Afriflu--
international conference on influenza disease burden in Africa, 1-2 June 
2010, Marrakech, Morocco. Vaccine, 29, 363-9. 
Stockton, J., Ellis, J. S., Saville, M., Clewley, J. P. & Zambon, M. C. 1998. 
Multiplex PCR for typing and subtyping influenza and respiratory syncytial 
viruses. J Clin Microbiol, 36, 2990-5. 
Straliotto, S. M., Siqueira, M. M., Muller, R. L., Fischer, G. B., Cunha, M. L. & 
Nestor, S. M. 2002. Viral etiology of acute respiratory infections among 
children in Porto Alegre, RS, Brazil. Rev Soc Bras Med Trop, 35, 283-91. 
Sun, Y. F., Fang, X. Q., He, H. X., Zhu, Q. Z., Wang, Q. & Chen, H. Y. 1992. 
Analysis of acute respiratory infections surveillance in children aged 0-4 
years old (0-4岁儿童急性呼吸道感染监测结果分析). Chinese Maternal 
and Child Health (中国妇幼保健), 7. 
Sung, R. Y., Chan, P. K., Choi, K. C., Yeung, A. C., Li, A. M., Tang, J. W., Ip, M., 
Tsen, T. & Nelson, E. A. 2008. Comparative study of nasopharyngeal 
aspirate and nasal swab specimens for diagnosis of acute viral respiratory 
infection. J Clin Microbiol, 46, 3073-6. 
Suntarattiwong, P., Sian-nork, C., Thongtipa, P., Thawatsupha, P., Kitphati, R. & 
Chotpitayasunondh, T. 2007. Influenza-associated hospitalization in urban 
Thai children. Influenza & Other Respiratory Viruses, 1, 177-82. 
Sutanto, A., Gessner, B. D., Djelantik, I., Steinhoff, M., Murphy, H., Nelson, C., 
Widjaya, A. & Arjoso, S. 2002. Acute respiratory illness incidence and death 
among children under two years of age on Lombok Island, Indonesia. Am J 
Trop Med Hyg, 66, 175-9. 
Sutmoller, F., Ferro, Z. P., Asensi, M. D., Ferreira, V., Mazzei, I. S. & Cunha, B. L. 
1995. Etiology of acute respiratory tract infections among children in a 
combined community and hospital study in Rio de Janeiro. Clin Infect Dis, 
20, 854-60. 
Tam, C. C., O'Brien, S. J. & Rodrigues, L. C. 2006. Influenza, Campylobacter and 
Mycoplasma infections, and hospital admissions for Guillain-Barre 
syndrome, England. Emerg Infect Dis, 12, 1880-7. 
Taubenberger, J. K., Reid, A. H., Lourens, R. M., Wang, R., Jin, G. & Fanning, T. G. 
2005. Characterization of the 1918 influenza virus polymerase genes. Nature, 
437, 889-93. 
Templeton, K. E., Scheltinga, S. A., Beersma, M. F., Kroes, A. C. & Claas, E. C. 
2004. Rapid and sensitive method using multiplex real-time PCR for 
diagnosis of infections by influenza a and influenza B viruses, respiratory 
syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol, 42, 
1564-9. 
Thomazelli, L. M., Vieira, S., Leal, A. L., Sousa, T. S., Oliveira, D. B., Golono, M. 
A., Gillio, A. E., Stwien, K. E., Erdman, D. D. & Durigon, E. L. 2007. 
Surveillance of eight respiratory viruses in clinical samples of pediatric 
patients in southeast Brazil. J Pediatr (Rio J), 83, 422-8. 
Thompson, M. G., Shay, D. K., Zhou, H., Bridges, C. B., Cheng, P. Y., Burns, E., 
Bresee, J. S. & Cox, N. J. 2010. Estimates of deaths associated with seasonal 
influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep, 59, 
1057-62. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  176 
Thompson, S. G. & Pocock, S. J. 1991. Can meta-analyses be trusted? Lancet, 338, 
1127-30. 
Thompson, W. W., Comanor, L. & Shay, D. K. 2006. Epidemiology of seasonal 
influenza: use of surveillance data and statistical models to estimate the 
burden of disease. J Infect Dis, 194 Suppl 2, S82-91. 
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Bridges, C. B., Cox, N. 
J. & Fukuda, K. 2004. Influenza-associated hospitalizations in the United 
States. JAMA, 292, 1333-40. 
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. 
J. & Fukuda, K. 2003. Mortality associated with influenza and respiratory 
syncytial virus in the United States. JAMA, 289, 179-86. 
Togashi, T., Matsuzono, Y., Narita, M. & Morishima, T. 2004. Influenza-associated 
acute encephalopathy in Japanese children in 1994-2002. Virus Res, 103, 75-
8. 
Tornheim, J. A., Manya, A. S., Oyando, N., Kabaka, S., Breiman, R. F. & Feikin, D. 
R. 2007. The epidemiology of hospitalized pneumonia in rural Kenya: the 
potential of surveillance data in setting public health priorities. Int J Infect 
Dis, 11, 536-43. 
Treanor, J. J. & Szilagyi, P. 2013. Influenza Vaccine - Glass half full or half empty? 
Clin Infect Dis. 
Tsolia, M. N., Logotheti, I., Papadopoulos, N. G., Mavrikou, M., Spyridis, N. P., 
Drossatou, P., Kafetzis, D., Konstantopoulos, A. & Outpatient Flu Study, G. 
2006. Impact of influenza infection in healthy children examined as 
outpatients and their families. Vaccine, 24, 5970-6. 
Tsolia, M. N., Psarras, S., Bossios, A., Audi, H., Paldanius, M., Gourgiotis, D., 
Kallergi, K., Kafetzis, D. A., Constantopoulos, A. & Papadopoulos, N. G. 
2004. Etiology of community-acquired pneumonia in hospitalized school-age 
children: evidence for high prevalence of viral infections. Clin Infect Dis, 39, 
681-6. 
Tsung, L. Y., Choi, K. C., Nelson, E. A., Chan, P. K. & Sung, R. Y. 2010. Factors 
associated with length of hospital stay in children with respiratory disease. 
Hong Kong Med J, 16, 440-6. 
Tupasi, T. E., de Leon, L. E., Lupisan, S., Torres, C. U., Leonor, Z. A., Sunico, E. S., 
Mangubat, N. V., Miguel, C. A., Medalla, F. & Tan, S. T. 1990. Patterns of 
acute respiratory tract infection in children: a longitudinal study in a 
depressed community in Metro Manila. Rev Infect Dis, 12 S940-9. 
United Nations Children's Fund 2012. The State of the World's Children 2012. New 
York: UNICEF. 
van der Sluijs, K., van der Poll, T., Lutter, R., Juffermans, N. P. & Schultz, M. J. 
2010. Bench-to-bedside review: bacterial pneumonia with influenza - 
pathogenesis and clinical implications. Crit Care, 14, 219. 
van Gageldonk-Lafeber, A. B., Bogaerts, M. A. H., Verheij, R. A. & van der Sande, 
M. A. B. 2009. Time trends in primary-care morbidity, hospitalization and 
mortality due to pneumonia. Epidemiol Infect, 137, 1472-8. 
Vellozzi, C., Burwen, D. R., Dobardzic, A., Ball, R., Walton, K. & Haber, P. 2009. 
Safety of trivalent inactivated influenza vaccines in adults: background for 
pandemic influenza vaccine safety monitoring. Vaccine, 27, 2114-20. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  177 
Venter, M., Lassauniere, R., Kresfelder, T. L., Westerberg, Y. & Visser, A. 2011. 
Contribution of common and recently described respiratory viruses to annual 
hospitalizations in children in South Africa. J Med Virol, 83, 1458-68. 
Vesikari, T., Pellegrini, M., Karvonen, A., Groth, N., Borkowski, A., O'Hagan, D. T. 
& Podda, A. 2009. Enhanced immunogenicity of seasonal influenza vaccines 
in young children using MF59 adjuvant. Pediatr Infect Dis J, 28, 563-71. 
Viboud, C., Alonso, W. J. & Simonsen, L. 2006. Influenza in tropical regions. PLoS 
Med, 3, e89. . 
Vicente, D., Montes, M., Cilla, G., Perez-Yarza, E. G. & Perez-Trallero, E. 2003. 
Hospitalization for respiratory syncytial virus in the paediatric population in 
Spain. Epidemiol Infect, 131, 867-72. 
Viegas, M., Barrero, P. R., Maffey, A. F. & Mistchenko, A. S. 2004. Respiratory 
viruses seasonality in children under five years of age in Buenos Aires, 
Argentina: a five-year analysis. J Infect, 49, 222-8. 
Waddington, C. S., Walker, W. T., Oeser, C., Reiner, A., John, T., Wilkins, S., 
Casey, M., Eccleston, P. E., Allen, R. J., Okike, I., et al. 2010. Safety and 
immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted 
whole virion H1N1 influenza vaccine in UK children aged 6 months-12 
years: open label, randomised, parallel group, multicentre study. BMJ, 340, 
c2649. 
Walter, E. B., Rajagopal, S., Zhu, Y., Neuzil, K. M., Fairchok, M. P. & Englund, J. 
A. 2010. Trivalent inactivated influenza vaccine (TIV) immunogenicity in 
children 6 through 23 months of age: do children of all ages respond equally? 
Vaccine, 28, 4376-83. 
Wang, L., Dong, S. P., Zhao, G. Z. & Li, J. S. 1997. Promoting standard case 
management of acute respiratory infections to reduce mortality in children 
aged 0-4 years old (推广儿童急性呼吸道感染标准病例管理降低0-4岁儿
童死亡率). Chinese Journal of Primary Health Care (中国初级卫生保健), 
11. 
Watt, J. P., Wolfson, L. J., O'Brien, K. L., Henkle, E., Deloria-Knoll, M., McCall, 
N., Lee, E., Levine, O. S., Hajjeh, R., Mulholland, K., et al. 2009. Burden of 
disease caused by Haemophilus influenzae type b in children younger than 5 
years: global estimates. Lancet, 374, 903-11. 
Weber, M. W., Milligan, P., Sanneh, M., Awemoyi, A., Dakour, R., Schneider, G., 
Palmer, A., Jallow, M., Oparaogu, A., Whittle, H., et al. 2002. An 
epidemiological study of RSV infection in the Gambia. Bull World Health 
Organ, 80, 562-568. 
Weber, M. W., Mulholland, E. K. & Greenwood, B. M. 1998. Respiratory syncytial 
virus infection in tropical and developing countries. Trop Med Int Health, 3, 
268-80. 
Weigl, J. A., Puppe, W., Belke, O., Neus, J., Bagci, F. & Schmitt, H. J. 2005a. 
Population-based incidence of severe pneumonia in children in Kiel, 
Germany. Klin Padiatr, 217, 211-9. 
Weigl, J. A. I., Puppe, W., Belke, O., Neususs, J., Bagci, F. & Schmitt, H. J. 2005b. 
The descriptive epidemiology of severe lower respiratory tract infections in 
children in Kiel, Germany. Klin Padiatr, 217, 259-67. 
Weinberg, G. A., Hall, C. B., Iwane, M. K., Poehling, K. A., Edwards, K. M., 
Griffin, M. R., Staat, M. A., Curns, A. T., Erdman, D. D., Szilagyi, P. G., et 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  178 
al. 2009. Parainfluenza virus infection of young children: estimates of the 
population-based burden of hospitalization. J Pediatr, 154, 694-9. 
WHO. 2010. Pandemic (H1N1) 2009 [Online]. Geneva: World Health Organization. 
Available: http://www.who.int/csr/disease/swineflu/en/index.html [Accessed 
18 August, 2010 2010]. 
WHO Global Influenza Programme 2012. WHO Interim Global Epidemiological 
Surveillance Standards for Influenza (July 2012). Geneva: World Health 
Organization. 
Williams, E. J., Thorson, S., Maskey, M., Mahat, S., Hamaluba, M., Dongol, S., 
Werno, A. M., Yadav, B. K., Shah, A. S., Kelly, D. F., et al. 2009. Hospital-
based surveillance of invasive pneumococcal disease among young children 
in urban Nepal. Clin Infect Dis, 48 S114-22. 
Williams, P., Gracey, M. & Smith, P. 1997. Hospitalization of aboriginal and non-
aboriginal patients for respiratory tract diseases in Western Australia, 1988-
1993. Int J Epidemiol, 26, 797-805. 
Wolf, D. G., Greenberg, D., Kalkstein, D., Shemer-Avni, Y., Givon-Lavi, N., Saleh, 
N., Goldberg, M. D. & Dagan, R. 2006. Comparison of human 
metapneumovirus, respiratory syncytial virus and influenza A virus lower 
respiratory tract infections in hospitalized young children. Pediatr Infect Dis 
J, 25, 320-4. 
Wolf, D. G., Greenberg, D., Shemer-Avni, Y., Givon-Lavi, N., Bar-Ziv, J. & Dagan, 
R. 2010. Association of human metapneumovirus with radiologically 
diagnosed community-acquired alveolar pneumonia in young children. J 
Pediatr, 156, 115-20. 
Wong, C. M., Chan, K. P., Hedley, A. J. & Peiris, J. S. M. 2004. Influenza-associated 
mortality in Hong Kong. Clin Infect Dis, 39, 1611-1617. 
Wong, C. M., Yang, L., Chan, K. P., Leung, G. M., Chan, K., Guan, Y., Lam, T., 
Hedley, A. & Peiris, J. S. 2006. Influenza-associated hospitalization in a 
subtropical city. PLoS Med, 3, e121. . 
World Health Organisation 2011. Report of the second WHO Consultation on the 
Global Action Plan for Influenza Vaccines (GAP). Geneva, Switzerland: 
World Health Organisation. 
World Health Organization 1991. Technical bases for the WHO recommendations on 
the management of pneumonia in children at first-level health facilities. 
Geneva: World Health Organization. 
World Health Organization 2008. Global burden of disease 2004 Update Geneva: 
World Health Organization. 
World Health Organization 2012. Vaccines against influenza- WHO position paper- 
November 2012. In: Immunization Vaccines and Biologicals (ed.). Geneva: 
World Health Organization. 
Wu, P., Chang, I., Tsai, F., Hsieh, Y., Shao, P., Chang, L. & Huang, L. 2009. 
Epidemiology and impacts of children hospitalized with pneumonia from 
1997 to 2004 in Taiwan. Pediatr Pulmonol, 44, 162-166. 
Xie, S. M., Chen, L., Hou, Y. J., Zhen, S. Y. & Yu, Q. 1993. Analysis of acute 
respiratory infections surveillance in 3097 children aged 0-4 years old (0-4岁
小儿急性呼吸道感染监测3097例分析). Chongqing Medical Journal 重庆
医学, 22. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  179 
Xu, G. L., Zheng, J. Y., Li, L. X., Wei, Y. H. & Cai, Z. L. 2000. Analysis of acute 
respiratory infections monitoring in children under 5 years in Huaning, 
Yunnan (云南省华宁县5岁以下儿童急性呼吸道感染监测分析). Maternal 
and Child Health (妇幼保健), 14. 
Ye, Y., Zulu, E., Mutisya, M., Orindi, B., Emina, J. & Kyobutungi, C. 2009. 
Seasonal pattern of pneumonia mortality among under-five children in 
Nairobi's informal settlements. Am J Trop Med Hyg, 81, 770-5. 
Yoo, Y., Sohn, J. W., Park, D. W., Kim, J. Y., Shin, H. K., Lee, Y., Choung, J. T., 
Lee, C. K. & Kim, M. J. 2007. Clinical evaluation of the SD Bioline 
influenza virus antigen test for rapid detection of influenza viruses A and B in 
children and adults during the influenza season. Clin Vaccine Immunol, 14, 
1050-2. 
Yorita, K. L., Holman, R. C., Sejvar, J. J., Steiner, C. A. & Schonberger, L. B. 2008. 
Infectious disease hospitalizations among infants in the United States. 
Pediatrics, 121, 244-52. 
Yoshida, L. M., Suzuki, M., Yamamoto, T., Nguyen, H. A., Nguyen, C. D., Nguyen, 
A. T., Oishi, K., Vu, T. D., Le, T. H., Le, M. Q., et al. 2010. Viral pathogens 
associated with acute respiratory infections in central vietnamese children. 
Pediatr Infect Dis J, 29, 75-7. 
Zaman, K., Baqui, A. H., Yunus, M., Sack, R. B., Bateman, O. M., Chowdhury, H. 
R. & Black, R. E. 1997. Acute respiratory infections in children: a 
community-based longitudinal study in rural Bangladesh. Journal of Tropical 
Pediatrics, 43, 133-7. 
Zaman, K., Roy, E., Arifeen, S. E., Rahman, M., Raqib, R., Wilson, E., Omer, S. B., 
Shahid, N. S., Breiman, R. F. & Steinhoff, M. C. 2008. Effectiveness of 
maternal influenza immunization in mothers and infants. N Engl J Med, 359, 
1555-64. 
Zambon, M. 1998. Laboratory diagnosis of influenza. In: Nicholson, K. G., Webster, 
R. G. & Hay, A. J. (eds.) Textbook of influenza. Oxford: Blackwell Science. 
Zambon, M. C., Stockton, J. D., Clewley, J. P. & Fleming, D. M. 2001. Contribution 
of influenza and respiratory syncytial virus to community cases of influenza-
like illness: an observational study. Lancet, 358, 1410-6. 
Zhang, Q., Guo, Z. & MacDonald, N. E. 2011. Vaccine preventable community-
acquired pneumonia in hospitalized children in Northwest China. Pediatr 
Infect Dis J, 30, 7-10. 
 

Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 












Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  182 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 













A1. Ethical Approval 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  184 
  
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  185 
A2. Glossary 
 
AIIMS – All India Institute of Medical Sciences 
ALRI– Acute Lower Respiratory Infections 
AMP – Agence de Médicine Préventive 
AOM – Acute Otitis Media 
ARI – Acute Respiratory Infections 
CDC – Centers for Disease Control and Prevention 
CFR – case fatality ratio 
CI– confidence interval 
DFA – Direct immunofluorescence 
DSS – Demographic Surveillance Site 
EIA – Enzyme-linked Immunoassay 
GISRS – Global Influenza Surveillance and Response System 
HA – Hemagglutinin 
HAART- Highly Active Antiretroviral Treatment 
HAI – haemagglutination inhibition 
HIV – Human Immunodeficiency Virus 
HUS – Healthcare Utilisation Survey 
ICD – International statistical classification of diseases and health related problems 
ICU – Intensive Care Unit 
IEIP – International Emerging Infections Program 
IFA – Indirect immunofluorescence 
ILI – Influenza like illness 
IMCI – Integrated Management of Childhood Illness 
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IRR – Incidence Rate Ratio 
LAIV – Live Attenuated Influenza Vaccines 
MOH – Ministry of Health 
NA – Neuraminidase 
NIC – National Influenza Centre 
PCR – Polymerase Chain Reaction 
POC – point of care 
PRISMA – preferred reporting items for systematic reviews and meta-analysis 
RFP – Request for Proposals 
RSV – Respiratory Syncytial Virus 
SARI – Severe Acute Respiratory Infections 
SAWG – Severe ALRI Working Group 
TAC – Taqman Array Card 
TAP – Technical Advisory Panel 
TIV – Trivalent Inactivated Vaccines 
URI – Upper Respiratory Infections 
WBC – white blood cells 
WHO – World Health Organization 
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3. *Influenza Vaccines/ or *Influenza A virus/ or *Influenza, Human/ or *Influenza 
A Virus, H1N1 Subtype/ 
4. exp Bronchiolitis/ or exp Bronchiolitis, Viral/ 
5. exp Respiratory Tract Diseases/ 
6. exp Respiratory Tract Infections/ or acute respiratory infections.mp. or Influenza, 
Human/ 
7. exp Pneumonia, Viral/ or *Pneumonia/ or acute lower respiratory infections.mp. 
8. exp Incidence/ 
9. exp Prevalence/ 
10. exp Morbidity/ 
11. exp Child Mortality/ or exp Infant Mortality/ or *Hospital Mortality/ or exp 
Mortality/ 
12. exp Death/ or exp "Cause of Death"/ 
13. burden.mp. 
14. (1 or 2 or 3) and (4 or 5 or 6 or 7) and (8 or 9 or 10 or 11 or 12 or 13) 
15. limit 14 to (humans and yr="1995 -Current" and ("all infant (birth to 23 months)" 




1. exp Influenza virus A/ or exp influenza/ or exp Influenza virus A H3N2/ or exp 
Influenza virus/ or exp Influenza virus A H1N1/ or exp Influenza virus B/ 
2. exp respiratory tract infection/ 
3. exp lower respiratory tract infection/ 
4. exp virus pneumonia/ or exp pneumonia/ 
5. exp bronchiolitis/ or exp viral bronchiolitis/ 
6. exp incidence/ 
7. exp prevalence/ 
8. exp morbidity/ 
9. exp mortality/ or exp childhood mortality/ or exp infant mortality/ 
10. exp death/ or exp child death/ 
11. burden.mp. 
12. 1 and (2 or 3 or 4 or 5) and (6 or 7 or 8 or 9 or 10 or 11) 





1. exp influenza A/ or exp Influenza A virus/ or exp Influenza B virus/ or exp 
influenza viruses/ or exp swine influenza A viruses/ or exp swine influenza viruses/ 
or exp influenza B/ or exp influenza/ 
2. (respiratory diseases or lower respiratory tract infections).sh. 
3. exp pneumonia/ 
4. bronchiolitis.mp. 
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5. exp incidence/ 
6. burden.mp. 
7. exp morbidity/ 
 
8. exp infant mortality/ or exp mortality/ 
9. exp death/ or exp "causes of death"/ 
10. 1 and (2 or 3 or 4) and (5 or 6 or 7 or 8 or 9) 







TI Influenza virus$ 
AND  
TI acute respiratory infection  
AND  
TI children 






TI acute respiratory infection  
AND  
TI children 
Publication year: 1995-2010 
 
Web of Science 
 
Title= (Influenza) AND Title= (Acute Respiratory Infections) OR Title= 
(Pneumonia) AND Topic=(Children) 
Time span= 1995-2010 
 






Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 












A4. Search strategy to identify studies reporting 
ALRI hospitalizations in young children 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  192 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  193 
MEDLINE 
1. exp Pneumonia/ 
2. exp Respiratory Tract Infections/ or acute lower respiratory infections.mp. 
3. acute respiratory infection$.mp. 
4. lower respiratory infection$.mp. 
5. exp Bronchiolitis/ or Bronchiolitis, Viral/ 
6. Pneumococcal Vaccines/ or Haemophilus Vaccines/ 
7. *Zinc/ 
8. Vitamin A/ 
9. exp Incidence/ 
10. disease burden.mp. 
11. exp Morbidity/ 
12. 1 or 2 or 3 or 4 or 5 
13. 6 or 7 or 8 
14. 1 and 13 
15. 9 or 10 or 11 
16. 12 or 14 
17. 15 and 16 
18. limit 17 to (yr="1990 -Current" and ("all infant (birth to 23 months)" or 
"preschool child (2 to 5 years)") and humans) 
 
EMBASE 
1. exp respiratory tract infection/ or exp lower respiratory tract infection/ or acute 
lower respiratory tract infection$.mp. or exp pneumonia/ 
2. lower respiratory infection$.mp. 
3. acute lower respiratory infection$.mp. 
4. exp BRONCHIOLITIS/ or VIRAL BRONCHIOLITIS/ 
5. exp Pneumococcus vaccine/ 
6. exp Haemophilus influenzae type b vaccine/ 
7. *ZINC/ 
8. *alpha tocopherol/ or Vitamin A.mp. 
9. exp INCIDENCE/ 
10. disease burden.mp. 
11. exp MORBIDITY/ 
12. 1 or 2 or 3 or 4 
13. 5 or 6 or 7 or 8 
14. 1 and 13 
15. 9 or 10 or 11 
16. 12 or 14 
17. 15 and 16 




1. (pneumonia or lower respiratory tract infections).sh. 
2. acute respiratory infection$.mp. 
3. exp bronchiolitis/ 
4. vaccines.sh. 
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 
  194 
5. (retinol or zinc).sh. 
6. exp incidence/ 
7. disease burden.mp. or morbidity.sh. 
8. exp children/ 
9. 1 or 2 or 3 
10. 4 or 5 
11. 9 and 10 
12. 6 or 7 
13. 9 or 11 
14. 12 and 13 
15. 8 and 14 





TI Community Acquired Pneumonia 
OR 
TI Pneumonia Virus$ 
OR 




TI Acute Lower Respiratory Infection. 
AND 
TI Children 
Limiters: 1990-2012; infants: 1 to 23 months & Child, Preschool 2-5 years 
 
WHO LIS 
Title "Pneumonia" OR title "Community acquired pneumonia" OR title "bacterial 
pneumonia" OR title "viral pneumonia" OR title "acute lower respiratory infection" 
AND title "children"  
 
LILACS 
Pneumonia [Title words] or Community Acquired Pneumonia [Title 
words] and Children [Title words]  
 
IndMED 
(Pneumonia) OR (Community acquired pneumonia) AND (Children) 
Web of Knowledge 





Pneumonia AND Child* 
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A5. Calculations for adjusting the reported 
incidence of hospitalised ALRI for the year 2002 
based on prevalence of paediatric HIV (<5 years) 
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Reported IR of hospitalised ALRI in all <5 year children (HIV pos and neg) in 
2002, Isev(2002) = 3565 per 100,000 
Prevalence of HIV in <5 year children in Soweto in 2002, Prev2002= 5.5% (Madhi 
S, personal communication) 
IR of hospitalised ALRI in HIV neg (Insev)= 2566 per 100,000 
IR of hospitalised ALRI in HIV pos (Ipsev)= 16724 per 100,000 
Isev(2002) = Ipsev + Insev     ---------------------------------------------(1) 
 
Prevalence of HIV in <5 year children (p1) in Soweto in 2008, p1 = 3.5% (Madhi 
S, personal communication) 
Thus, IR of overall hospitalised ALRI adjusting for HIV prevalence in 2008, 
Iunadjsev(2008) 
= [Ipsev x p1] + [Insev x (1-p1)] 
= Ipunadjsev(2008) + Insev(2008)  
=[16724x 0.035] + [2566 x 0.965] 
= 585.34 +2476.19 = 3061.53 
Now Ipunadjsev(2008) is a combination of IR in those who receive HAART and those 
who don’t 
Proportion of access to HAART in Soweto in 2002, Part(2002) = 9% 
Let us assume that risk of hospitalised ALRI in those who receive HAART= same 
as in HIV negative 
Risk of hospitalised ALRI in HIV positive (with HAART) = X1 
Risk of hospitalised ALRI in HIV positive (without HAART) = X2 
Incidence of hospitalised ALRI in HIV positive, Ipunadjsev(2008) 
=585.34= (9*X1) + (91*X2)  -----------------------------------------------------------(2) 
 The risk of hospitalised ALRI in HIV positive compared to HIV negative in 
placebo group = Ipsev/Insev = 6.5 
Thus, X2/X1= 6.5 
Substituting these in equation (2)  
Ipunadjsev(2008) =585.34= 9X1 + 591.5X1 = 600.5X1 
Thus, X1= 0.97 
And X2= 6.31 
 
Proportion of access to HAART in Soweto in 2008= 75% 
Substituting these values in equation (2)  
Ipadjsev(2008) = 75*0.97+25*6.31 
 =72.75+157.75 =230.5  ------------------------------------------------------------
-----(3) 
 
Substitutiting this value in equation (1) 
Isev(2008) = Ipadjsev(2008) + Insev(2008)  
=2476.19+230.5 
= 2706.7 
Incidence of hospitalised ALRI in 2008 after adjusting for HIV prevalence and 
HAART access = 2706.7 per 100,000 person years 
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A6. Questionnaire to assess perceived gaps in 
and needs for a manual to estimate influenza 
disease burden associated with seasonal 
influenza in low and middle income countries 
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WHO Project to Develop a Manual for Estimating Influenza Disease 
Burden  
Dear Sir/ Madam, 
The WHO Global Influenza Program is currently developing a manual on how to use 
existing surveillance data to produce disease burden estimates for influenza in WHO 
Member States. This manual will target healthcare planners and decision-makers of 
WHO Member States, particularly in those states with limited resources. The manual 
will aim to provide easy to use methods and techniques to estimate burden of severe 
human influenza-related respiratory disease using existing surveillance data.  It 
would be useful in a wide range of settings using different types of available data and 
is aimed at public health professionals with basic epidemiological training. We aim 
to prepare a manual which is user friendly and responsive to the needs of the end 
user.  
We would appreciate if you could please take out some of your valuable time to give 
your considered opinion on the topics we propose to include in this manual. We will 
use your feedback for developing the manual and will be pleased to share with you 
the draft and final version of the manual for comments. We will also formally 
acknowledge your contributions towards the development of the manual. 
Thanking you, 
With warm regards, 
Dr. Harish Nair  
Professor Harry Campbell 
Centre for Population Health Sciences, 
The University of Edinburgh, 
Medical School, Teviot Place, 
Edinburgh EH8 9AG 
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Influenza Disease Burden Manual Questionnaire 
 
I. Personal details: 
1. Country 
 
2. What is your job title or position? 
 
3. What is your professional qualification? 
 
4. How many years have you been working in influenza / infectious 
disease surveillance? 
Period Tick where applicable 
Less than 1 yr  
1 - 3  yrs  
3 - 6 ys  
6 – 10 yrs  
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II. Your perspective regarding a manual to estimate  influenza disease 
burden 
 
Please answer the following questions briefly so that we can understand the 
perspectives of the potential target end-users of the manual. 
 
1. Which division(s) in the Ministry of Health in your country is responsible 
for the surveillance and control of influenza? 
 





3. What data sources can you think of which could contribute to influenza 
burden estimation in your country? (Please circle appropriate options 
and give details of any other sources) 
a) Population based data from sentinel sites conducting influenza 
surveillance 
b) Data (from secondary or tertiary care hospitals) on hospitalised 
children with ALRI in whom influenza virus has been identified and a 
denominator population (for the hospital catchment area) can be estimated 
using health utilization surveys  
c) Hospital data on proportion of children hospitalised for ALRI who are 
positive for influenza virus but no denominator population for the hospital 
catchment area can be estimated 
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d) Population-based data from areas under demographic surveillance 
which are testing for influenza virus in children presenting with influenza like 
illness (ILI) and severe acute respiratory infection (SARI)  
e) Population-based data from cohort studies which are testing for 
influenza virus in children presenting with ILI and SARI 
f) Other- please specify 
 
 
g) Other- please specify 
 
 
h) Other- please specify 
 
 
4. Influenza surveillance data 
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5. What in your opinion are the gaps in the capacities to do disease burden 
estimation in your setting / country? (E.g. lack of relevant data, lack of 
influenza testing capacity, shortage of trained manpower, lack of data 







6. In the context of your country, how useful do you think would be a 
manual which would provide general guidelines for influenza disease 
burden estimation? (Please circle appropriate option and give reason why 
you think this) 
a. essential     b. very useful  c. useful    d. somewhat useful    e. not 
useful                f. can’t say 
 
7. What do you think would be the most useful aspects or elements of the 
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Please find below a draft table of contents for the manual for your perusal.  
 
Table of contents (draft) 
 
S.No Topic Page Nos. 
1 Background  
   1.1     Rationale and need for influenza burden estimate  
   1.2     Definitions of disease burden   
   1.3     Descriptions of various ways to describe burden  
2 Identifying and selecting data sources  
   2.1     Identifying the various sources of data for influenza disease  
   2.2     Critically reviewing data for quality and relevance  
   2.3     Selecting appropriate data sources   
3 Analysing identified data   
   3.1     Mapping case definitions / data to appropriate ICD codes to 
aid interpretation of data 
 
   3.2     Accounting for sampling variation  
   3.3     Utilizing data from health utilization surveys to improve 
burden estimates  
 
   3.4     Adjusting for incomplete data on case counts  
   3.5     Adjusting for incomplete data on denominator population   
4 Estimating disease burden   
   4.1     Estimating annual incidence of influenza-associated acute  
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S.No Topic Page Nos. 
1 Background  
lower respiratory infections (ALRI)  
   4.2     Estimating number of new episodes influenza-associated 
ALRI in a year 
 
   4.3     Estimating annual range of influenza-associated mortality   
5 Interpreting the data   
   5.1     Delineating influenza season  
   5.2     Relating seasonal influenza patterns to seasonal patterns in 
ALRI hospital admission 
 
   5.3     Expressing a confidence range for estimates  
   5.4     Carrying out a plausibility check with other available data  
   5.5     Looking at time trends over the years   
6 Communicating burden estimates and their interpretation  
   6.1     Communicating the results with health professionals   
   6.2     Communicating the results with policy makers and other 
government agencies 
 
   6.3     Developing strategies for appropriate use of burden 
estimates data for  health services planning and priority setting 
 
 Appendices  
        Developing local ownership for the data  
        Developing strategies for improved sharing of data with 
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Looking at the proposed table of contents, could you please answer the 
following questions specifically in relation to your country? 
 
8. Do you think this manual will be relevant in your country specific 













11. Do you think that adding a simple spread-sheet based model to help 
individual countries develop and triangulate country estimates (based on 
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12. Based on the table of contents, do you think the end-users will require 





13. If yes, what do you think will be the approximate number of persons who 
will need to be trained in your country so that the manual can be used 
routinely for influenza burden estimation? 
 
 
Please consider some other questions regarding development of the manual. 
 
14. We intend to desk-top pilot the manual in at least a couple of low and 
middle income countries before finalizing it. How useful do you think this 
would be and would you be interested in participating in this exercise? 
(Please circle most appropriate option and give reasons) 
a. essential     b. very useful  c. useful    d. somewhat useful    e. not 
useful                f. can’t say 
 
15. Do you think that the manual would require being field tested before being 
adopted globally? Would you be interested in participating in this exercise? 
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III. General comment on the content of the manual 
Attached is a draft table of contents for the manual for your perusal.  
Please tick whether you think the following sections of the manual are: 
 
 Essential Useful to 
include 
Uncertain 
about need to 
include 
Should not be 
included 











various ways to 
describe burden) 
    
Description of 
target audience 
    
Identifying the 
various 
sources of data 
for influenza  
    
Critical review 
of data for 
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 Essential Useful to 
include 
Uncertain 
about need to 
include 






data sources  
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 Essential Useful to 
include 
Uncertain 
about need to 
include 









    
Estimating 
incidence, 
number of new 
episodes and 
mortality range 
in a calendar 
year 
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 Essential Useful to 
include 
Uncertain 
about need to 
include 





over the years  
    
Presenting the 




















    
Encouraging 
data sharing 
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 Essential Useful to 
include 
Uncertain 
about need to 
include 























IV. Detailed comments 
We would appreciate your detailed comments on any of the sections which are 
listed here (e.g. what details you might think will be more relevant in your 
context, which sections may be redundant etc.). Additionally, if you feel any 
aspect relating to influenza burden estimation has been omitted please let us 
know.  
Role of seasonal influenza in the aetiology of hospitalised ALRI in young children 




Many thanks for taking the time to complete the questionnaire. Please return the 




Harish.Nair@ed.ac.uk or Essers@who.int 
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